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The reactivity of manganese centers with dioxygen and its derivatives is well known in 
nature, but the exact nature of the intermediates involved is often unclear. Synthetic manganese 
complexes have been developed to serve as models of some of these enzymatic systems and aid in 
our understanding of what factors control these important pathways. The work presented herein 
focuses on the reactivity of Mn complexes supported by pentacoordinate amide-containing ligands 
with O2, alkylhydrogenperoxide, and H2O2. These studies have resulted in the formation and 
characterization of many new intermediates, adding to the general knowledge base regarding this 
kind of reactivity. 
The dioxygen activation pathways of mononuclear MnII complexes supported by 
pentacoordinate amide-containing ligands, [MnII(dpaq)](OTf) and the sterically modified 
[MnII(dpaq2Me)](OTf), are investigated. Through titration experiments and isotopic-labeling 
studies, a change of mechanism is observed as a result of the steric modification of 
[MnII(dpaq2Me)](OTf). This highlights the use of steric effects as a means to control which 
intermediates form along dioxygen activation pathways.  
The formation and properties of two new MnIII-alkylperoxo complexes, 
[MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+, are described. These complexes were 
generated by reacting the corresponding MnII precursors with a large excess of tBuOOH at -15 °C 
in MeCN. These unstable MnIII-alkylperoxo complexes were spectroscopically characterized, and 
complementary density functional theory (DFT) calculations were also performed to gain insight 
into their bonding and structural properties.  
Additionally, the development of a new derivative of the dpaq ligand with steric 
functionalization is reported herein. The MnII and MnIII-hydroxo complexes of this ligand have 
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been both spectroscopically and structurally characterized, revealing elongated equatorial Mn-N 
bonds as a result of the steric functionalization. These new complexes react with tBuOOH at room 
temperature to generate the first room temperature-stable MnIII-alkylperoxo species. Based on the 
ability to form MnIII-alkylperoxo species from the reaction between MnIII-hydroxo species and 
alkylhydrogenperoxides, the reactivity of MnIII-hydroxo complexes with H2O2 has been 
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An Overview of the Reactivity of Mn Complexes with O2 




1.1 Introduction. The reactions of transition metal complexes with O2 or its derivatives 
have been an area of interest in regard to both biological pathways and synthetic applications.1-10 
While a majority of studies regarding this kind of reactivity have focused on Fe- and Cu-containing 
enzymes or model complexes,1-3, 10 there are also cases of Mn-containing enzymes and model 
complexes that participate in O2 activation.
4, 5 Mn-dependent enzymes react with O2 and its 
derivatives to perform a variety of  reactions, including the detoxification of reactive oxygen 
species,6-8 peroxidation of fatty acids,11-15 the biosynthesis of dexyribonucleotides,16 and the 
oxidation of water to dioxygen.17-22 The active sites of these enzymes typically consist of one or 
more Mn centers bound to histidine and carboxylate ligands and solvent (Figure 1.1). Synthetic 
systems also react with dioxygen and its derivatives, forming various intermediates capable of a 
wide range of reactions, including olefin epoxidation and the oxidation of alcohols.4, 5, 23-36  
 
Figure 1.1. Active site structures of two Mn-dependent enzymes. Left: Mn-LOX.12 Right: Mn-
RNR.37 
 
1.2 Reactivity of manganese-dependent enzymes with O2. Important examples of 
manganese-dependent enzymes that employ O2 include oxalate oxidase and oxalate decarboxylase, 
which serve to degrade toxic oxalate.38 Many fungal species produce oxalate to serve a variety of 
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functions, including pathogenesis on plant hosts and control of nutrients in the environment.39, 40 
Oxalate decarboxylase is expressed in these fungal species as a means to control oxalate 
concentration, using dioxygen to break down oxalate into formate and CO2.
40 Oxalate oxidase is 
found in plants and serves the purpose of defending against the chemical attack of the oxalate-
forming fungi.41  The products of oxalate degradation by oxalate oxidase are CO2 and H2O2, the 
latter of which the plant uses for cross-linking within the cell wall and for tissue remodeling.41, 42 
In addition to the oxalate degrading enzymes, there are two other Mn-dependent enzymes that 
utilize O2 for substrate oxidation, Mn-dependent dioxygenases (MndD) in soil bacteria and Mn-
lipoxygenases (Mn-LOX) in certain fungi, for which complete mechanisms have been proposed.4, 
5, 11-15, 43-46 The Mn-dependent dioxygenases serve to break down aromatic catechol substrates 
through a ring-opening mechanism involving the insertion of two oxygen atoms from O2.
43, 47 An 
EPR study from Hendrich et al., in which samples were prepared at different time points of the 
reaction between enzyme and O2, resulted in the observation of several intermediates along the 
MndD pathway.43 The treatment of a substrate-bound MnII center (Scheme 1.1, I) with dioxygen 
resulted in the initial observation of an EPR signal consistent with an S=5/2 system that was 
attributed to the coupling of a MnIII ion to a radical center, presumably a superoxo adduct (Scheme 
1.1, II).43  The EPR spectrum obtained proceeding the formation of this intermediate was 
consistent with the formation of an S=5/2 MnII center with significant geometric distortions.43 This 
signal was attributed to a MnII-alkylperoxo intermediate formed through the reaction of the MnIII-
superoxo species with the bound substrate molecule (Scheme 1.1, III).43 The formation of this 
intermediate is proposed to be followed by a Criegee rearrangement involving O-O bond cleavage 





Scheme 1.1.  Proposed catalytic cycle of Mn-dependent extradiol catechol dioxygenase. 
 
Mn-lipoxygenase is responsible for the hydroperoxidation of fatty acids with cis,cis-1,4-
diene motifs. The resultant peroxides serve as precursors in the biosynthesis of a class of signaling 
molecules known as eicosanoids.4, 46 The catalytic cycle is initiated by the rate-limiting abstraction 
of a hydrogen atom from a fatty acid substrate by an active-site MnIII-hydroxo adduct (Scheme 
1.2, I), resulting in the formation of a MnII-aqua species and an organic radical (II).11, 13, 45 The 
resultant organic radical reacts with dioxygen to form an alkylperoxyl radical. The final 
alkylhydroperoxide product (III) can be formed by one of two proposed pathways that diverge at 
the MnII-aqua intermediate (Scheme 1.2, A or B). One possibility is that the substrate radical could 
displace the aqua ligand and oxidize the MnII center, forming an MnIII-alkylperoxo adduct (Scheme 
2B).4 Indirect support for this mechanism comes from the X-ray crystal structure of an iron-
containing soybean lipoxygenase which shows the alkylperoxyl radical bound to the metal 
center.46 A subsequent ligand substitution reaction with water would generate the product and the 
MnIII-hydroxo resting state.4 Alternatively, proton-coupled electron transfer from the bound water 
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molecule to the alkylperoxyl radical could yield the organic product and regenerate the MnIII-
hydroxo oxidant (Scheme 1.2A).48 
 
Scheme 1.2. Proposed mechanisms for fatty acid oxidation by manganese lipoxygenase. 
Reproduced with permission from Inorg. Chem. 2018, 575, 2489-2502. Copyright 2018 American 
Chemical Society. 
 
1.3 MnIII-peroxo intermediates in Mn-superoxide dismutase. There are also examples 
of manganese-dependent enzymes in nature that are known to react with the reduced derivatives 
of O2, such as superoxide and hydrogen peroxide.
6, 7 One such class of enzymes, the manganese 
superoxide dismutases (Mn-SOD), are found in both prokaryotic and eukaryotic cells, including 
the mitochondria of humans.7, 8 These enzymes catalyze both the oxidation of superoxide to O2 
and the reduction of superoxide to H2O2 through separate reactions in which the Mn center 
alternates between reactive MnIII and MnII states.7 Under normal conditions, the reduction of 
superoxide occurs through a prompt protonation pathway (Scheme 1.3). However, under high 
concentrations of superoxide, Mn-SOD forms a product-inhibited complex (Scheme 1.3).49-51 The 
product-inhibited complex slowly re-enters the catalytic cycle through an inner-sphere pathway 




Scheme 1.3. Catalytic cycle of Mn-SOD including both the prompt protonation and inner-sphere 
mechanisms of the reduction of superoxide to H2O2.
7, 9, 49, 50, 52 
 
The product-inhibited complex is proposed to be a MnIII-peroxo adduct based on 
spectroscopic characterization.50, 51 However, the exact nature of this intermediate is a matter of 
contention. Computational studies have proposed both end-on hydroperoxo and side-on peroxo 
adducts (Figure 1.2, A and B).53-55 Regardless of protonation state, these studies all show the 
peroxo moiety bound to the metal center in between the two equatorial hisitidine residues. In 
contrast to this, a crystal-structure obtained from a H2O2 treated crystal of Escherichia coli Mn-
SOD included a side-on peroxo adduct bound to the metal center in the axial site (Figure 1.2, C).56 
 
 
Figure 1.2. Possible structures of the product-inhibited complex in Mn-SOD. A) End-on MnIII-
hydroperoxo adduct. B) Side-on MnIII-peroxo adduct geometry from computational studies. C) 




1.4 Reactivity of Mn-containing model complexes with O2. The possibility of pairing an 
earth-abundant metal like Mn with an oxidant as benign and ubiquitous as O2 is attractive, 
especially as industrial O2 activation often employs expensive precious-metal catalysts.
58 
However, examples of MnII complexes that can activate dioxygen to give isolable products are 
relatively uncommon. This lack of reactivity towards O2 is due in part to the high reduction 
potential of the MnIII/II redox couple (1.5 V vs. NHE in H2O).
59 To circumvent this shortcoming, 
electron-rich ligands have been used to modulate the redox potential of the MnII center and 
therefore facilitate O2 activation.
60 MnII systems employing these electron-rich ligand scaffolds 
perform catalytic dioxygen reduction and organic substrate oxidation using O2.
61-69 The 
mechanistic details of many of these catalysts remain unclear, due in part to the fleeting nature of 
the intermediates along these reaction pathways.60, 64, 67, 68 
An early example of O2 as an oxidant for Mn-catalyzed substrate oxidation was reported 
by Fontecave and coworkers and utilized the Mn(TPP) system (TPP = tetraphenylporphyrin).64 In 
the presence of O2, 1-methylimidazole as a co-catalyst, and acetic acid as a proton source, the 
[MnII(TPP)] catalysts performed epoxidation of cyclooctene, 2-methylhept-2-ene, cyclohexene, 
and non-1-ene, with up to 75 turnovers.64 Although impressive in coupling O2 activation with 
substrate oxidation, the mechanistic details of this system are not well understood.  
Much of the founding work in this area focused on Schiff-base ligands as a means to control 
the electronic and steric properties of the metal complexes (Figure 1.3).70 The reaction of Mn 
Schiff-base complexes with dioxygen resulted in a complex mixtures of products, possibly 
consisting of both monomeric and dimeric species. Consequently, the exact nature of all of the 
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products and the mechanistic details of O2 activation by Mn Schiff-base complexes remain 
unclear.70 
 




In one of the first reports to propose a mechanism of O2 activation by a Mn Schiff-base 
complex, Horwitz described electrocatalytic epoxidation of cyclootene, trans-2-octene, and 
cyclohexene using the [MnII(salen)] complex, which was generated electrochemically via 
reduction of [MnIII(salen)]+ (salen = N,N′-bis(salicylidene)ethylenediamine).65 On the basis of 
cyclic voltammetry, the MnII species was proposed to bind dioxygen and, with the electrochemical 
transfer of a second electron, yield a peroxomanganese(III) complex (Scheme 1.4, I). The putative 
[MnIII(O2)(salen)]
- species was proposed to react with benzoic anhydride to form a high-valent 
MnV-oxo adduct (II) that performed olefin epoxidation or allylic hydroxylation (Scheme 1.4).65 
The [MnIII(salen)]+ complex is capable of catalytic turnover under electrochemical conditions, but 




Scheme 1.4. Proposed mechanism of the electrochemical epoxidation of olefins by 
[MnIII(salen)]+.65 
 
While the systems discussed above have primarily been studied in regards to the catalytic 
ability of dioxygen-activating Mn complexes in substrate oxidation, there have also been a small 
number of MnII complexes for which mechanistic studies of O2-activation have been performed 
(Scheme 3).11, 72-79 Borovik and co-workers described a MnII complex with trianionic N4 ligation 
that reacts with O2 to form a monomeric Mn
III-hydroxo complex, with a Mn:O2 stoichiometry of 
2:1.72 Isotopic labeling experiments with 18O2 confirmed that the O atoms in the Mn
III-hydroxo 
product came solely from dioxygen. When this reaction was carried out in the presence of 1 
equivalent of PPh3, the oxygen atom transfer (OAT) product Ph3P=O was observed in 33% yield. 
Additionally, reactions in deuterated solvent yielded only the MnIII−OD complex. These 
observations support a mechanism involving the initial formation of a peroxodimanganese(III) 
species from two equivalents of the MnII complex and O2. This dimer was proposed to undergo 
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homolytic O−O bond cleavage to yield a MnIV-oxo complex that abstracts hydrogen atoms from 
solvent to generate the observed MnIII-hydroxo product (Scheme 1.5A).72 
 
Scheme 1.5. Proposed mechanisms for the reaction of MnII complexes with O2 to generate Mn
III-
hydroxo species. Ligand abbreviations are as follows: 1cyp = tris(N-
cyclopentylcarbamoylmethyl)amine; SMe2N4(6-Me-DPEN) = (E)-3-((2-(bis((6-methylpyridin-2-
yl)methyl)amino)ethyl)imino)-2-methylbutane-2-thiolate); TMSPS3 =  (2,2′,2″-trimercapto-
3,3′,3″-tris(trimethylsilyl)triphenylphosphine); LS = 2,2′-(2,2′-bipyridine-6,6′-diyl)bis(1,1′-
diphenylethanethiolate).62, 72-75, 77, 78 
 
More recently, Kovacs et al. reported a series of MnII complexes featuring N4S
- ligation 
that also reacted with O2 to give the corresponding mononuclear Mn
III-hydroxo complexes.22 
However, these systems operate with a Mn:O2 stoichiometry of 4:1, differing from that of the 
Borovik system (2:1). An X-ray diffraction structure of [MnIIIMnIII(μ-η1:η1-O2)(S
Me2N4(6-Me-
DPEN))2]
2+ confirmed the initial formation of a peroxodimanganese(III, III) species from the 
reaction of two equivalents of the five-coordinate [MnII(SMe2N4(6-Me-DPEN))]
+ complex with O2
 
(SMe2N4(6-Me-DPEN)) = (E)-3-((2-(bis((6-methylpyridin-2-yl)methyl)amino)ethyl)imino)-2-
methylbutane-2-thiolate). The decay of [MnIIIMnIII(μ-η1:η1-O2)(S
Me2N4(6-Me-DPEN))2]
2+ yielded 
the (µ-oxo)dimanganese(III, III) species [MnIIIMnIII(µ-O)(SMe2N4(6-Me-DPEN))2]
2+,20 which can 
undergo hydrolysis to generate the MnIII-hydroxo complex (Scheme 1.5B).62, 73, 75 The formation 
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of the (µ-oxo)dimanganese(III, III) species, which was also characterized by X-ray diffraction, 
suggests a mechanism where a MnIV-oxo adduct is intercepted by unreacted MnII complex, rather 
than abstracting a hydrogen atom from solvent.78  
A similar mechanism was invoked by Lee et al. for O2 activation by the 
[Mn(TMSPS3)(DABCO)]- system (TMSPS3 = (2,2′,2″-trimercapto-3,3′,3″-
tris(trimethylsilyl)triphenylphosphine) and DABCO = 1,4- diazabicyclo[2.2.2]octane).77 In this 
work, a crystallographically characterized monomeric side-on MnIV-peroxo species is formed from 
the reaction of [Mn(TMSPS3)(DABCO)]- with O2. This species is able to dimerize with additional 
[Mn(TMSPS3)(DABCO)]-, leading to the formation of a putative peroxodimanganese(III, III) 
species that is proposed to decay and form either a terminal MnIV-oxo or a bis(µ-
oxo)dimanganese(IV, IV) intermediate. This intermediate undergoes a subsequent 
comproportionation with residual MnII complex in solution to form a (µ-oxo)dimanganese(III, III) 
species.77, 79 
A subtly different mechanism of O2 activation, by a dimercapto-bridged Mn
II dimer, was 
recently proposed by Duboc et al.74, 76 In this system, O2 activation resulted in the production of a 
(µ-hydroxo)dimanganese(III, III) complex, which was characterized crystallographically. The 
initial formation of a peroxodimanganese(III, III) intermediate was proposed from the reaction of 
the MnII dimer with O2. However, instead of yielding terminal Mn
IV-oxo species upon homolytic 
O−O bond cleavage, the peroxo-bridged dimer was proposed to convert to a bis(µ-
oxo)dimanganese(IV, IV) intermediate, which was crystallographically characterized.21 The bis(µ-
oxo)dimanganese(IV, IV) complex then decayed by an intramolecular proton transfer between the 
supporting ligand and one of the bridging oxo atoms to give yields a (µ-oxo)(µ-
hydroxo)dimanganese(IV) species. Finally, the (µ-oxo)(µ-hydroxo)dimanganese(IV) species was 
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proposed to comproportionate with residual MnII dimer to give the final (µ-
hydroxo)dimanganese(III) product (Scheme 1.5C).74, 76 
Collectively, these reports highlight some central features in O2 activation by Mn
II centers. 
In all cases, a µ-peroxodimanganese(III, III) species is invoked as an early intermediate, and this 
species decays by O−O homolysis to give either mononuclear MnIV-oxo or dinuclear bis(µ-
oxo)dimanganese(IV, IV) intermediates. At this point, the paths diverge (Scheme 1.5), but isolable 
MnIII complexes are the products of all pathways, and trapping of high-valent MnIV species by 
reaction with the MnII starting complex is common. Importantly, in no pathway is the starting MnII 
complex regenerated. 
1.5 Dioxygen activation by a series of MnII complexes supported by amide-containing 
pentadentate ligands. As part of the on-going efforts to mimic the chemistry of Mn-dependent 
enzymes,23, 9 the Jackson group has reported a pair of MnII complexes supported by amide-
containing N5 ligands, [Mn
II(dpaq)](OTf) and [MnII(dpaq2Me)](OTf), that  react with O2 to yield the 
corresponding MnIII-hydroxo adducts, [MnIII(OH)(dpaq)]+ and [MnIII(OH)(dpaq2Me)]+, in 98% 
yield (Scheme 1.6, dpaq = 2-[bis(pyridin-2-ylmethyl)]amino-N-quinolin-8-yl-acetamidate and 
dpaq2Me = 2-[bis(pyridin-2-ylmethyl)]amino-N-2-methyl-quinolin-8-yl-acetamidate). These 
MnIII-hydroxide complexes can oxidize 2,2-6,6-tetramethylpiperidine-1-ol (TEMPOH), phenols, 
and xanthene through a hydrogen-atom transfer (HAT) mechanism, mimicking the reactivity of 





Scheme 1.6. [MnII(dpaq)(MeCN)]+ reacts with O2 to produce a (µ-oxo)dimanganese(III, III) 
complex that is in equilibrium with monomeric [MnIII(OH)(dpaq)]+ (top). 
[MnII(dpaq2Me)(MeCN)]+ does not show formation of a (µ-oxo)dimanganese(III, III) complex in 




Scheme 1.7. [MnIII(OH)(dpaq)]+ reacts with the weak O−H bond of TEMPOH to yield a MnII-
aqua complex and TEMPO radical. 
 
The pathway by which [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) react with dioxygen 
has not been explored. A recent report has shown that, upon dissolution of the 
[MnIII(OH)(dpaq)](OTf) salt in MeCN solution, the mononuclear MnIII-hydroxo adduct exists in a 
water-dependent equilibrium with a (µ-oxo)dimanganese(III, III) species (Scheme 1.6).81 Using 
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1H-NMR and electronic absorption spectroscopies, it was demonstrated that the addition of a small 
amount of water (440 equivalents per MnIII) to an equilibrium mixture of [MnIII(OH)(dpaq)]+ and 
[MnIIIMnIII(µ-oxo)(dpaq)2]
2+ shifts the equilibrium to favor the mononuclear MnIII-hydroxo 
species.81 This equilibrium has also been observed for complexes featuring different substituents 
in the 5-quinolinyl position of the dpaq ligand ([MnIII(OH)(dpaq5Cl)2](OTf), 
[MnIII(OH)(dpaq5OMe)2](OTf), and [Mn
III(OH)(dpaq5NO2)2](OTf)), and XRD structures of each of 
the respective [MnIIIMnIII(µ-O)(dpaq5R)2](OTf)2 complexes have been obtained (R = Cl, OMe, and 
NO2).
82 The observation of the (µ-oxo)dimanganese(III, III) complexes could be taken to suggest 
that the [MnII(dpaq5R)](OTf) complexes carry out O2 activation in a manner similar to that 
observed for the [MnII(SMe2N4(6-Me-DPEN))]
+ complex of Kovacs and co-workers (Scheme 
4B).22 Intriguingly, complementary 1H-NMR investigations studies of [MnII(dpaq2Me)](OTf) 
provided no evidence for a (µ-oxo)dimanganese(III, III) species (Scheme 1.6, bottom).81 
Presumably, the steric bulk of the 2-Me-appended quinoline moiety in dpaq2Me disfavors the 
formation of an oxo-bridged dimer. 
1.6 Reactivity of Mn-containing model complexes with reduced dioxygen derivatives. 
In addition to modeling the O2 reactivity of metalloenzymes, synthetic complexes have also been 
used to investigate the reactivity of MnII centers with reduced dioxygen derivatives. There are 
several reports of MnII complexes that react with H2O2 or superoxide to yield side-on Mn
III-peroxo  
species.83-102 The reaction between the MnII center and superoxide presumably proceeds through 
the one-electron oxidation of the metal center, much like the reactivity proposed for Mn-SOD 
under high superoxide concentration.7 The mechanism through which MnII reacts with H2O2 to 
form MnIII-peroxo complexes is currently unknown, and understanding this kind of reactivity is 
complicated by the fact that a base is sometimes, but not always, required for MnIII-peroxo 
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formation through the reaction with H2O2.
9 MnIII-peroxo complexes have been supported by both 
heme and non-heme ligand platforms, and crystal structures have been reported for several MnIII-
peroxo complexes.83-90 MnIII-peroxo complexes have been supported by a wide variety of ligands 
(Figure 1.4). These include tetradentate ligands, and ligands that are normally pentadentate 
coordinating in a tetradentate fashion (Figure 1.4).9 Additionally, both neutral and anionic ligands 
have been reported to support MnIII-peroxo adducts, leading to a wide range of structural and 
electronic properties and obscuring a general understanding of the reactivity of this class of 
complexes.9 Several of the reported MnIII-peroxo complexes are capable of performing 
nucleophilic aldehyde deformylation reactions.61, 88-92, 101-104  
 
Figure 1.4. Molecular structures of select side-on MnIII-peroxo species.85, 88, 90-92, 95, 99, 103, 105 
 
O−O bond activation of MnIII-peroxo complexes leads to the formation of various 
intermediates, including (μ-O)2Mn
IIIMnIV dimers, high valent MnIV-oxo complexes, or MnIII-
hydroxo species. Reports in which MnII complexes react with H2O2 to yield (μ-O)2Mn
IIIMnIV 
species, presumably through a MnIII-peroxo intermediate, are numerous.6, 31, 106-110 The putative 
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MnIII-peroxo species is proposed to react with residual MnII complex in solution to form a 
peroxodimanganese(II,III) intermediate that can isomerize to form the final (μ-O)2Mn
IIIMnIV 
dimer product. In support of this pathway, the O−O bonds of select MnIII-peroxo complexes have 
shown to be cleaved through reactions with MnII complexes, generating (μ-O)2Mn
IIIMnIV 
species.105, 111 The addition of [MnII(N4Py)(OTf)](OTf) to a solution of the MnIII-peroxo complex 
[MnIII(O2)(κ
4-N4Py)]+ in MeCN results in the formation of a species with electronic absorption 
features at 710 nm and 550 nm and an EPR spectrum consisting of a sixteen-line signal similar to 
that observed for previously reported (μ-O)2Mn
IIIMnIV  complexes (N4Py = N,N-bis(2-
pyridylmethyl)-N-bis(2-pyridyl)methylamine).105 An X-ray crystal structure confirmed the 
formulation of the species as [MnIIIMnIV(μ-O)2(κ
4-N4Py)2]
3+ (Scheme 1.8).105 The (μ-
O)2Mn
IIIMnIV  complex can also be formed directly through the reaction of [MnII(N4Py)(OTf)]+ 
with H2O2 in the presence of Et3N (Scheme 1.8).
105 Similar reactivity was observed for 









4-N4Py)2] (OTf )2.8(PF6)0.2 shown with thermal ellipsoids at the 
50% probability level with hydrogen atoms, solvent molecules, and counterions omitted for clarity. 
 
Cleavage of MnIII-peroxo O−O bonds has also been reported to yield other products besides 
(μ-O)2Mn
IIIMnIV species.99, 112 The [MnIII(O2)(Me2EBC)]
+ complex was formed in 60% yield from 
the reaction of [MnII(Me2EBC)(Cl)2] with 4 equivalents of KO2.
99 Under these conditions, the 
MnIII-peroxo complex thermally decays to result in the formation of a solution composed of a 
mixture of products. Through EPR analysis, this complex mixture was determined to be composed 
of a MnIV-oxo complex, a MnIII-hydroxo complex, and an unidentified MnII species.99 Based on 
these decay products, it was proposed that the thermal decay involved the reaction of residual MnII 
complex in solution with [MnIII(O2)(Me2EBC)]
+ to form an unobserved peroxodimanganese(II,III) 
species. This proposed peroxo-bridged dimer would then undergo O−O bond homolysis to 




IIIMnIV complex due to the steric effect of the methyl substituents (Scheme 1.9).99 The 
MnIV-oxo subsequently decayed to form the MnIII-hydroxo complex.  
 
 
Scheme 1.9. Proposed decay pathway of [MnIII(O2)(Me2EBC)]
+ to yield a mixture of products that 
include a MnIV-oxo species and a MnIII-hydroxo complex.99 
 
 
Adding to this, different products are also seen upon the addition of acid to MnIII-peroxo 
complexes. A solution of the [MnIII(O2)(N4O)] complex in dimethylformamide (DMF) decayed 
electrochemically in the presence of a weak acid (such as water) to generate a bis-
hydroxomanganese(III) species (Scheme 1.10).112 This report also showed that the addition of a 
strong acid like HClO4 pulled the reaction away from O−O bond activation, generating H2O2 as a 








A report from Groves and coworkers in which an aqueous solution of [MnIII(TDMImP)]Cl 
is treated with H2O2 at 25°C to form high-valent Mn
IV- or MnV-oxo complexes proposes an end-
on MnIII-hydroperoxo species as an intermediate (TDMImP = 5,10,15,20-tetrakis-(1,3-
dimethylimidazolium-2-yl)porphyrin).113 The nature of the ligand trans to the hydroperoxo ligand 
was proposed to direct whether the O−O bond of the hydroperoxo ligand decayed via homolytic 
or heterolytic cleavage.113 The formation of the end-on MnIII-hydroperoxo complex 
[MnIII(OOH)(TMC)]2+ has also been reported to occur through the reaction of a side-on MnIII-
peroxo species with HClO4 in MeCN at -40°C (Scheme 1.11). This spectroscopically characterized 
species is capable of performing both nucleophilic aldehyde deformylation and electrophilic 
oxygen atom- or hydrogen atom-transfer reactions.114, 115  
 
Scheme 1.11. The protonation of [MnIII(O2)(TMC)]





1.7 Reactivity of Fe- and Mn-containing model complexes with alkylhydroperoxides. 
The properties of Mn-alkyperoxo complexes have also been studied over the last 8 years, both for 
the relevance to enzymatic pathways and as analogues to end-on MnIII-hydroperoxo complexes.116-
118 However, our understanding of these complexes remains very limited. The first synthetically 
isolated Mn-alkylperoxo complex was a MnII-alkylperoxo complex reported by Komatsuzaki and 
coworkers (Figure 1.5).116 This species was generated through the addition of 
cumenylhydroperoxide (CmOOH) to a solution of [MnII(OH)(TptBu,iPr)] (TptBu,iPr = hydrotris(3-
tert-butyl-5-iso-propyl-1-pyrazolyl)borate). Though the MnII-alkylperoxo complex was unstable 
at room temperature, a crystal structure was obtained for this MnII-alkylperoxo complex. The 
[MnII(OOCm)(TptBu,iPr)] complex was unreactive towards organic substrates.116  
 
Figure 1.5. Molecular structures of representative MnII and MnIII-alkylperoxo complexes. 
 
Kovacs and co-workers have used a series of N4S
- ligands to generate an array of MnIII-
alkylperoxo complexes generated through the reaction of MnII complexes with 1.5 equivalents of 
either tert-butylhydroperoxide (tBuOOH) or CmOOH in the presence of 2 equivalents of Et3N 
(Figure 1.5).117, 118 The MnIII-alkylperoxo complexes have all been structurally characterized by 
X-ray crystallography, and feature a donating thiolate ligand cis to the η1-alkylperoxo ligand, as 
well as two elongated Mn-N bonds cis to the alkylperoxo moiety (average distance of 2.46 Å).117, 
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118 Decreasing length of the elongated Mn-N bond correlated with increasing O−O bond length, 
consistent with electron donation from ligands giving rise to more activated O−O bonds.118 An 
analysis of the organic decay products of two MnIII-cumenylperoxo complexes provided strong 
evidence for O−O bond homolysis.118 Further evidence for decay by O−O bond cleavage was 
provided by variable-temperature kinetic studies of the decay process. Both the enthalpy (ΔH‡) 
and entropy (ΔS‡) of activation for the decay process decreased with increasing O−O distance, 
while there was no trend between the activation parameters of decay and Mn−O bond length.118 
The Mn-based decay products could not be identified, although a black precipitate was observed 
and attributed to formation of a manganese oxide. 
While our understanding of Mn-alkylperoxo complexes remains limited, the analogous Fe 
systems have been thoroughly investigated.4, 10, 119-133 These complexes are thermally unstable, and 
have only been characterized spectroscopically. The pathway that these complexes decay through 
is dependent on spin state. In computational studies of [Fe(TPA)(OHx)(OO
tBu)]x+ (TPA = tris(2-
pyridylmethyl)amine, x = 1 or 2), homolytic cleavage of the O−O bond in high-spin FeIII-
alkylperoxo complexes was calculated to be thermodynamically unfavorable, suggesting that 
Fe−O cleavage is a viable pathway for high-spin FeIII-alkylperoxo complexes.121 Likewise, Fe−O 
bond cleavage was found to be thermodynamically unfavorable for low-spin FeIII-alkylperoxo 
complexes.121 These computational findings were supported by resonance Raman studies of the 
Fe−O and O−O vibrations of both low-spin and high-spin complexes.120, 121 The low-spin FeIII-
alklyperoxo complexes were found to generally have higher energy Fe−O vibrations and lower 
energy O−O vibrations than their high-spin analogues.120, 121  Limited structural information has 
come from EXAFS analysis, but the available data also supports the difference in decay 
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mechanism between spin state.129, 131 A high-spin FeIII-alkylperoxo complex has been reported to 
have an Fe−O bond length of 1.88Å, while low-spin FeIII-alkylperoxo species exhibit Fe−O bond 
lengths around 1.76-1.78 Å.10, 120, 129, 131 Additional studies on FeIII-alkylperoxo complexes have 
shown that the nature of the ligands cis to the alkylperoxo moiety have an effect on the spin state 
of the complex.134 It was observed that methylation of the amine ligands cis to the alkylperoxo 
ligand, thereby weakening electron donation, results in a change in the spin state from a low-spin 
to a high-spin FeIII-alkylperoxo complex.134 Additionally, modification of the ligand trans to the 
alkylperoxo moiety was observed to have an effect on the Fe−O bond strength of low-spin FeIII-
alkylperoxo complexes.123 Complexes featuring strongly donating thiol ligands trans to the 
alkylperoxo ligand exhibited weak Fe−O bonds in comparison to other low-spin FeIII-alkylperoxo 
complexes.123 The strength of the O−O bond was not affected. 
Although there has been much work regarding the reactivity of Mn-containing enzymes 
and model complexes with O2 and its derivatives, there remains a gap in our understanding of the 
mechanisms through which these important reactions occur. The few mechanisms that have been 
proposed often invoke the formation of intermediates that either lack characterization or remain 
unobserved. The work presented in the following chapters was carried out in an effort to add to 
the limited knowledge regarding some of these reactive pathways. The reactivity of 
[MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) with O2 is more thoroughly explored, including 
mechanistic studies and an investigation into the effect of steric bulk on the O2 activation pathway. 
Three new MnIII-alkylperoxo complexes are reported, adding to the limited number of examples 
of this class of compounds. The reactivity of MnIII-hydroxo complexes with H2O2 is explored as a 
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Steric Control of Dioxygen Activation Pathways for MnII 





Dioxygen activation at metal centers is widespread in biology.1-4 Mn enzymes that require 
dioxygen for activity include manganese-dependent homoprotocatechuate 2,3-dioxygenase 
(HPCD),5, 6 manganese lipoxygenase,7-11 and the oxalate-degrading enzymes oxalate oxidase12, 13 
and oxalate decarboxylase.14, 15 Synthetic transition metal complexes have proven to be a valuable 
tool for understanding and modeling the reactivity observed for nature’s metalloenzymes. Much 
work has been done regarding O2 activation by Fe and Cu systems,
16, 17 but examples of MnII 
complexes that can activate dioxygen to give isolable products are relatively uncommon. Several 
of the systems that are capable of dioxygen activation perform catalytic organic substrate oxidation 
using O2.
18-26 The mechanistic details of many of these catalysts remain unclear.21, 24, 25, 27 
There have been a small number of MnII complexes for which a mechanism of dioxygen 
activation has been proposed.11, 28-31 Among these systems, it is commonly proposed that MnII 
complexes bind O2 to initially form a Mn
III-superoxo adduct that is trapped by a second MnII 
complex to generate a peroxodimanganese(III, III) species (Scheme 1).28, 29, 32 Each mechanism 
invokes O−O homolysis of the peroxodimanganese(III, III) intermediate to generate mononuclear 
MnIV-oxo adducts (Scheme 1).28, 31 These high-valent MnIV complexes serve as the point of 
divergence between the reported mechanisms.28-30 The [MnII(1cyp)]- complex reported by Borovik 
et al. invokes a hydrogen-atom transfer step, in which the proposed MnIV-oxo complex abstracts a 
hydrogen atom from solvent to give the MnIII-hydroxo product.28 The Kovacs report proposes a 
comproportionation reaction between the MnIV-oxo species and residual MnII complex in solution 
to yield a (-oxo)dimanganese(III, III) product.29, 30, 32, 33 In the presence of water, the (-




Scheme 1. Proposed mechanisms for the reaction of MnII complexes with O2 to generate Mn
III-
hydroxo species. Ligand abbreviations are as follows: 1cyp = tris(N-
cyclopentylcarbamoylmethyl)amine; SMe2N4(6-Me-DPEN) = (E)-3-((2-(bis((6-methylpyridin-2-
yl)methyl)amino)ethyl)imino)-2-methylbutane-2-thiolate) 
 
In this study, we have performed O2 titrations, substrate trapping experiments, and isotopic 
labeling studies to evaluate the O2 activation mechanisms of the [Mn
II(dpaq)](OTf) and 
[MnII(dpaq2Me)](OTf) complexes. The O2 titrations revealed that dioxygen activation by 
[MnII(dpaq)](OTf) and [MnII(dpaq2Me)]+ proceeds by different Mn:O2 stoichiometries. 
Specifically, [MnII(dpaq)](OTf) operates according to a Mn:O2 stoichiometry of 4:1 while 
[MnII(dpaq2Me)]+ operates with a Mn:O2 stoichiometry of 2:1. Dioxygen activation experiments 
for [MnII(dpaq)](OTf) in deuterated solvent showed complete formation of the unlabeled 
MnIII−OH product, suggesting that hydrogen-atom abstraction from solvent is not involved in the 
O2-activation pathway of this complex. In contrast, when the [Mn
II(dpaq2Me)](OTf) complex, 
which features a bulkier supporting ligand, was treated with dioxygen in deuterated solvent, we 
observed the MnIII−OD product, indicative of  an alternative dioxygen-activation pathway 
involving hydrogen-atom abstraction from solvent. These results demonstrate that subtle changes 






Scheme 2. [MnII(dpaq)(MeCN)]+ reacts with O2, presumably to produce a (µ-
oxo)dimanganese(III, III) complex that can be hydrolyzed by H2O and yield the monomeric 
[MnIII(OH)(dpaq)]+ (top).34 [MnII(dpaq2Me)(MeCN)]+ does not show formation of a (µ-




Materials and Instrumentation. All chemicals were used as obtained from commercial sources 
unless noted otherwise. Acetonitrile, diethyl ether, and methanol were dried and degassed using a 
PureSolv Micro solvent purification system. This drying procedure results in MeCN that, on 
average, contains 64(8) ppm (or 3.6 mM) H2O. The O2 gas used was >99% pure and further 
purified by passing through a column packed with drierite and 5 Å molecular sieves. 
[MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) were synthesized and characterized as reported 
previously.20, 35 Electronic absorption experiments were performed using a Varian Cary 50 Bio 
UV-Visible spectrophotometer. Electrospray ionization-mass spectrometry (ESI-MS) experiments 
were performed using an LCT Premier MicroMass electrospray time-of-flight instrument. 1H and 
31P NMR spectra were obtained on a Bruker DRX 400 MHz NMR spectrometer. Gas 
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chromatography-mass spectrometry (GC-MS) experiments were performed with a Quattro Micro 
GC quadrupole mass analyzer via an Agilent 6890 N gas chromatograph.  
Determination of manganese:oxidant stoichiometry in MnIII-hydroxo formation from 
[MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and O2. Solutions of [Mn
II(dpaq)](OTf) or 
[MnII(dpaq2Me)](OTf) (6 mM in MeCN) were prepared under an argon atmosphere in a glove box. 
The solutions were sealed in quartz cuvettes with pierceable septa. In a separate vial, dried MeCN 
was saturated with O2 by bubbling the gas through the solvent after running the gas through a 20 
cm column packed with drierite and 5 Å molecular sieves. Although the O2 was passed through 
drying materials, this procedure did not remove all the H2O. Karl-Fischer titrations of a 4 mL 
MeCN solution with a Mettler Toledo DL39 coulometric titrator of a MeCN solution following a 
30 minute O2 purge showed a water content of 2352(4) ppm (or 131 mM), an increase of 368% 
relative to dried MeCN. This amounts to 0.1 – 1 equivalents of H2O being introduced to the system 
in this manner. The concentration of O2 in saturated MeCN is known to be 8.1 mM at 25°C.36  
Measured amounts of saturated solvent were added to the solutions of [MnII(dpaq)](OTf) or 
[MnII(dpaq2Me)](OTf) using gastight syringes to deliver 0.1, 0.18, 0.25,  0.5, or 1 equivalents of O2 
relative to MnII concentration. This resulted in 0.1 – 1 equivalents of H2O relative to the Mn 
concentration being introduced to the system. Additionally, 400 equivalents of H2O were added to 
the solutions of [MnII(dpaq)](OTf) to ensure formation of the monomeric 
[MnIII(OH)(dpaq)](OTf).37 The reactions were monitored by electronic absorption spectroscopy at 
25°C until the spectra ceased to change (typically ~4 hours). The percent formation of 
[MnIII(OH)(dpaq)](OTf) or [MnIII(OH)(dpaq2Me)](OTf) was determined by exposing the reaction 
mixtures to additional O2 (i.e., opening the solutions to atmosphere) until full formation of the 
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MnIII-hydroxide species was achieved (~18 hours), upon which absorption spectra were obtained 
and compared to those obtained from the titrations. 
Reactions between [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and O2 in deuterated solvent. 
6 mM solutions of [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf)  in deuterated d3-MeCN were 
prepared under an inert atmosphere in a glove box. The solutions were sealed in vials with 
pierceable septa. 1 equivalent of O2 was added to the solution via measured amounts of saturated 
solvent with a gas-tight syringe. The reactions were allowed to stir overnight, and the resulting 
solutions were analyzed by ESI-MS.  
Reactions between [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and O2 in the presence of PPh3. 
6 mM solutions of [MnII(dpaq2Me)](OTf) with 50 equivalents of PPh3 in d3-MeCN were prepared. 
Excess O2 gas was added via syringe, and the reaction was allowed to stir for 3 hours at 25°C. 
Following the reaction, the solvent was removed and the organic products were dissolved in diethyl 
ether. The colorless solution was filtered through a syringe filter. Product analysis was performed 
by GC-MS and 31P NMR, and signals were compared to authentic samples of PPh3 and O=PPh3. 
Reactions between [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and O2 in the presence of 
hydrocarbon substrates. 6 mM solutions of [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf)  with 250 
equivalents of cyclohexane, cis-dimethylcylohexane, cyclooctane, or ethylbenzene in d3-MeCN 
were prepared and sealed in vials with pierceable septa. Reactions exploring the oxidation of 
toluene were carried out in a 1:1 mixture of toluene and d3-MeCN. Excess O2 gas was introduced 
to each solution via syringe, and the reactions were allowed to stir for 3 hours at 25°C. Following 
the reaction, the solutions were passed through a silica plug and eluted with 2 mL of d3-MeCN or 
deuterated chloroform. Product analysis was performed by 1H-NMR using naphthalene as an 
internal standard.  
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The oxidation of 9,10-dihydroanthracene (DHA) was performed in a similar manner by 
preparing 6 mM solutions of [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) in d3-MeCN and adding 
100 equivalents of DHA that had been dissolved in the minimal amount of dichloromethane. The 
vials were sealed with pierceable septa, excess O2 was added via syringe, and the reactions were 
allowed to stir for three hours. The reaction mixtures were passed through silica plugs and eluted 
with dichloromethane. The solvent was removed and product analysis was performed by 1H NMR 
in CDCl3 with 1,4-benzoquinone as a quantitative reference. ESI-MS experiments were also 
performed following a reaction between [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and DHA in 
the presence of 1 equivalent of O2 (delivered via saturated solvent in a gas-tight syringe) in d3-
MeCN. 
Reactions between [MnIII(OH)(dpaq)](OTf) or [MnIII(OH)(dpaq2Me)](OTf) and 9,10-
dihydroanthracene in the presence of O2. 6 mM solutions of [Mn
II(dpaq)](OTf) or 
[MnII(dpaq2Me)](OTf) in d3-MeCN were prepared, and 100 equivalents of DHA that had been 
dissolved in the minimal amount of dichloromethane was added. The vials were sealed with 
pierceable septa, excess O2 was added via syringe, and the reactions were allowed to stir for three 
hours. The reaction mixtures were passed through silica plugs and eluted with dichloromethane. 
The solvent was removed and product analysis was performed by 1H NMR in CDCl3 with 1,4-
benzoquinone as a quantitative reference. 
Reactions between [MnIII(OH)(dpaq)](OTf) or [MnIII(OH)(dpaq2Me)](OTf) and 9,10-
dihydroanthracene in the absence of O2. 6 mM solutions of [Mn
II(dpaq)](OTf) or 
[MnII(dpaq2Me)](OTf) in d3-MeCN were prepared under inert atmosphere in vials sealed with 
pierceable septa, and 100 equivalents of DHA that had been dissolved in the minimal amount of 
dichloromethane was added. The reactions were allowed to stir for three hours. The reaction 
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mixtures were passed through silica plugs and eluted with dichloromethane. The solvent was 
removed and product analysis was performed by 1H NMR in CDCl3 with 1,4-benzoquinone as a 
quantitative reference. 
Reactions between [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and excess iodosylbenzene. A 
1.5 mM solution of [MnII(dpaq)](OTf) in MeOH was prepared under an inert atmosphere in a 
glove box. The solution was transferred to a quartz cuvette and sealed with a pierceable septum. 
In a separate vial, 20 equivalents of PhIO were dissolved in minimal MeOH, and the vial was 
sealed with a pierceable septum. The PhIO solution was added to the cuvette at -40°C, and the 
reaction monitored by electronic absorption spectroscopy. 
Determination of manganese:oxidant stoichiometry in MnIII-methoxy formation from 
[MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf) and iodosylbenzene. Solutions of [MnII(dpaq)](OTf) 
or [MnII(dpaq2Me)](OTf) (2 mM in MeOH) were prepared under an argon atmosphere in a glove 
box. The solutions were sealed in quartz cuvettes with pierceable septa. In a separate vial, a 9 mM 
solution of PhIO in MeOH was prepared and sealed with a pierceable septum. Measured amounts 
of the PhIO solution were added to the solutions of [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) 
using gas tight syringes to deliver 0.1, 0.25, or 0.5 equivalents of PhIO, and the reactions were 
allowed to stir for 2 hours. After the reactions were complete, absorption spectra were obtained. 
The percent formations of [MnIII(OMe)(dpaq)]+ and [MnIII(OMe)(dpaq2Me)]+ were determined by 
adding excess PhIO (up to 1 equivalent) to the reaction cuvettes, accounting for dilution, and 
comparing the absorption spectra to those of the titrations. 
Reactions of [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) with iodosylbenzene in MeCN. 2 
mM solutions of [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf)  in MeCN were prepared under an 
argon atmosphere in a glove box. The solutions were transferred to quartz cuvettes and sealed with 
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pierceable septa. In separate vials, 0.5 equivalents of PhIO were suspended in 100 µL of MeCN 
under an argon atmosphere in a glove box. The vials were subsequently sealed with pierceable 
septa and sonicated. While monitoring via electronic absorption spectroscopy, the PhIO was 
transferred to each quartz cuvette containing the solution of [MnII(dpaq)](OTf) or 
[MnII(dpaq2Me)](OTf) using a gastight syringe, and the reactions were stirred until the spectra 
ceased to change. 1H NMR samples were prepared from similar reactions performed in deuterated 
MeCN. 2 mM solutions of [MnII(dpaq)](OTf) or [MnII(dpaq2Me)](OTf)  in deuterated MeCN were 
prepared in vials under argon atmosphere in a glove box. Solid PhIO was added to each solution 
(0.5 equivalents), which were allowed to stir for two hours. An NMR sample was prepared by 
transferring ~500 L of the solution following the reaction into an NMR tube and subsequently 
sealing the tube with a septum. 
2.3 Results and Analysis. 
Formation of [MnIII(OH)(dpaq)](OTf) from the reaction of [MnII(dpaq)](OTf) with O2. 
Titration experiments were performed to determine the Mn:O2 stoichiometry for the reaction of 
[MnII(dpaq)](OTf) and O2
 to generate the [MnIII(OH)(dpaq)](OTf) complex. A potential 
complication in these experiments is the equilibrium between [MnIII(OH)(dpaq)](OTf) and 
[MnIIIMnIII(-O)(dpaq)2]
2+ (Scheme 2).34 We addressed this complication by adding 400 
equivalents of N2-sparged H2O to each sample, based on previous investigations that demonstrated 
that the addition of 400 equivalents of water caused the equilibrium to shift such that 
[MnIII(OH)(dpaq)](OTf) is the only species observed by 1H-NMR spectroscopy.34 
As the concentration of O2 in saturated MeCN is known (8.1 mM at 25°C),36 the addition of 
O2-saturated solvent is a convenient method for accurate O2 delivery. Aliquots of MeCN solutions 




percent formation of [MnIII(OH)(dpaq)](OTf) from these experiments is shown in Figure 1 and 
Table 1 (overlay of the electronic absorption spectra collected for each aliquot is shown in Figure 
A1.1). From these data, it is evident that complete formation of [MnIII(OH)(dpaq)](OTf) is 
accomplished with  0.25 equivalents of O2




Figure 1. Plot of percent conversion to [MnIII(OH)(dpaq)](OTf) (blue markers) and 
[MnIII(OH)(dpaq2Me)](OTf) (red markers) as a function of added O2. Trend lines for 4:1 (blue 
dashes) and 2:1 (red dashes) Mn:O2 stoichiometry are shown for comparison. 
 
Table 1. Percent Conversion to MnIII-hydroxo Adducts [MnIII(OH)(dpaq)](OTf) and 
[MnIII(OH)(dpaq2Me)](OTf) Compared to Expected Yields for 4:1 and 2:1 Mn:O2 Stoichiometry. 
Equivalents 













0 0 0  0 0 
0.1 43±9 23±6  40 20 
0.18 64±12 41±11  72 36 
0.25 85±6 50±8  100 50 
0.5 87±15 95±5  100 100 




To assess the involvement of solvent in the formation of [MnIII(OH)(dpaq)](OTf) from the 
reaction of [MnII(dpaq)](OTf) with O2, we carried out the oxygenation reaction in deuterated d3-
MeCN. We observed no change in the apparent rate of formation of [MnIII(OH)(dpaq)](OTf) in 
d3-MeCN (Figure A1.2), and an ESI-MS analysis of the solution following the reaction showed 
only the presence of non-deuterated [MnIII(OH)(dpaq)](OTf) (m/z = 454.1086, calculated m/z = 
454.11, Figure 2A). An additional low-intensity peak around 455.11 m/z arises from the natural 
isotopic splitting of the compound, as illustrated by the mass spectrum of crystalline 
[MnIII(OH)(dpaq)](OTf) dissolved in d3-MeCN (Figure 2B). Thus, we observe no evidence that 
the formation of [MnIII(OH)(dpaq)](OTf) involves a HAT reaction with the solvent as the 
hydrogen-atom donor. 
As the 4:1 manganese:dioxygen stoichiometry in the reaction of [MnII(dpaq)](OTf) with O2 
could indicate the involvement of a transient MnIV-oxo species (Scheme 1B), we attempted to trap 
this putative intermediate by carrying out the oxygenation of [MnII(dpaq)](OTf) in the presence of 
PPh3, a substrate known to react with Mn
IV-oxo adducts.28, 38-40 In a typical reaction, 
[MnII(dpaq)](OTf) was treated with an excess of O2 in the presence of 50 equivalents of PPh3 in 
d3-MeCN. GC-MS experiments showed no evidence for the formation of the expected product of 




Figure 2. (A) ESI-MS data of [MnIII(OH)(dpaq)]+ from the reaction of [MnII(dpaq)](OTf) with O2 
in deuterated MeCN. (B) ESI-MS data of [MnIII(OH)(dpaq)](OTf) dissolved in deuterated MeCN. 
(C) ESI-MS data for [MnIII(OD)(dpaq2Me)]+ and [MnIII(OH)(dpaq2Me)]+ from the reaction of 
[MnII(dpaq2Me)](OTf) with O2 in deuterated MeCN. (D) ESI-MS data for 
[MnIII(OH)(dpaq2Me)](OTf)  dissolved in deuterated MeCN. 
 
We also attempted to trap a putative MnIV-oxo intermediate by performing the oxygenation of 
[MnII(dpaq)](OTf) in the presence of various hydrocarbons, which can react with a putative MnIV-
oxo intermediate by a hydrogen-atom transfer mechanism.39-45 For these experiments, 
[MnII(dpaq)](OTf) was incubated with an excess of O2 in the presence of 250 equivalents of the 
substrates in deuterated MeCN for 3hours. Oxygenation experiments in the presence of 
40 
 
cyclohexane, cis-dimethylcylohexane, cyclooctane, toluene, and ethylbenzene resulted in no 
detection of oxidized organic products. When 100 equivalents of DHA, which has the weakest 
C−H bond dissociation free energy of this series, was used as the substrate, the formation of 3 
equivalents of anthracene, 13 equivalents of anthrone, 2 equivalents of anthraquinone, and 8 
equivalents of 9,10-dihydroanthracen-9-ol was observed by 1H NMR spectroscopy (Figure A1.3). 
In total, 26 equivalents of DHA were consumed during the oxygenation reaction (Table A1.1). 
Control experiments in which d3-MeCN solutions of DHA were stirred with excess O2 in the 
absence of MnII complex did not yield any oxidized products. However, control experiments where 
[MnIII(OH)(dpaq)]+ was treated with 100 equivalents DHA in d3-MeCN in the presence of O2 
revealed comparable formation of oxidized products (see Table A1.1), corresponding to the 
consumption of 30 equivalents of DHA. Accordingly, the DHA oxidation observed upon 
oxygenation of [MnII(dpaq)](OTf) does not necessarily provide evidence for the formation of a 
MnIV-oxo intermediate. Instead, reaction of DHA with the MnIII-hydroxo product, which can be 
regenerated by O2 oxidation of [Mn
II(dpaq)]+, could account for the observed DHA oxidation.  
 Formation of [MnIII(OH)(dpaq2Me)](OTf)  from the reaction of [MnII(dpaq2Me)](OTf) 
with O2. We have previously noted that oxygenation of [Mn
II(dpaq2Me)](OTf) is substantially 
slower than that of [MnII(dpaq)](OTf),35 and 1H-NMR investigations of 
[MnIII(OH)(dpaq2Me)](OTf) show no signals associated with a (-oxo)dimanganese(III, III) 
species, suggesting that this dimeric species is disfavored due to the bulk of the dpaq2Me ligand.34 
As such, dioxygen titration experiments were performed for solutions of [MnII(dpaq2Me)](OTf) to 
investigate the effect of the steric bulk imposed by the methyl-quinoline group on this process. 
Similar to the experiments investigating the dioxygen reactivity of [MnII(dpaq)](OTf), aliquots of 
MeCN solutions containing 0.1, 0.18, 0.25, 0.5, and 1 equivalents of O2 were added to 
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[MnII(dpaq2Me)](OTf). The percent formation of [MnIII(OH)(dpaq2Me)](OTf) from these 
experiments is shown in Figure 1 and Table 1 (overlay of the electronic absorption spectra 
collected for each aliquot is shown in Figure A1.4). In contrast to what is observed for 
[MnII(dpaq)](OTf), full formation of [MnIII(OH)(dpaq2Me)](OTf) requires the addition of 0.5 
equivalents of O2 to a solution of [Mn
II(dpaq2Me)](OTf), suggesting a different reaction pathway 
(Figure 1 and Scheme 1A). 
To further investigate the difference in mechanism observed for [MnII(dpaq2Me)](OTf), we 
performed the oxygenation reaction in d3-MeCN. As is the case for [Mn
II(dpaq)](OTf), we 
observed no change in the apparent rate of formation of [MnIII(OH)(dpaq2Me)](OTf) in d3-MeCN 
(Figure A1.5). However, an ESI-MS analysis of the product solution revealed signals at m/z of 
468.0992 and 469.1281, corresponding to [MnIII(OH)(dpaq2Me)](OTf) and 
[MnIII(OD)(dpaq2Me)](OTf), respectively, of nearly equal intensity (Figure 2C). A control 
experiment of [MnIII(OH)(dpaq2Me)](OTf) dissolved in d3-MeCN showed no ESI-MS signals 
associated with [MnIII(OD)(dpaq2Me)](OTf) (Figure 2D). The low-intensity peak around 469.13 
m/z arises from the natural isotopic splitting of the compound. Together, these observations suggest 
that the deuterium incorporation for [MnIII(OD)(dpaq2Me)](OTf) arises from a hydrogen-atom 
abstraction from d3-MeCN, although not during the rate determining step of the reaction. The 
observation of a mixture of [MnIII(OH)(dpaq2Me)](OTf) and [MnIII(OD)(dpaq2Me)](OTf)  could 
arise from ligand substitution, where a portion of the OD- ligands in [MnIII(OD)(dpaq2Me)](OTf) 
are substituted by OH- from adventitious water present in the MeCN solution.  
Substrate trapping experiments aimed to probe the formation of a MnIV-oxo intermediate upon 
oxygenation of [MnII(dpaq2Me)](OTf) produced similar results to that seen for [MnII(dpaq)](OTf). 
Oxygenation of [MnII(dpaq2Me)](OTf) in the presence of 50 equivalents of PPh3 failed to yield any 
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observable oxidized products. Oxygenation experiments in the presence of cyclohexane, cis-
dimethylcylohexane, cyclooctane, toluene, and ethylbenzene likewise resulted in no detection of 
oxidized organic products. Oxygenation of [MnII(dpaq2Me)](OTf) in the presence of DHA yielded 
3 equivalents of anthracene, 11.5 equivalents of anthrone, 7.5 equivalents of 9,10-dihydroanthran-
9-ol, and 1.6 equivalents of anthraquinone (Figure A1.6). These amounts correspond to ca. 24 
equivalents of DHA consumption during oxygenation (Table A1.1). An ESI-MS examination of a 
representative solution following the reaction of [MnII(dpaq)]+ with O2 in the presence of DHA 
showed no deuterium incorporation into the MnIII-hydroxo product, indicating that the proton of 
the hydroxo ligand is not derived from a solvent molecule under these conditions (Figure A1.7). 
When a control experiment using [MnIII(OH)(dpaq2Me)](OTf) was performed, comparable product 
formation, corresponding to 34 equivalents of DHA consumed, was observed (Table A1.1). 
Presumably, the reaction between [MnIII(OH)(dpaq2Me)]+ and DHA results in the formation of a 
MnII-aqua complex that can react with excess O2 and regenerate the Mn
III-hydroxo species.  
2.4 Discussion of O2 reactivity.  
 
Synthetic MnII systems that are capable of dioxygen activation are relatively rare, and the 
mechanisms by which these systems operate represent an emerging area of research.21, 24, 25, 27 
Mechanisms of MnII-based O2 activation proposed in separate reports are similar in the early 
steps.28-30, 32, 33, 46 It is commonly proposed that MnII complexes bind O2 to initially form a Mn
III-
superoxo adduct that is trapped by a second MnII complex to generate a peroxodimanganese(III, 
III) species (Scheme 1).28, 29, 32 Each reported mechanism subsequently invokes O−O homolysis, 
giving either two mononuclear MnIV-oxo adducts28, 31 or a bis(µ-oxo)dimanganese(IV, IV) 
complex (Scheme 1).21, 33 These high-valent Mn complexes react further to generate MnIII 
products.28-30, 32, 33, 46 The system reported by Borovik et al. includes a hydrogen-atom transfer 
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step, in which the proposed MnIV-oxo complex abstracts a hydrogen atom from a solvent molecule 
to give the MnIII-hydroxo product.28 The Kovacs, Lee, and Duboc reports all propose that the MnIV 
species (either a mononuclear MnIV-oxo adduct or a bis(µ-oxo)dimanganese(IV) complex) react 
with residual MnII complex in solution to yield (-oxo)dimanganese(III, III) products.29, 30, 32, 33 In 
certain cases, and in the presence of a suitable amount of water, the (-oxo)dimanganese(III, III) 
products can be hydrolyzed to give mononuclear MnIII-hydroxo species.19, 34 
Steric control of O2 activation pathways. Our titration experiments investigating the 
oxygenation of [MnII(dpaq)](OTf) show that this reaction occurs with a Mn:O2 stoichiometry of 
4:1. This result supports a mechanism in which a peroxodimanganese(III, III) dimer undergoes 
homolytic O−O bond cleavage to yield either a monomeric MnIV-oxo complex or a bis(µ-
oxo)dimanganese(IV) dimer. Either of these species can be sequestered by unreacted 
[MnII(dpaq)]+ in solution to form [MnIIIMnIII(µ-O)(dpaq)2]
2+. This dinuclear product has been 
previously observed and characterized by Mn K-edge X-ray absorption spectroscopy (XAS) and 
1H NMR spectroscopy.34 In the presence of sufficient concentrations of H2O, the [Mn
IIIMnIII(µ-
O)(dpaq)2]
2+ species undergoes hydrolysis to result in monomeric [MnIII(OH)(dpaq)]+ (Scheme 
3).34  This mechanism is further supported by the lack of deuterium incorporation observed during 




Scheme 3. Proposed pathways for the reactions between [MnIIdpaqR](OTf) with O2 to generate 
MnIII-hydroxo species. 
 
The pathway proposed for [MnII(dpaq)](OTf) is very similar to the mechanism proposed by 
Kovacs and coworkers for N4S
- bound MnII complexes.29, 30 In that work, the (-
oxo)dimanganese(III, III) species is proposed to form from the reaction of a MnIV-oxo intermediate 
with residual MnII complex in solution (Scheme 1B).29, 30 Similarly, a mechanism proposed by 
Duboc and coworkers suggests that a bis(µ-oxo)dimanganese(IV, IV) species undergoes a series 
of intramolecular proton transfers and a comproportionation with residual MnII complex in 
solution to yield a (µ-hydroxo)dimanganese(III, III) species (Scheme 1C).32, 46 In a system without 
acidic protons available from the ligand, one can envision a pathway along which the bis(µ-
oxo)dimanganese(IV, IV) intermediate reacts with residual MnII complex in solution to form a (µ-
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oxo)dimanganese(III, III) species (Scheme 4). Such a mechanism has been proposed for the 
reaction of MnII(SALPRN) with O2 (SALPRN = l,3-bis(salicylideneamino)propane).
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Scheme 4. A bis(µ-oxo)dimanganese(IV, IV) dimer could react with MnII complex in solution to 
form a (-oxo)dimanganese(III, III) species through a tetranuclear intermediate. 
 
O2 titration experiments for the bulkier [Mn
II(dpaq2Me)](OTf) complex show that dioxygen 
activation proceeds with a 2:1 Mn:O2 stoichiometry, and deuterium incorporation is observed in a 
deuterated solvent. Compared to [MnII(dpaq)](OTf), these results suggest a divergent mechanism 
in which a MnIV-oxo intermediate (either a terminal oxo or a bis(µ-oxo)dimanganese(IV, IV) 
species) abstracts a hydrogen-atom from solvent (Scheme 3).  
Mononuclear Oxomanganese(IV) versus dinuclear bis(-oxo)dimanganese(IV, IV) 
intermediates. The formation of [MnIII(OD)(dpaq2Me)]+ from oxygenation of 
[MnII(dpaq2Me)](OTf) in d3-MeCN is consistent with hydrogen-atom abstraction from solvent by 
a high-valent oxomanganese(IV) intermediate. Our proposed mechanism for O2 activation for 
[MnII(dpaq)](OTf) also requires the formation of an oxomanganese(IV) intermediate (Scheme 3). 
In either system, it is unclear whether the proposed high-valent intermediate is a mononuclear 
MnIV-oxo adduct or a bis(µ-oxo)dimanganese(IV, IV) species. The formation of a bis(µ-
oxo)dimanganese(IV, IV) intermediate would likely require the dissociation of an arm of the dpaqR 
ligand to retain hexacoordination at the Mn center (Scheme 3). Thus, in the hypothetical 
[MnIVMnIV(-oxo)2(dpaqR)2]2+ species, the dpaqR ligand would be bound in a tetradentate (4) 
fashion, rather than the commonly observed pentadentate (5) mode. The 4 binding of potentially 
46 
 
pentadentate ligands has been observed in the XRD structures of dimanganese complexes with 
two bridging oxo ligands. Specifically, the XRD structures of [MnIIIMnIV(µ-O)2(N4Py)2]
3+, 
[MnIVMnIV(μ-O)2(bpmg)2](ClO4)2, and [Mn
IVMnIV(μ-O)2(mcbpen)2](ClO4)2 each show nominally 
pentadentate ligand bound in a 4 mode with non-coordinated pyridine moiety (N4Py = N,N-bis(2-
pyridylmethyl)-N-bis(2-pyridyl)methylamine, bpmg = d 2-[[2-[bis(pyridin-2-ylmethyl)amino]- 
ethyl](methyl)amino]acetic acid, mcbpen = N-methyl-N0 - carboxymethyl-N,N0 -
bis(pyridylmethyl)ethane-1,2-diamine).48, 49 Tetradentate binding of the dpaq ligand has been 
previously proposed for the [MnIIIMnIV(µ-O)(dpaq)2]3+ complex, which was generated from the 
reaction between [MnIII(OH)(dpaq)]+ and H2O2.
50 Although a crystal structure of this bis(µ-
oxo)dimanganese(III, IV) complex was not reported, a DFT-optimized structure showed a non-
coordinated quinoline moiety.50 The reaction of [MnIIIMnIV(µ-O)(dpaq)2]3+ with phenolic 
substrates generated the monomeric [MnIII(OH)(dpaq)]+ complex in quantitative yield, where the 
dpaq ligand is again pentadentate.50 These results suggest that the dpaq ligand can alternate 
between pentadentate and tetradentate binding modes without decordinating fully from the Mn 
center. This flexibility could allow for the formation of bis(µ-oxo)dimanganese(III, IV) 
intermediate en route to (µ-oxo)dimanganese(III, III) or hydroxomanganese(III) products (Scheme 
3).  
Alternatively, a terminal MnIV-oxo adduct could serve as the high-valent intermediate formed 
during oxygenation of [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf). A recent report has proposed 
that iodosylbenzene oxidation of [MnIII(OH)(dpaq)]+ in the presence of the redox-inactive Lewis 
acid salts (such as Sc(OTf)3) results in the formation of Mn
IV-oxo – Lewis acid adducts.51 EPR 
experiments provided evidence for the MnIV oxidation state. The MnIV-oxo – Lewis acid adducts 
were capable of reacting with substrates with weak C‒H bonds. Oxygenation of 
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[MnII(dpaq2Me)](OTf) appears to result in the oxidation of the strong C‒H of acetonitrile (C‒H 
bond dissociation energy of ~94 kcal mol-1).52 Given that the coordination of Lewis acids to MnIV-
oxo species can suppress reactivity towards C‒H bonds, a [MnIV(O)(dpaq2Me)]+ species formed in 
the absence of Lewis acids could be a strong oxidant. However, when the oxygenation of 
[MnII(dpaq2Me)]+ was performed in the presence of substrates with C‒H bonds weaker than that of 
MeCN (such as ethylbenzene and toluene, which have bond dissociation energies of ~86 and ~92 
kcal mol-1, respectively),53, 54 no substrate oxidation was observed. The reason for the lack of 
substrate oxidation under these conditions is unclear at present. It could be that the large excess of 
MeCN relative to substrate favors oxidation of the former. Alternatively, if a bis(µ-
oxo)dimanganese(IV, IV) intermediate is responsible for abstracting a hydrogen atom from 
MeCN, the expected steric bulk of this high-valent species could hinder the approach of substrates 
more sterically bulky than the relatively small MeCN molecule. 
2.5 Reactivity of MnII complexes with Iodosylbenzene 
Formation of [MnIII(OMe)(dpaq)]+from the reaction of [MnII(dpaq)]+ with PhIO. The 
4:1 Mn:O2 stoichiometry determined from titration experiments with O2 is consistent with a 
pathway in which a MnIV-oxo species is intercepted by unreacted MnII complex in solution. Thus, 
PhIO was explored as a shunt oxidant, as this oxo-atom transfer agent could react with 
[MnII(dpaq)]+ to afford a MnIV-oxo species directly. These reactions were carried out in MeOH 
due to the low solubility of PhIO in MeCN, and the reaction was monitored by electronic 
absorption spectroscopy at -40°C. The [MnII(dpaq)](OTf) complex retains reactivity with O2 in 
MeOH, in this case forming the MnIII-methoxy complex [MnIII(OMe)(dpaq)]+ in quantitative 
yield.55 The reaction of [MnII(dpaq)]+ with an excess of PhIO resulted in the formation of electronic 
absorption features at 510 and 760 nm (Figure 3). These electronic absorption features are 
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diagnostic of the MnIII-methoxy complex [MnIII(OMe)(dpaq)]+, which, using published extinction 
coefficients for this complex, is formed in 90% yield.55 The electronic absorption data provide no 
evidence for the formation of any intermediates before the formation of [MnIII(OMe)(dpaq)]+ 
(Figure 3). The formation of a monomeric MnIII product from the reaction of a MnII precursor with 
PhIO was observed previously by Stack and co-workers. In that case, a MnII complex of the neutral 
N5 ligand PY5 (2,6-bis(bis(2-pyridyl)methoxymethane)- pyridine), [Mn
II(PY5)(H2O)]
2+, reacted 
with PhIO in MeCN at 25°C to generate the [MnIII(PY5)(OH)]2+ complex).56  
 
Figure 3. Electronic absorption spectra following the reaction between a 1.5 mM solution of 




The Mn:PhIO stoichiometry for the formation of [MnIII(OMe)(dpaq)]+ from [MnII(dpaq)]+ 
and PhIO  was determined by adding various amounts of PhIO and determining the extent of 
[MnIII(OMe)(dpaq)]+ formation. Under the assumption that [MnII(dpaq)]+ reacts with PhIO to form 
an unobserved [MnIV(O)(dpaq)]+ intermediate, titrations of [MnII(dpaq)]+ with PhIO could result 
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in one of two Mn:PhIO stoichiometries. If the MnIV-oxo is trapped by [MnII(dpaq)]+, then a 2:1 
Mn:PhIO stoichiometry would be observed. Alternatively, if the MnIV-oxo adduct abstracts an H-
atom to give [MnIII(OH)(dpaq)]+, then a 1:1 Mn:PhIO stoichiometry would be observed. These 
possibilities are summarized in Scheme 3.  
 
Scheme 3. Possible mechanisms for the reaction between [MnII(dpaqR)]+ with PhIO to generate 




Figure 4. Left: Plot of PhIO titration data (blue) showing percent formation of 
[MnIII(OMe)(dpaq)]+ as a function of added PhIO. Expected trend lines for 2:1 (red) and 1:1 
(green) Mn:PhIO stoichiometry are shown for comparison. Right: Electronic absorption spectra 
following the addition of sub-stoichiometric amounts of PhIO to solutions of [MnII(dpaq)]+ in 




We determined the percent formation of [MnIII(OMe)(dpaq)]+ after each addition of PhIO 
by comparing the intensity of the feature at 760 nm for the completed reaction and after further 
addition of PhIO (up to 1 equivalent total). The titration results are summarized in Table 2. 
Complete formation of [MnIII(OMe)(dpaq)]+ was observed following the addition of at least 0.5 
equivalents of PhIO (Figure 4).  
 
Table 2. Percent Formation of MnIII-methoxide Complex, [MnIII(OMe)(dpaq)]+ Compared to 















0 0 0 0 0 
0.1 23±2 26±2 20 10 
0.25 49±10 56±6 50 25 
0.5 91±12 99±1 100 50 
 
The reaction between [MnII(dpaq)]+ and PhIO in MeOH was also carried out in MeCN. 
The electronic absorption spectrum obtained following this reaction is identical to the that 
observed after the reaction of [MnII(dpaq)]+ with 0.25 equivalents of O2 (Figure 5). The 
1H NMR 
spectrum of the reaction between [MnII(dpaq)]+ and 0.5 equivalents of PhIO in deuterated MeCN 
is shown in Figure 6. The spectrum shows 28 signals over the range of -60 to 130 ppm. In the 
window of -10 to 30 ppm, there are 15 peaks that are at the same chemical shift values as those 
previously attributed to the antiferromagnetically coupled (µ-oxo)dimanganese(III) species 
[MnIIIMnIII(µ-O)(dpaq)2]2+. Three signals at 7.8, 7.4, and 7.2 ppm are assigned to phenyl iodide, 
the product of O-atom transfer from PhIO.  Outside of the window of 0 to 20 ppm, 8 lower intensity 
signals are observed that were previously assigned to the paramagnetic [MnIII(OH)(dpaq)]+ 
monomer.37 Thus, the electronic absorption and 1H NMR data provide strong evidence that both 
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PhIO and O2 oxidation of [Mn
II(dpaq)]+ result in a mixture of mononuclear MnIII-hydroxo and (-
oxo)dimanganese(III,III) species. 
 
Figure 5. Electronic absorption spectrum of the solution following the reaction of [MnII(dpaq)]+ 
with 0.25 equivalents of O2 in MeCN at 20°C (red) compared with the spectrum of the solution 
following the reaction of [MnII(dpaq)]+ with 0.5equivalents of PhIO in MeCN at 20°C (blue). 
 
 
Figure 6. 1H NMR spectra obtained following the reaction of a 2 mM solution of [MnII(dpaq)]+ 
with 0.5 equivalents of PhIO in d3-MeCN at 25°C. The asterisks mark resonances attributed to 





Reactivity of [MnII(dpaq2Me)](OTf) with PhIO. The reactivity of [Mn
II(dpaq2Me)]+ with 
PhIO was also investigated. Unexpectedly, titration experiments in MeOH revealed that the 
formation of [MnIII(OMe)(dpaq2Me)]+ from [MnII(dpaq2Me)]+ only requires 0.5 equivalents of PhIO 
(Table 2, Figure 7). This stoichiometry is indicative of a mechanism that involves dimerization 
instead of HAT from a solvent molecule (Scheme 2).  
 
Figure 7. Left: Plot of PhIO titration data (blue) showing percent formation of 
[MnIII(OMe)(dpaq2Me)]+ as a function of added PhIO. Expected trend lines for 2:1 (red) and 1:1 
(green) Mn:PhIO stoichiometry are shown for comparison. Right: Electronic absorption spectra 
following the addition of sub-stoichiometric amounts of PhIO to 2 mM solutions of 
[MnII(dpaq2Me)]+ in MeOH at 20°C.  
 
The reactivity between [MnII(dpaq2Me)]+ and PhIO was also investigated in MeCN. When 
a 2 mM solution of [MnII(dpaq2Me)]+ in MeCN was allowed to react with 0.5 equivalents of PhIO 
at 25°C, the electronic absorption spectrum of the product solution differed from that of 
[MnIII(OH)(dpaq2Me)]+ (Figure 8, blue trace). The electronic absorption spectrum featured 
broadened peaks that were shifted to higher energy than the corresponding features of 
[MnIII(OH)(dpaq2Me)]+ (Figure 8). Similarly broadened spectra have been reported for MeCN 
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solutions of equilibrium mixtures of monomeric MnIII-hydroxo complexes and dimeric (µ-
O)dimanganese(III) species.34, 57 In those cases, the addition of H2O to the equilibrium mixtures 
caused the monomeric MnIII-hydroxo complexes to be favored, resulting in the spectral features 
becoming more defined.34, 57 The addition of 250 equivalents of N2-sparged H2O to the solution 
obtained following the reaction between [MnII(dpaq2Me)]+ with 0.5 equivalents of PhIO leads to 
similar sharpening of the electronic absorption features to give a spectrum consistent with the 
formation of [MnIII(OH)(dpaq2Me)]+ in 90% yield (Figure 8, red trace). These observations support 
the titration results in suggesting a dimerization pathway for MnII oxidation by PhIO. However, 
mass spectral analysis of the MnIII product from the reaction of [MnII(dpaq2Me)]+ with 0.5 
equivalents of PhIO in d3-MeCN without the addition of water revealed a peak at m/z = 469.12, 
consistent with deuterium incorporation from a solvent molecule to form [MnIII(OD)(dpaq2Me)]+ 
(Figure 9). The observation of deuterium incorporation from solvent stands counter to a 





Figure 8. Electronic absorption spectrum following the reaction of a 2 mM solution of 
[MnII(dpaq2Me)]+ with 0.5 equivalents of PhIO in MeCN at 20°C (blue). Upon the addition of 250 
equivalents of H2O, formation of [Mn
III(OH)(dpaq2Me)]+ is observed (red trace). 
 
 
Figure 9. ESI-MS of [MnIII(OD)(dpaq2Me)]+ from the reaction between [MnII(dpaq2Me)]+ and PhIO 




Figure 10. Electronic absorption spectra showing 1 formed through the reaction of a 4 mM 
solution of [MnII(dpaq2Me)]+ with 0.5 equivalents of PhIO in d3-MeCN at 25°C (red trace) and the 
decay to form [MnIII(OH)(dpaq2Me)]+ (blue trace). 
 
A reaction between [MnII(dpaq2Me)]+ and 0.5 equivalents of PhIO was carried out at 4 mM 
in d3-MeCN at 25°C in order to prepare a sample for 1H-NMR analysis. In deuterated solvent, a 
green intermediate (intermediate 1) with a defined electronic absorption feature around 700 nm 
was observed (Figure 10). 1 decayed to form [MnIII(OH)(dpaq2Me)]+ in 99% yield over the course 
of three hours at room temperature (Figure 10).  
1H NMR analysis of the solution resulting from the reaction of [MnII(dpaq2Me)]+ with 0.5 
equivalents of PhIO in d3-MeCN shows hyperfine-shifted peaks, as well as several peaks in the 
range of 0-30 ppm of equal intensity (Figure 11). The observation of peaks corresponding to 
[MnIII(OH)(dpaq2Me)]+ is likely the result of partial decay of 1 within the timeframe of 1H NMR 
spectrum collection. Another set of lower intensity hyperfine-shifted peaks indicates that the decay 
of 1 is complicated. The set of peaks in the 0 to 30 ppm range of the spectrum indicate that 1 is an 
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antiferromagnetically coupled species. It is tempting to assign 1 as a (µ-O)dimanganese(III) 
species, based on the PhIO titration data and the diamagnetic signals in the 1H NMR spectrum. 
However, it is important to note that the peaks in the diamagnetic region bear little similarity to 
those reported for the antiferromagnetically coupled [MnIIIMnIII(µ-O)(dpaq)2]
+ complex (Figure 
11, inset).34 Additional characterization of this species, including measurement of its magnetic 
moment and the temperature dependence of its magnetic properties, will aid in the exact 
formulation of 1.  
 
Figure 11. 1H NMR spectra of [MnIII(OH)(dpaq2Me)]+ (black dashes) and a 4 mM solution of 1 
(red trace) formed by the reaction of a 4 mM solution of [MnII(dpaq2Me)]+ with 0.5 equivalents of 
PhIO in d3-MeCN at 25°C. Inset: expanded view of the -10 to 20 ppm region of the spectra of 1 
(red trace) and [MnIIIMnIII(µ-O)(dpaq)2]2+ (blue trace). 
 
2.6 Conclusion. 
Inspired by the dioxygen activating ability of some of Nature’s Mn-containing 
metalloenzymes, there has been interest in developing Mn-based synthetic catalysts that can 




complexes that are capable of dioxygen activation, and details regarding their mechanistic 
pathways are limited. In an effort to garner further mechanistic understanding of O2-activation 
processes, this report investigates two pentadentate monomeric MnII complexes that have been 
previously reported to react with O2 to produce monomeric Mn
III-hydroxo species. One of the 
complexes, [MnIIdpaq](OTf), activates dioxygen by a 4:1 Mn:O2 stoichiometry. This 
stoichiometry suggests a mechanism in which a (-oxo)dimanganese(III, III) dimer is formed 
through the comproportionation of a MnIV-oxo species (either a terminal Mn-oxo or a bis(µ-
oxo)dimanganese(IV, IV) dimer) and residual MnII complex in solution. This proposed 
comproportionation mechanism joins the majority of preceding systems described to form MnIII-
hydroxo complexes by O2 oxidation of Mn
II precursors.29-33, 46 In contrast, the bulkier 
[MnIIdpaq2Me](OTf) complex operates according to a 2:1 Mn:O2 stoichiometry, suggesting a 
mechanism where a terminal MnIV-oxo species abstracts a hydrogen atoms from solvent. In 
support, oxygenation of [MnII(dpaq2Me)](OTf) in deuterated MeCN resulted in MnIII−OD 
formation. The only other system for which a dioxygen activation mechanism involving hydrogen-
atom abstraction from solvent was reported also employed a sterically-encumbered ligand.28 Thus, 
simple steric modification of ligands may be an important approach to generate reactive, high-
valent Mn species through O2 activation. Studies investigating the oxidation of Mn
II complexes 
with PhIO reveal that the conversion of [MnII(dpaq2Me)]+ to [MnIII(OH)(dpaq2Me)]+ only requires 
0.5 equivalents of PhIO. This Mn:PhIO stoichiometry suggests a mechanism involving 
dimerization as opposed to HAT from a solvent molecule. 
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3.1 Introduction. Manganese-dependent enzymes participate in a number of biologically 
important processes, including detoxification of reactive oxygen species by manganese superoxide 
dismutase (MnSOD) and manganese catalase,1-4 oxalate degradation by oxalate oxidase and 
oxalate decarboxylase,5 and water splitting by the oxygen-evolving complex of photosystem II.6 
Peroxo-level intermediates have been invoked in the catalytic cycles of many of these enzymes, 
although only a few examples have been spectroscopically or structurally characterized.7 For 
MnSOD, a MnIII-peroxo adduct has been proposed to form under conditions of high superoxide 
concentration.1, 8-10 Intriguingly, X-ray crystallographic studies of MnSOD crystals soaked in 
hydrogen peroxide revealed a side-on peroxomanganese center in several of the enzyme active 
sites.11 On the basis of rapid-freeze-quench EPR investigations, a MnII-alkylperoxo intermediate 
has been proposed for manganese-dependent homoprotocatechuate 2,3-dioxygenase (HPCD), 
which catalyzes oxidative aromatic ring cleavage in certain bacteria.12 An analogous FeII-
alkylperoxo adduct was crystallographically characterized in the iron-dependent HPCD by using 
the slow substrate 4-nitrocatechol.13 For both the Fe- and Mn-forms of HPCD, the metal-
alkylperoxo decays by a redox reaction to facilitate the dioxygenation of the homoprotocatechuate 
substrate.  
Alkylperoxometal intermediates have also been proposed to form in the catalytic cycles of 
the iron- and manganese-dependent lipoxygenase enzymes (M-LOX; M = Fe or Mn).14, 15 LOX 
enzymes convert fatty acids with cis,cis-1,4-diene motifs to the corresponding alkylhydroperoxide 
products. In both Fe- and Mn-LOX, this process is rate-controlled by a concerted proton-electron-
transfer reaction between the fatty acid substrate and an active-site MIII-hydroxo moiety (M = Fe 
or Mn; Scheme 3.1(I)).16-18 The nascent, carbon-based substrate radical (II) subsequently reacts 
with dioxygen to form a peroxyl radical. From this point in the catalytic cycle, the 
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alkylhydroperoxide product (III) could be formed by one of several pathways (e.g., Scheme 1, A 
or B). The substrate radical could displace the aqua ligand and oxidize the MII center, forming a 
MIII-alkylperoxo adduct (Scheme 3.1B).15 This species would then undergo a ligand substitution 
reaction with water to form the product (III), and the MIII-hydroxo resting state (I). Circumstantial 
support for this pathway is provided by an X-ray crystal structure of the so-called purple soybean 
lipoxygenase, which contains an active-site FeIII-alkylperoxo unit.14 Alternatively, a proton-
coupled electron transfer (PCET) from the MII-aqua species to the substrate radical would yield 
the organic product (III), and regenerate the MIII-hydroxo oxidant (Scheme 3.1A, (I)).19 The latter 
pathway has the advantage of being more direct, and the former invokes decay of a metal-
alkylperoxo by a ligand substitution reaction, rather than a redox transformation.  
Scheme 3.1. Proposed mechanisms for fatty acid oxidation by lipoxygenase enzymes. M is either 
Fe or Mn. 
 
 
Because of their relevance to important biochemical transformations, the properties and 
reactivity of FeIII-alkylperoxo model complexes have been the subject of thorough experimental 
and theoretical investigation.20-34 There is evidence that FeIII-alkylperoxo complexes can decay by 




Significantly less is known concerning the fundamental properties and reactivity of MnIII-
alkylperoxo species. Nonetheless, the reactivity proposed for the putative MnIII-alkylperoxo 
intermediate in Mn-LOX (i.e., decay via Mn−O bond cleavage) stands in contrast to the O−O bond 
decay pathway proposed for related model complexes. Kovacs and co-workers have used a series 
of N4S
- ligands to generate an array of MnIII-alkylperoxo complexes, which have all been 
characterized structurally by X-ray crystallography.37, 38 In those model systems, an analysis of the 
organic components of the decay products of two MnIII-cumylperoxo complexes provided strong 
evidence for O−O bond homolysis.37, 38 Further evidence for decay by O−O bond cleavage was 
provided by variable-temperature kinetic studies of the decay process. Both the enthalpy (ΔH‡) 
and entropy (ΔS‡) of activation for the decay process showed a linear correlation with the O−O 
distance determined by X-ray crystallography, with a decrease in both ΔH‡ and ΔS‡ with increasing 
O−O distance.38 Unfortunately, the Mn-based products of the decay reaction could not be 
identified, although a black precipitate was observed and attributed to formation of a manganese 
oxide. 
These prior studies demonstrate the need to advance understanding of the fundamental 
properties and chemical reactivity of Mn-alkylperoxo species. Kovacs and co-workers have 
elegantly established tuning of properties through subtle modifications cis to the alkylperoxo 
ligand,37,38 and it is of interest to determine how more drastic changes in the primary coordination 
sphere could influence spectroscopic properties and reactivity. We have recently described two 
MnIII-hydroxo complexes supported by pentadentate amide containing ligands, dpaq (dpaq = 2-
[bis(pyridin-2-ylmethyl)]amino-N-quinolin-8-yl-acetamidate) and dpaq2Me (dpaq2Me = 2-
[bis(pyridin-2- ylmethyl)]amino-N-2-methyl-quinolin-8-yl-acetamidate), which are able to carry 
out PCET reactions of relevance to the Mn-LOX mechanism (Figure 1).39,40 Motivated by the 
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potential to mimic further the features of the proposed Mn-LOX mechanism, we set out to 
determine if these ligands would be able to support MnIII-alkylperoxo species.  
We report here the formation and characterization of the [MnIII(OOtBu)(dpaq)]+ and 
[MnIII(OOtBu)(dpaq2Me)]+ complexes, which contain a t-butylalkylperoxo ligand trans to the 
amide group of the supporting ligand (Figure 3.1). Spectroscopic experiments, including Mn K-
edge X-ray absorption (XAS) measurements, support the formulation of these complexes. The 
spectroscopic data are interpreted with the aid of electronic structure calculations to understand 
differences in bonding between the [MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+ 
complexes and MnIII-alkylperoxo species with cis-thiolate ligation.37-38 
 
 
Figure 3.1. MnIII-hydroxo and MnIII-alkylperoxo complexes discussed in this work, 1a = 




3.2 Experimental Methods 
Materials and Instrumentation. All chemicals were used as obtained from commercial 
sources unless noted otherwise. Acetonitrile, diethyl ether, and methanol were dried and degassed 
using a PureSolv Micro solvent purification system. [MnII(dpaq)]OTf (1), [MnII(dpaq2Me)]OTf (2), 
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[MnIII(OH)(dpaq)]OTf  (1a), and [MnIII(OH)(dpaq2Me)]OTf (2a) were synthesized and 
characterized as reported previously.39,40 The concentration of tert-butyl hydroperoxide (tBuOOH) 
in decane stock solution was found to be 4.3 M by an iodometric titration procedure.41 tBu18O18OH 
was synthesized as previously described.42 Electronic absorption spectroscopy was performed 
using a Varian Cary 50 Bio UV-Visible spectrophotometer equipped with a Unisoku cryostat and 
stirrer cooled with liquid N2. Vibrational data were obtained using a PerkinElmer Spectrum100 
FT-IR spectrometer with samples sealed in 0.1 mm gas-tight NaCl cells. ESI-MS experiments 
were performed using an LCT Premier MicroMass electrospray time-of-flight instrument. X-band 
EPR experiments were performed using a Bruker EMXplus with Oxford ESR900 continuous-flow 
liquid helium cryostat and an Oxford ITC503 temperature system. 
Formation of [MnIII(OH)(dpaqR)]+ complexes from tBuOOH and Mn(II) complexes. A 
2 mM solution of 1 in MeCN was prepared under inert atmosphere in a glovebox and transferred 
to a quartz cuvette with a stir bar and a septum. Upon cooling the solution to -15 °C, 10 equivalents 
of triethylamine (Et3N) were added. Then, 
tBuOOH diluted in MeCN to 0.043 M was added via a 
gas-tight syringe in successive aliquots of 0.12 - 0.24 equivalents, up to 1 equivalent. The reaction 
of 1 with each aliquot of tBuOOH was monitored with electronic absorption spectroscopy at -15 
°C until the spectra ceased to change, upon which the next aliquot was added. Full formation of 
the MnIII-hydroxo complex 1a was observed following the addition of 0.5 equivalents tBuOOH. 
Similar experiments monitoring the reaction of 2 with substoichiometric amounts of tBuOOH 
likewise revealed complete formation of the corresponding MnIII-hydroxo complex, 2a, following 
the addition of 0.5 equivalents tBuOOH. The percent formations of 1a and 2a were determined 
based on previously reported molar absorptivities.39,40 
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Formation of [MnIII(OOtBu)(dpaqR)]+ complexes. 2 mM solutions of 1a or 2a in MeCN 
were prepared and transferred to quartz cuvettes with stir bars and pierceable septa with 10 
equivalents of Et3N. In a typical experiment, the solution was cooled to -15 °C, and varied 
equivalencies of diluted tBuOOH in MeCN (0.43 M) were added via a gastight syringe. The 
amount of tBuOOH added was varied from 5 - 100 equivalents, and 100 equivalents were required 
to fully form [MnIII(OOtBu)(dpaq)]+ (1b) and [MnIII(OOtBu)(dpaq2Me)]+ (2b). The reaction 
mixture, maintained at -15 °C, was monitored by electronic absorption spectroscopy during each 
addition until the spectra ceased to change. An EPR sample was prepared for a solution after the 
reaction of 1a (2 mM in MeCH) with 50 equivalents of tBuOOH in the presence of Et3N. The EPR 
spectrum was collected at 20 K (9.64 GHz microwave frequency, 0.126 mW microwave power, 
0.4 mT modulation amplitude, 100 kHz modulation frequency). Spin quantification of the signal 
was determined against a 0.54 mM frozen solution of [MnIIIMnIV(-O)2(N4py)2]
+ in MeCN, 
prepared as reported previously.43 FT-IR analyses of 1b and 2b were performed by injecting the 
cold solutions directly into gastight IR cells, which had been cleaned with CH2Cl2, and 
immediately collecting spectra. FT-IR experiments of isotopically labeled complexes were carried 
out using a similar procedure that employed tBu18O18OH for the generation of 1b and 2b. Dry 
MeCN was used as a solvent background, and the IR spectrum of tBuOOH was acquired for 
comparison. At -15 °C, the complete decay of a 2 mM sample of both 1b and 2b occurred in 
approximately 2 hours after their maximum formation. The influence of base on the reactivity of 
the Mn centers with tBuOOH was evaluated by performing similar experiments to those described 
above in the absence of Et3N. The products of these reactions were monitored using electronic 
absorption spectroscopy. EPR samples of 1b and 2b (each 2 mM in Mn in MeCN), as well as their 
decay products, were prepared upon their full formation in the presence of Et3N and following 
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their full decay, respectively. EPR spectra for 1b, 2b, and their decay products were collected at 
5K (9.64 GHz microwave frequency, 0.126 mW microwave power, 0.4 mT modulation amplitude, 
100 kHz modulation frequency). The spectrum of 1b was also collected at 77 K (9.64 GHz 
microwave frequency, 5 mW microwave power, 0.1 mT modulation amplitude, 100 kHz 
modulation frequency). Spin quantification of the spectrum of 1b was determined against a 
TEMPO (2,2,6,6-tetramethylpiperidin-1-yl)oxyl) standard (9.64 GHz microwave frequency, 2 
mW microwave power, 0.4 mT modulation amplitude, 100 kHz modulation frequency). 
X-ray Absorption Data Collection and Analysis. Samples of 1a and 2a were prepared in 
MeCN (10 mM) and transferred to 2 mm pathlength cuvettes which were sealed with pierceable 
septa. Upon cooling the solution to -15 °C, 107 equivalents of tBuOOH (250 L of 4.3 M stock 
solution) were added via a gas-tight syringe. The contents of the cuvette were thoroughly mixed 
with a pipette that was pre-chilled with liquid nitrogen. Formation of 1b and 2b was monitored by 
electronic absoprtion spectroscopy. Upon full formation, the solutions were injected into sample 
holders with a Kapton tape window using a pre-cooled syringe and frozen in liquid nitrogen 
immediately. Mn K-edge XAS data were collected at SSRL Beamline 2-2. Mn K-edge X-ray 
absorption spectra were collected at 15 K over a range in energy from 6.3 to 7.25 keV using a 
Si(111) monochromator. The fluorescence excitation spectra were obtained using a 13-element Ge 
array. Spectra of manganese foil were collected with each scan as a reference and were calibrated 
by assigning the zero crossing of the second derivative of the foil K-edge energy to 6539.0 eV. 
During data collection, the rising edge of each spectrum was monitored for evidence of photo-
reduction. No photo-reduction was observed. 
XAS data reduction and averaging was carried out using the Athena program.44 A Gaussian 
function was fit to the pre-edge background and subtracted from the whole spectrum as a 
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background correction. The spectrum was then spline corrected to remove low-frequency 
background. EXAFS refinement was carried out on k3χ(k) data, using phase and amplitude 
functions obtained from FEFF, version 6,45 and structural models of 1b and 2b obtained from DFT 
geometry optimizations (vide infra). The EXAFS data were fit using the Artemis program.44 The 
average distances between Mn and scattering atoms (r) and Debye-Waller factors 2) were 
optimized for each fit, while the number of atoms in the shell (n) was kept fixed. n was 
systematically varied between fits. The threshold energy, E0, in electronvolts (k = 0 point) was 
kept at a common, variable value for every shell of a given fit. The goodness of fit was evaluated 
using the R-factor:  
𝑅 = ∑ (
𝑖
𝑑𝑎𝑡𝑎  −  
𝑖
𝑓𝑖𝑡




𝑖=1   
Electronic Structure Calculations. Density functional theory (DFT) calculations were 
carried out using the ORCA 3.0.1 software package.46 Initial coordinates for each MnIII-
alkylperoxo complex were based on crystal structure data of the respective hydroxide analogues.39-
40 The hydroxide ligands were replaced with a t-butylperoxo moiety and the resulting structure 
was subjected to unconstrained geometry optimization converged to the S = 2 spin state. In order 
to facilitate comparison with DFT computations performed for the MnIII-alkylperoxo complexes 
of Kovacs and co-workers, we used the same level of theory;38 i.e., these calculations employed 
the TPSS functional47,48 with the def2-TZVP(-f) basis set for all atoms,49 along with the resolution 
of identity (RI) approximation50 and def2-TZV/J auxiliary basis sets.49 The ZORA approximation 
was employed to account for scalar relativistic effects,51,52 and Grimme’s atom-pairwise dispersion 
correction was included.53 Acetonitrile solvation was accounted for using COSMO.54 All geometry 
optimizations were carried out with an integration grid of 7 for the Mn atom and a grid of 5 for the 
remainder of the complex. 
70 
 
Electronic absorption spectra were calculated using the time-dependent (TD)-DFT method, 
as implemented in ORCA.46 The TD-DFT calculations used the hybrid B3LYP functional55-57 with 
the Ahlrichs TZVP basis set employed for manganese and all heteroatoms, and the SVP basis set 
for carbon and hydrogen.58,59 The RIJCOSX approximation60,61 was utilized with the TZVP/J and 
SVP/J auxiliary basis sets.58,59 Acetonitrile solvation was accounted for using COSMO.54 An 
integration grid of 5 and tight SCF convergence criteria were employed. 
3.3 Results and Analysis 
Reactions of [MnII(dpaq)](OTf) (1) and [MnII(dpaq2Me)](OTf) (2) with tBuOOH. In order 
to identify conditions for the formation of the MnIII-alkylperoxo complex [MnIII(OOtBu)(dpaq)]+ 
(1b), we explored the reactivity of [MnII(dpaq)]+ (1) with tBuOOH. These reactions were 
performed in MeCN at -15°C and monitored by electronic absorption spectroscopy. The addition 
of sub-stoichiometric amounts of tBuOOH to solutions of 1 resulted in the appearance of electronic 
absorption features at 550 and 780 nm (Figure 3.2). These absorption bands are consistent with 
the formation of [MnIII(OH)(dpaq)]+ (1a; Scheme 3.2). Using published extinction coeffecients for 
1a,39 stoichiometric conversion of 1 to 1a is suggested upon the addition of ~0.5 equivalents of 
tBuOOH (Figure 3.2, blue trace). However, while ESI-MS data collected for a MeCN solution of 
1 treated with 0.5 equivalents of tBuOOH show the most prominent peak to be associated with 1a 
(m/z of 454.1; see Figure A2.1), a weaker peak is also observed at 510.2 m/z. This peak can be 
attributed to the formation of [MnIII(OtBu)(dpaq)]+. As the MnIII-methoxy analogue of 1a, 
[MnIII(OMe)(dpaq)]+, shows electronic absorption signals nearly identical to those of 1a,62 we 
propose that a mixture of 1a and [MnIII(OtBu)(dpaq)]+ would show an electronic absorption 
spectrum resembling that of a pure solution of 1a. In addition, the [MnIII(OMe)(dpaq)]+ complex 
can be rapdily converted to 1a by the addition of water.62 By analogy, we propose that 
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[MnIII(OtBu)(dpaq)]+ can be converted to 1a by reaction with trace water in MeCN. The reaction 
pathway for this process is elaborated in the Discussion section. 
 
Scheme 3.2. Complex 1 reacts with ~0.5 eq. tBuOOH to predominantly form 1a (a minor peak 
associated with [MnIII(OtBu)(dpaq)]+ is observed by ESI-MS experiments; see Figure A2.1). When 
reacted with ~100 eq. tBuOOH, 1a converts to 1b. 
 
 
Figure 3.2. Electronic absorption changes upon the addition of sub-stoichiometric amounts of 
tBuOOH to solutions of 1 in MeCN at -15°C. The addition of ~0.5 equivalents of tBuOOH is 
required to fully form 1a (blue trace and inset). Additional aliquots react with 1a to produce a 
mixture of species. Inset: Plot of the titration data including a trendline (red). 
 
 
Treatment of solutions of 1a with additional equivalents of tBuOOH led to further spectral 
changes. For example, the addition of one equivalent of tBuOOH to 1a resulted in a poorly-defined 
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electronic absorption spectrum lacking clear band maxima (Figure 3.3, orange trace). Reactions in 
the absence of a base resulted in the appearance of a similar chromophore, but with a better-defined 
electronic absorption spectrum with a maximum near 550 nm (Figure A2.2), showing the influence 
of added base on this chemistry. The addition of 10, 20, and 50 equivalents of tBuOOH to 1a in 
the presence of 10 equivalents Et3N resulted in the appearance of a new electronic absorption band 
centered near 700 nm, as shown in Figure 3. The temporal evolution of the electronic absorption 
signals of 1a upon the addition of 50 equivalents of tBuOOH in the presence of 10 equivalents 
Et3N are shown in Figures 4 and S3. Insight into the composition of this final solution was obtained 
through X-band EPR experiments. The 5 K perpendicular-mode EPR spectrum of 1a following 
the addition of 50 equivalents of tBuOOH in the presence of Et3N shows a 16-line signal (Figure 
3.4, inset; g = 2.02, A = 7.81 mT); the corresponding parallel-mode spectrum is silent at X-band 
frequency. Because complex 1a is EPR silent in both perpendicular and parallel-mode at X-band 
frequency, this sixteen-line signal must arise from a product of the reaction of 1a and tBuOOH. 
Spin quantification of the sixteen-line signal associated with the MnIIIMnIV center indicates that 
this signal represents 70 ± 20 % of the total Mn. The position and hyperfine splitting pattern of 
this EPR signal are within the range reported for MnIIIMnIV(µ-O)2 dimers, and the appearance of 
the EPR signal is strikingly similar to that of the [MnIIIMnIV(µ-O)2(dpaq)2]
+ complex reported by 
Nam and co-workers.43,63-65 This [MnIIIMnIV(µ-O)2(dpaq)2]
+ complex was formed upon the 
addition of 5 equivalents of H2O2 with Et3N to 1a. The electronic absorption spectrum of 
[MnIIIMnIV(µ-O)2(dpaq)2]
+ consisted of broad features extending from ~800 – 400 nm.63 In 
contrast, the spectrum we observed following the addition of 50 equivalents tBuOOH to 1a has 
sharper features (Figure 3.3). Thus, on the basis of the EPR and electronic absorption data, we 
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conclude that the addition of 50 equivalents of tBuOOH to 1a results in a mixture of [MnIIIMnIV(µ-
O)2(dpaq)2]
+ and other, EPR-silent, products.  
 
Figure 3.3. Electronic absorption spectra of the product of the reaction of 1a (black line) with 
increasing equivalents tBuOOH in the presence of 10 equivalents Et3N in MeCN at -15°C. 
 
Figure 3.4. Electronic absorption spectra showing the time course of the reaction of 1a with 50 
equivalents tBuOOH in the presence of 10 equivalents Et3N in MeCN at -15°C. Inset. 5K EPR 
spectrum of the final reaction mixture showing a sixteen line signal indicative of [MnIIIMnIV(µ-
O)2(dpaq)2]
+, which represents ca. 70% of Mn in the sample. 
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Additional experiments showed that the broad electronic absorption features observed 
following the addition of tBuOOH to 1a became more defined with increased amounts of added 
tBuOOH. Species 1b is maximally formed when approximately 100 equivalents of tBuOOH are 
added either in the presence or absence of Et3N, and this conversion appears to proceed with 
isosbestic behavior (Figure 3.5, left and Figure A2.4). The rate of formation of 1b in the presence 
or absence of base is essentially identical (Figure A2.5). The electronic absorption spectrum of 1b 
has features at 710 and 500 nm (ε = 150 and 400 M-1cm-1, respectively; see Figure 3.5, left panel; 
Figure A2.6). Importantly, the perpendicular-mode EPR spectrum of 1b lacks the sixteen-line 
signal from [MnIIIMnIV(µ-O)2(dpaq)2]
+ and does not contain signals from mononuclear MnII 
species. Instead, the EPR spectrum now shows a radical signal with g-values, at 77 K, of 2.033, 
2.007, and 2.002 (Figure A2.7). These g-values are identical to those of the tBuOO• radical.66 Spin 
quantification of the radical signal indicates tBuOO• formation of ca. 10% relative to the total Mn 
concentration. The lack of any other signal in either perpendicular or parallel mode supports the 
assignment of 1b as an EPR-silent species, potentially a mononuclear Mn(III) complex with a 
moderate zero-field splitting. An alternative route to 1b was achieved by adding 50 equivalents 
tBuOOH to the MnIII-hydroxo complex 1a in the absence of any added Et3N (Figure A2.8). 
However, in this case the conversion does not proceed with isobestic behavior, suggesting the 
formation of one or more intermediates with electronic absorption bands in the visible region. 
It is important to note that these data do not necessarily provide evidence that 1b is the only 
species present in solution under these conditions, as the presence of other EPR-silent species 
cannot be ruled out. ESI-MS experiments, which should, in principle, be useful for addressing this 
issue, are complicated by the thermal instability of 1b. Our assessment that 1b is maximally, if not 
exclusively, formed upon the addition of 100 equivalents of tBuOOH comes from the lack of EPR 
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signals associated with MnIIIMnIV or mononuclear MnII species, the ability to fit EXAFS data for 
these solutions with metric parameters consistent with a MnIII-OOtBu adduct (vide infra), and the 
analysis of the ratio of electronic absorption intensities at 710 nm (local maximum absorbance of 
1b) and 590 nm (local minimum absorbance for 1b, but with absorbance contributions from 1a 
and the MnIIIMnIV dimer) as a function of added equivalents of tBuOOH. As shown in Figure A2.4, 
this ratio is maximized upon the addition of 100 equivalents of tBuOOH to 1a. 
 
Figure 3.5. Characterization of 1b generated from the reaction of 1a (2 mM in MeCN) with 100 
equivalents tBuOOH in the presence of Et3N in MeCN at -15°C. Left: Electronic absorption 
spectra showing the appearance of features at 710 and 500 nm (red trace) with the disappearance 
of features at 550 and 780 nm that correspond to 1a (blue trace). Right: Solution FT-IR spectrum 
showing a signal at 872 cm-1 corresponding to the O−O stretch of the alkylperoxo complex. The 
signal is lost when 1a reacts with labeled tBu18O18OH. Asterisks (*) denote background signals 
from tBuOOH (846 and 887 cm-1) and CH2Cl2 contaminant (900 cm
-1).67,68 
 
Similar tBuOOH titration experiments were performed for 2, and the observed reaction 
chemistry parallels that described for 1. For example, ~0.5 equivalents of tBuOOH are required to 
convert 2 into the MnIII-hydroxo complex 2a in the presence of Et3N (Figure A2.9). The addition 
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of approximately 100 equivalents of tBuOOH to 2a in the presence of Et3N leads to the maximum 
formation of a new chromophore, 2b, which shows a prominent absorption band of 690 nm (ε = 
115 M-1cm-1, Figure A2.10). The perpendicular-mode EPR spectrum of 2b has a sharp signal near 
g = 2.0 attributable to the tBuOO• radical (Figure A2.11).  
Characterization of 1b and 2b. The electronic absorption spectra of both 1b and 2b bear 
resemblance to spectra previously reported for MnIII-alkylperoxo complexes (Table 3.1). For 
example, the MnIII-alkylperoxo complexes reported by Kovacs et al. show broad absorption 
features with λmax values from 585 to 600 nm (extinction coefficients from 320 to 575 M
-1cm-1), 
which were tentatively attributed to MnIII ligand-field transitions.37,38 In comparison, 1b and 2b 
show weak bands near 700 nm (Figure 3.5, left and Table 3.1). In addition, the MnIII-alkylperoxo 
complexes of Kovacs and co-workers showed more intense, higher energy absorption features with 
λmax values ranging from 355 to 420 nm (extinction coefficients from 240 to 1060 M
-1cm-1).37,38 
These bands were attributed to alkylperoxo πip
* → MnIII charge-transfer (CT) transitions, where 
the alkylperoxo πip
* MO is the O−O π-antibonding MO that lies in-plane with the Mn−O bond axis 
(vide infra). The analogous bands for 1b and 2b appear as shoulders at ~475 nm, with significant 
overlap with more intense bands in the near-UV region (Figure 3.5, left and Table 3.1). 
Further support for the assignment of 1b as the MnIII-t-butylperoxo complex, 
[MnIII(OOtBu)(dpaq)]+, comes from FT-IR experiments. The solution FT-IR spectrum of 1b is 
dominated by vibrations from the large excess of tBuOOH (100 equivalents) required for the 
formation of 1b. However, the FT-IR spectrum of the still cold reaction solution of 1b shows a 
feature at 872 cm-1 (Figure 3.5, right panel), which is not observed in the FT-IR spectrum of 
tBuOOH or 1a in MeCN (Figure A2.12). The FT-IR spectrum of 1b also includes a weak feature 
at 821 cm-1 that could be due to a small amount of residual 1a in solution (Figure A2.12). The band 
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at 872 cm-1 is absent in a sample of 1b prepared using tBu18O18OH, further supporting the 
assignment of this feature as an O−O vibration (Figure 3.5, right). The isotopically-labeled sample 
of 1b displays two new features at 836 and 819 cm-1. Assuming the O−O vibration behaves as a 
harmonic oscillator, a 16O/18O isotopic shift of 51 cm-1 is expected. The 819 cm-1 vibration 
observed for isotopically-labeled 1b would correspond to an isotopic shift of 53 cm-1, in good 
agreement with the prediction. While the appearance of the second new band at 836 cm-1 for 
isotopically-labeled 1b is difficult to rationalize, we note that coupling of the O−O and t-butyl 
C−C vibrations in high-spin FeIII-alkylperoxo adducts has been observed to give rise to two 
vibrations near 850 cm-1.69 On the basis of these collective observations, we assign the 872 cm-1 
mode to the O−O stretching vibration of 1b. The energy of this vibration is comparable to O−O 
vibrations reported for other MnIII-alkylperoxo complexes (875 to 893 cm-1).37,38  Corresponding 
FT-IR experiments performed for 2b did not result in the observation of any bands attributable to 
the O−O vibration, presumably because this vibration overlaps with one of the intense vibrations 
of free tBuOOH (Figure A2.13). 
 
Table 3.1. Comparison of Electronic Absorption Band Maxima (nm), Mn−O and O−O Distances 
(Å), and O−O Stretching Frequencies (νO-O; cm
-1) for MnIII-alkylperoxo Complexes. 
Complex λmax O–O Mn–O νO-O 
[MnIII(OOtBu)(dpaq)]+ ~475 710 1.477a  1.837a  872 
[MnIII(OOtBu)(dpaq2Me)]+ ~475 690 1.477a  1.840a  -- 
[MnIII(SMe2N4(6-Me-DPPN))(OO
tBu)]+ b 420 585 1.431 1.843 893 
[MnIII(SMe2N4(QuinoPN))(OO
tBu)]+ b 415 590 1.438 1.840 895 
[MnIII(SMe2N4(QuinoEN))(OO
tBu)]+ b 385 590 1.457 1.848 888 
[MnIII(SMe2N4(6-Me-DPEN))(OO
tBu)]+ b 355 600 1.468 1.853 875 




The formulations of 1b and 2b were further bolstered by analysis of Mn K-edge X-ray 
absorption (XAS) data. The XAS technique was previously used to characterize the related MnII 
complexes 1 and 2, as well as the MnIII-hydroxo species 1a and 2a,70 making it straightforward to 
compare Mn oxidation state and metric parameters for 1b and 2b relative to these structurally well-
defined complexes. The Mn K-edge energies of 1b and 2b (6550.4 and 6549.5 eV, respectively) 
are essentially identical to those observed for the MnIII-hydroxo complexes 1a and 2a (Figure 6), 
and 1.5-2.5 eV higher in energy than the MnII complexes 1 and 2 (Table 3.2). In addition, the pre-
edge features observed for 1b and 2b are of similar energy and area as those of 1a and 2a (Table 
3.2). Because the energetic position of the Mn K-edge and pre-edge features are very sensitive to 
changes in Mn oxidation data, and the pre-edge areas are reflective of Mn geometry, these 
similarities provide strong support that 1b and 2b contain MnIII centers with Mn-ligand metric 
parameters comparable to those of 1a and 2a. More detailed structural comparisons were afforded 




Figure 3.6. Comparison of Mn K-edge near-edge spectra of 1a (blue), 1b (red), 2a (orange), 2b 
(green) collected for frozen solutions in MeCN at 15 K. Inset: Pre-edge features of the four 
complexes.  
Table 3.2. Comparison of XANES data between 1, 1a, 1b, 2, 2a, and 2b. All data are from sample 








[MnII(dpaq)]+ (1)a 6540.2 4.9 6547.9 
[MnII(dpaq2Me)]+ (2) a 6540.2 4.3 6548.6 
[MnIII(OH)(dpaq)]+ (1a) a 6540.2  4.3  6550.6 
 6541.8   
[MnIII(OH)(dpaq2Me)]+ (2a) a 6540.2  4.1  6550.0 
 6541.6   
[MnIII(OOtBu)(dpaq)]+ (1b)   6540.2  4.6  6550.4 
 
6542.0   
[MnIII(OOtBu)(dpaq2Me)]+ (2b)   6540.5  4.1  6549.5 
 
6541.7   




The Fourier transform of the EXAFS data of 1b consists of an intense peak at 1.79 Å that 
has shoulders at 1.18, 1.43, 2.10, and 2.41 Å (Figure 3.7). This set of EXAFS peaks is best fit using 
a shell of two O/N atoms at 1.90 Å and a shell of five N atoms at 2.17 Å (Table 3.3). The MnIII-
OOR series of complexes previously reported by Kovacs and co-workers displayed Mn−OOtBu 
distances ranging from 1.840 – 1.861 Å.38 In addition, the X-ray structure of 1a displays a 
Mn−N(amide) distance of 1.975 Å.39 Because we are fitting EXAFS data for 1b within a k-window 
of 2 – 14 Å-1, the Mn−OOtBu and Mn−N(amide) shells are expected to fall within the resolution 
of 0.13 Å. Accordingly, the shell at 1.90 Å likely includes contributions from both axial ligands; 
i.e., the t-butylperoxo oxygen and the amide nitrogen. The EXAFS data of 1a in MeCN were also 
best fit including a shell at 1.92 Å that accounted for both axial ligands.70 The shell of five nitrogen 
scatterers at 2.17 Å is attributed to the equatorial nitrogen ligands. In support, the X-ray diffraction 
structure of 1a shows an average Mn−N distance of 2.18 Å.39 It is important to note that the 
goodness of fit does not change appreciably when going from a fit including four N scatterers to a 
fit including five N scatterers (Table 3.3). This insensitivity to the number of scatterers is consistent 
with the low sensitivity of EXAFS fits to the number of scatterers within a given shell, which has 
been reported to have an intrinsic uncertainty of ±1.71 A shell of 6 C atoms at ~2.97 Å was included 
to account for the second coordination sphere. For comparison, crystal structure data of 1a show 
an average Mn---C distance of 3.02 Å for atoms within the same radius as the EXAFS fitting 
shell.39  
The Fourier transform of the EXAFS data for 2b is very similar to that of 1b (Figure 3.7). 
Therefore, fits of the EXAFS data for 2b resulted in similar Mn-scatter distances; specifically, two 
O/N atoms at 1.89 Å, four N atoms at 2.16 Å, and six C atoms at 2.93 Å (Table 3.3). Collectively, 
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our analysis of XAS data for 1b and 2b support the formulation of these complexes as MnIII-
alkylperoxo adducts. 
 
Figure 3.7. Fourier transforms of Mn K-edge EXAFS data, and EXAFS spectra (inset), for 1b 
(top) and 2b (bottom) in frozen MeCN. Experimental data are in black, while (black line) and fits 
(red lines).  
 
 
Table 3.3. Fits of EXAFS data of 1b and 2b.a 
Fit 
Mn−N  Mn−O/N  Mn−C  Goodness of 
Fitb n r(Å) σ2 (Å2)  n r(Å) σ2 (Å2)  n r(Å) σ2 (Å2)  
[MnIII(OOtBu)(dpaq)]+ (1b)           
1 6 2.47 0.032          0.685 
2 4 2.16 0.007  2 1.89 0.005      0.402 
3 4 2.17 0.007  2 1.90 0.005  6 2.97 0.010  0.225 
4 5 2.17 0.009  2 1.90 0.004  6 2.97 0.010  0.212 
              
[MnIII(OOtBu)(dpaq2Me)]+ (2b)         
1 6 1.84 0.022          0.900   
2 4 2.15 0.004  2 1.89 0.003      0.386 
3 4 2.16 0.004  2 1.89 0.003  6 2.93 0.005  0.255 




Table 3.4. Comparison of EXAFS fits of 1b and 2b to DFT-optimized structures (distances in Å). 
 [MnIII(OOtBu)(dpaq)]+ (1b) [MnIII(OOtBu)(dpaq2Me)]+ (2b) 
 EXAFS DFT EXAFS DFT 
Mn−O/Nax 1.90 1.837(O), 1.992(N) 1.89 1.840(O), 1.985(N) 
Mn−Odistal ND
a 2.709 NDa 2.766 
O−O NDa 1.477 NDa 1.477 
∠Mn−O−O NAb 109.16° NAb 112.54° 
Mn−Neq 2.17 2.079(NQ
c), 2.177(avg.) 2.16 2.149(NQc), 2.182 (avg.) 
Mn---C 2.97 3.005d 2.93 2.979e 
a  Not determined. b Not applicable. c NQ refers to the nitrogen donor atom of the quinoline ring.  
d 
Average distance of 9 carbon atoms ranging from 2.901 to 3.070 Å. e Average distance of 9 carbon 
atoms ranging from 2.881 to 3.059 Å. 
 
 
Thermal Decay of 1b and 2b. Complexes 1b and 2b have half lives of t1/2 = 3200 and 3600 
seconds, respectively, at -15 °C (for 2 mM solutions in MeCN). Unfortunately, the large excess of 
tBuOOH required to generate 1b and 2b complicates investigation of the decay mechanism. The 
decay is characterized by a loss of electronic absorption intensity at ~710 nm, with the final decay 
spectrum of 1b showing no clearly defined bands (Figure 3.8 and S14). Although no precipitation 
was observed, the thermal decay of both 1b and 2b is accompanied by significant gas evolution. 
The gas is presumed to be dioxygen, as alkylperoxyl radicals are known to undergo decomposition 
that leads to the production of O2 (Equation 3.1).
72  
2 •OOtBu → tBuO−OtBu + O2    (3.1) 
 
The presence of O2 in the headspace of a decaying sample of 1b was confirmed by allowing 
the headspace gas to pass through an anaerobic 2 mM solution of 1 in MeCN. The MnII complex 
1 is known to react with O2 to produce the Mn
III-hydroxo 1a.39 After stirring for 2 hours while 
continuing to pass the headspace gas through the solution, formation of 1a was confirmed by 
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electronic absorption spectroscopy (~40% yield relative to the initial concentration of 1). EPR 
analysis of frozen solutions of the decay products revealed a loss of intensity of the sharp signal 
due to tBuOO• radical (Figures A2.15 and A2.16), consistent with the decay of this radical to give 
dioxygen.66,72 The EPR spectra of the decay solutions of 1b and 2b also display six-line signals 
corresponding to mononculear MnII products (Figures A2.15 and A2.16), although the intensity of 
these signal are modest. No signals associated with a MnIIIMnIV dimer are observed. Analysis of 
the decayed reaction solutions by electrospray ionization mass spectrometry revealed weak signals 
associated with the MnIII-hydroxo species 1a, which could be formed by O2 oxidation of a Mn
II 
product (Figure A2.17). Collectively, the electronic absorption and EPR characterization of the 
decay solutions of 1b and 2b provide limited insight into the nature of the decay products, 
rendering it challenging to determine by which mechanism(s) the MnIII-alkylperoxo adducts decay. 
 
 
Figure 3.8. UV-Vis spectra of the decay of 1b in MeCN at -15°C. Inset: X-band EPR spectrum of 
reaction solution showing a less intense radical signal from excess tBuOOH and a weak six-line 
signal typical of a MnII species. 
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DFT Calculations of 1b and 2b. In order to compare the bonding in the Mn−OOtBu units 
of 1b and 2b with those of the previously reported MnIII-alkylperoxo adducts with N4S
- ligation, 
we performed DFT calculations for complexes 1b and 2b. The structures afforded by these 
computations, which are shown in Figure 3.9, have the alkylperoxo ligand trans to the dpaq amide 
group, giving six-coordinate MnIII centers. The DFT-computed Mn−OOtBu distances are 1.837 
and 1.840 Å for 1b and 2b, respectively, which are within the range of, or just shorter than, the 
Mn−OOtBu distances previously observed by X-ray crystallography for complexes with N4S
- 
ligation (1.840 – 1.861 Å).38 The comparatively short Mn−O distances are somewhat surprising, 
given that the trans amide donor of the dpaq and dpaq2Me ligands might be expected to exert a 
trans influence, elongating the Mn−OOtBu bond length. The computed MnIII−OOtBu distances for 
1b and 2b are also longer than the crystallographic distances of the corresponding MnIII-hydroxo 
complexes 1a and 2a (1.806(13) and 1.819(3), respectively),39,40 but the MnIII−Namide distances are 
quite similar (1.99 Å versus 1.98 Å for MnIII-alkylperoxo and MnIII-hydroxo complexes, 
respectively).39,40  The DFT-computed Mn−OOtBu and MnIII−N(amide) distances lead to average 
Mn−N/Oaxial distances of 1.91 Å for both 1b and 2b, which are in good agreement with the EXAFS 
distances obtained for the two-atom N/O scattering shells (~1.9 Å; see Table 3.4). In addition, the 
average Mn−Nequatorial distances for the DFT-computed structures of 1b and 2b (2.18 Å for both), 
are in good agreement with the corresponding distances of four-atom EXAFS shells (Table 4). The 
calculated Mn−Nequatorial
 distances of 1b cover the range of 2.08 - 2.27 Å, while the calculated 
distances of 2b fall in a more narrow range of 2.13 - 2.26 Å. The DFT optimized O−O distances 
for 1b and 2b were both calculated to be 1.477 Å (Table 3.4), which are longer than those reported 
for previous MnIII-alkylperoxo complexes (1.431-1.468 Å).37,38  
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The calculated MnIII 3d orbital splitting patterns of 1b and 2b are shown in Figure 3.10. 
The MnIII 3d orbitals are labeled according to a coordinate system with the z-axis along the Mn−O 
bond and the y-axis along the Mn−Nquinoline bond (Figure 3.9). Calculations suggest substantial 
mixing of the MnIII 3d-orbitals with both dpaq and alkylperoxo ligand orbitals (Tables A2.3 and 
A2.4). In many cases, MnIII 3d orbital character is distributed over several molecular orbitals 
(MOs). Surface contour plots of the frontier MOs of 1b show that the Mn 3dz2 MO (a σ-type orbital) 
has significant contributions from the strongly donating trans amide N (7.1%) and the in plane π* 
orbital of the alkylperoxo moiety (12.8% oxygen character; Figure 11). In contrast, little 
contribution from the out of plane π* orbitals of the alkylperoxo ligand is observed in the π-type 
MnIII 3dxz and 3dyz orbitals (3.4% and 2.7% oxygen character, respectively; Table A2.3, Figure 
A2.18). Thus, the MnIII−alkylperoxo bonding in 1b is dominated by a Mn−OOtBu σ-interaction, 
with little apparent Mn=OOtBu character.  Frontier MO calculations for 2b predict similar 
alkylperoxo bonding as compared to that observed for 1b (Figure A2.19, Table A2.4), consistent 
with the spectroscopic similarities between the two species.  
The TD-DFT calculated absorption spectrum for 1b corresponds well to the experimental 
spectrum (Figure 3.12). Band i, which is predicted at 731 nm, is in good agreement with the feature 
at 710 nm in the experimental spectrum. This low-intensity feature arises from a d-d transition 
from Mn dx2-y2 to dz2, which is the lowest energy Mn
III d-d transition (Figure 3.10 and Table A2.5). 
Band ii, which corresponds to the poorly defined experimental band around 475 nm, is calculated 
to include contributions from both dpaq-to-MnIII ligand-to-metal charge transfer (LMCT) and 
alkylperoxo-to-MnIII LMCT transitions. The TD-DFT-calculated absorption spectrum of 2b also 
corresponds well to experiment (Figure A2.20). Mn d-d transitions and LMCT features are 
observed at similar energies to 1b and to previously reported MnIII-alkylperoxo complexes.38 For 
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both complexes, TD-DFT calculations predict additional alkylperoxo-to-Mn CT transitions and 
another Mn d-d transition (dxy to dz2) at higher energies (band iii in Figures 12 and S20; see also 
Tables A2.5 and A2.6).  
 
Figure 3.9. DFT optimized structures of 1b (left) and 2b (right).  
 
 
Figure 3.10. Molecular orbital (MO) energy-level diagrams for 1b (left) and 2b (right) obtained 
from DFT calculations. MOs are labeled according to their principal contributors, which reveal a 
high degree of mixing (py = pyridine, qn = quinoline). For clarity, only MnIII d-based and OOtBu 
π*-based MOs are included. TD-DFT-calculated transition energies of prominent electronic 




Figure 3.11. Surface contour plot of spin up, unoccupied MnIII 3dz2 MO of 1b as calculated by 
DFT calculations. The contour plot reveals significant contribution from the alkylperoxo moiety 




Figure 3.12. Comparison of experimental (top) and simulated (bottom) absorption spectra of 1b 
based on TD-DFT calculations. Calculated spectra show a feature arising from a Mn dx2-y2 to dz2 
transition (i), higher energy features arising from ligand-to-metal charge transfer from both dpaq 
and the alkylperoxo moiety to MnIII (ii), and higher intensity features corresponding to additional 





3.4 Discussion. At present, knowledge of both synthetic and biological MnIII-alkylperoxo 
intermediates is quite limited. Although a MnIII-alkylperoxo adduct has been proposed as a 
potential intermediate in Mn-LOX (Scheme 3.1), there is no direct evidence for the formation of 
such a species.15,17,18 To date, only a handful of synthetic MnIII-alkylperoxo complexes have been 
isolated and characterized. Of these complexes, all feature N4S
- supporting ligands with the thiolate 
donor cis to the alkylperoxo ligand.37,38 In this present work, we have generated and characterized 
two new MnIII-alkylperoxo species supported by N5
- ligands that feature a strongly donating 
anionic amide ligand trans to the alkylperoxo unit. Although the MnIII-alkylperoxo complexes 1b 
and 2b were able to be characterized by an array of spectroscopic methods, the extreme excess of 
oxidant necessary for their full formation rendered it difficult to determine the decay mechanism, 
and prevented any meaningful investigations of reactivity with substrates. However, the reaction 
pathway for formation of the MnIII-alkylperoxo complexes 1b and 2b from their MnII precursors 
is informative when compared to formation reactions of other metal-alkylperoxo adducts. 
Additionally, a structural and spectroscopic comparison of 1b and 2b with previously reported 
MnIII-alkylperoxo species with N4S
- ligations provides insight into spectro-structural correlations 
for this class of compounds.  
Reactions of 1 and 2 with tBuOOH. Initial treatment of the MnII complexes 1 or 2 with 
0.5 equivalents of tBuOOH led to the quantitative formation of the mononuclear MnIII-hydroxo 
complexes 1a and 2a (Figure 3.2). On the basis of the stoichiometry of this reaction, as well as the 
observation of [MnIII(OtBu)(dpaq)]+ by ESI-MS experiments (Figure A2.1), we postulate a 
reaction pathway involving homolytic cleavage of the O−O bond of tBuOOH to initially give 
MnIII-hydroxo and MnIII-tbutoxide species (Scheme 3.3, top). We have previously generated and 
characterized the MnIII-methoxide complex [MnIII(OMe)(dpaq)]+, which has electronic absorption 
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signals nearly identical to those of 1a.62 Thus, under the reasonable assumption that the 
[MnIII(OMe)(dpaq)]+ and [MnIII(OtBu)(dpaq)]+ complexes would have similar electronic 
absorption band maxima and intensities, formation of a mixture of MnIII-hydroxo and MnIII-t-
butoxide species in the reaction of 1 with tBuOOH would be compatible with our electronic 
absorption data (Figure 3.2). Because ESI-MS experiments on solutions of 1 with 0.5 equivalents 
tBuOOH predominantly show peaks associated with 1a, we propose that water present in the 
MeCN and/ or tBuOOH solutions converts the majority of the initially formed MnIII-tbutoxide 
species to 1a through a ligand substitution reaction. In support, we have previously demonstrated 
that 1a and the MnIII-methoxy analogue [MnIII(OMe)(dpaq)]+ can be readily interconverted by the 
addition of MeOH or H2O.
62 
 
Scheme 3.3. Postulated reaction pathways for formation of MnIII-hydroxo, bis-µ-oxo-
dimanganese(III,IV), and MnIII-alkylperoxo species formed from the reaction of 1 with tBuOOH. 
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Formation of a metal(III)-hydroxo species by tBuOOH oxidation of a metal(II) precursor 
has been reported for other systems. For example, Que and co-workers observed that the addition 
of 0.5 equivalents of tBuOOH to the FeII complex [FeII(6-Me-TPA)(O2CAr)]
+ (TPA = 
trispyridylmethylamine) resulted in complete conversion to the mononuclear FeIII-hydroxo 
complex [FeIII(OH)(6-Me-TPA)(O2CAr)]
+.73 Further addition of five equivalents tBuOOH to 
[FeIII(OH)(6-Me-TPA)(O2CAr)]
+ gave the corresponding FeIII-alkylperoxo complex 
[Fe(OOtBu)(6-Me-TPA)(O2CAr)]
+.73 This result stands in contrast to the reactivity we have 
described here, where treatment of the MnIII-hydroxo complex 1a leads to different products 
depending on the amount of tBuOOH added. 
Electronic absorption experiments suggest that treatment of 1a with excesses of tBuOOH 
below 100 equivalents in the presence of a base results in a mixture of products (Figure 3.3). At 
50 equivalents of tBuOOH and 10 equivalents Et3N, a bis-µ-oxo-dimanganese(III,IV) dimer is 
formed. For comparison, Nam and co-workers observed that the addition of H2O2 to 1a results in 
formation of the [MnIIIMnIV(µ-O)(dpaq)]2+ complex.63 In contrast, when 1a is treated with 100 
equivalents of tBuOOH and 10 equivalents Et3N, formation of the Mn
III-alkylperoxo species 1b is 
observed. Under these conditions, EPR experiments show no signals associated with the bis-µ-
oxo-dimanganese(III,IV) dimer. Species 1b could also be observed following the addition of 50 
equivalents of tBuOOH to 1a in the absence of added base (Figure A2.8); however, the spectral 
evolution for the reaction of 1a and tBuOOH differs from that observed with the addition of 100 
equivalents of tBuOOH (cf. Figures 3.5 and A2.8). 
We propose a reaction pathway, summarized in Scheme 3.3, that accounts for these 
observations. First, the addition of tBuOOH to 1a establishes an equilibrium between the MnIII-
hydroxo and MnIII-alkylperoxo species, which are related by a ligand substitution (Scheme 3.3). 
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This step is influenced by the presence of Et3N, which serves to deprotonate 
tBuOOH, facilitating 
exchange of tBuOO- with the hydroxide ligand. At small excesses of tBuOOH and base, this 
equilibrium lies predominantly to the left, in favor of the MnIII-hydroxo species 1a. Under these 
conditions, the MnIII-alkylperoxo adduct 1b could react directly with 1a, forming the bis-µ-oxo-
dimanganese(III,IV) dimer in a multistep process. An alternative decay pathway for 1b could 
involve O−O homolysis to yield a MnIV-oxo species that could react with 1a to again give the bis-
µ-oxo-dimanganese(III,IV) dimer. Additionally, this MnIV-oxo species could be capable of 
abstracting a H atom from tBuOOH to generate 1a and tBuOO radical. These scenarios are 
illustrated in Scheme 3.3. 
In contrast, when 1a is treated with a large excesses of tBuOOH (100 equivalents or 
greater), the ligand substitution equilibrium favors the MnIII-alkylperoxo species 1b. This 
relatively straightforward reaction is supported by the apparent isosbestic behavior observed by 
electronic absorption spectroscopy for this reaction (Figure 3.5, left). Under similar reaction 
conditions, but lacking added base, the formation of 1b is more complex, as evidenced by the lack 
of isosbestic points for these reactions (Figure A2.8). In addition, EPR spectra collected for 
solutions of 1a treated with 100 equivalents of tBuOOH and base lack any signals associated with 
the bis-µ-oxo-dimanganese(III,IV) dimer. The only signals observed are from a small amount of 
tBuOO, which could result from homolytic decay of the Mn−OOtBu bond of 1b. tBuOO radicals 
are known to couple to form O2 and relatively stable 
tBuOOtBu species.72  Thus, the evolution of 
O2 during the decay of 1b could support a Mn−O homolysis pathway. This decay mechanism 
would yield the [MnII(dpaq)]+ starting material, which could react further with O2 in solution to 
generate 1a. Although ESI-MS experiments for the decay solutions show the presence of 1a, the 
electronic absorption spectrum of the corresponding solution is not consistent with the clean 
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conversion of 1b to 1a during the thermal decay of the former (Figure 3.8). Thus, the decay 
pathway is likely more complex than simple Mn−O homolysis. 
The seemingly complex pathway required for the formation of 1b and 2b stands in sharp 
contrast to previously reported routes for generating MnIII-alkylperoxo adducts reported by Kovacs 
and co-workers. In those examples, the [MnII(N4S)]
+ complexes (where N4S
- represent a variety 
of pentadentate ligands with thiolate, amine, imine, and bis-2-Me-pyridine or bis-quinoline 
ligation) yield the corresponding [MnIII(OOtBu)(N4S)]
+ species in high yield when treated with 
only 2 equivalents of tBuOOH and base.37,38  There was no evidence for formation of a 
mononuclear MnIII-hydroxo intermediate or multinuclear intermediates, suggesting that particular 
properties of the supporting ligands influence the stabilities and/ or rates of formation and decay 
of such species. In addition, a large body of experimental evidence suggests that the 
[MnIII(OOtBu)(N4S)]
+ complexes decay by O−O cleavage, while there is indirect, and 
circumstantial, evidence that 1b decays by Mn−O cleavage. An understanding of how ligand 
properties modulate Mn reactivity towards tBuOOH is clearly in its infancy.  
Spectroscopic and structural comparison with previous MnIII-alkylperoxo complexes. 
The MnIII-alkyperoxo complexex 1b and 2b show very similar spectroscopic properties, consistent 
with their nearly identical coordination spheres (Figure 3.9). The only notable spectroscopic 
difference between the two is a 20 nm (400 cm-1) blue-shift in the lowest-energy electronic 
absorption band for 2b compared to 1b. TD-DFT computations allowed us to assign this absorption 
band as the MnIII 3dx2-y2 to 3dz2 transition. Because the Mn
III-alkylperoxo bonding descriptions 
afforded by DFT computations are quite similar, we can attribute the modest shift in this electronic 
transition to the subtly different properties of the dpaq and dpaq2Me ligands. The inclusion of the 
2-methyl-quinoline group in 2b leads to a weaker Mn−Nquinoline interaction, as described 
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previously.40 This weakened interaction should stabilize the energy of the 3dx2-y2 MO, which is 
largely MnIII-dpaq -antibonding, causing the observed blue-shift for 2b relative to 1b. 
For comparison, the [MnIII(OOtBu)(N4S)]
+ complexes of Kovacs and co-workers show a 
corresponding electronic absorption feature that ranges from 600 – 585 nm, at significantly higher 
energy than the bands of 1b and 2b. The [MnIII(OOtBu)(N4S)]
+ complexes contain two 6-Me-
pyridine or quinoline donors in the equatorial plane cis to the alkylperoxo ligand. X-ray structures 
show highly elongated MnIII−N distances of 2.354 to 2.522 Å, suggesting very weak interactions.38 
Accordingly, we attribute the more substantial blue-shift of these bands to further stabilization of 
the MnIII 3dx2-y2 donor orbitals due to the equatorial bond elongations. 
The O−O vibrational frequency observed for 1b is on the low end of O−O vibrations 
reported for the [MnIII(OOtBu)(N4S)]
+ series (Table 3.1). While this observation is consistent with 
the relatively long O−O bond of 1b predicted by DFT computations, this comparison must be made 
with caution. The 16O/18O isotopic shifts observed for the [MnIII(OOtBu)(N4S)]
+ complexes did 
not follow that predicted on the basis of a harmonic oscillator model, suggesting some vibrational 
coupling. In addition, isotopic labeling of 1b led to the appearance of two additional IR features 
(Figure 5, right), also suggestive of coupling. Thus, care should be taken in relating the O−O 
vibrational frequencies of these complexes to the O−O bond strength. 
3.5 Conclusions. Spectroscopic and structural studies of two new MnIII-alkylperoxo 
complexes described in this work add to the otherwise limited knowledge base for this class of 
compound. The axial donating amide motif employed herein is unique among model manganese-
alkylperoxo complexes, and the variety of species apparent in reactions of 1 with tBuOOH reveals 
the versatility of this platform in supporting biologically relevant intermediates. Complexes 1 and 
2 were shown to react with tBuOOH to generate the previously characterized MnIII-hydroxo 
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species 1a and 2a. These MnIII-hydroxo adducts could react with tBuOOH to form the MnIII-
alkylperoxo species 1b and 2b. However, this conversion required a large excess of tBuOOH. 
Structural comparison with previously reported MnIII-alkylperoxo complexes revealed a relatively 
short Mn−O bond, and DFT calculations suggest a long, and therefore more activated, O−O bond. 
Although the large excess of tBuOOH needed for full formation of the MnIII-alkylperoxo species 
complicated investigations of reactivity, structural and spectroscopic characterization of these 
species points to the potential of the dpaq system, as well as other similar platforms that feature 
strongly donating trans ligand motifs, for the formation and activation MnIII-alkylperoxo 
complexes.  
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4.1 Introduction. Mn-alkylperoxo species have been proposed as important intermediates 
in certain enzymatic pathways, though none have been isolated.1-7 Mn-dependent dioxygenases, 
such as homoprotocatechuate 2,3-dioxygenase (Mn-HPCD), are proposed to generate a MnII-
alkylperoxo intermediate during substrate oxidation.2 The formation of this intermediate is 
proposed to occur through the reaction of a MnII center with dioxygen to form a MnIII-superoxo 
species that is able to react with a bound substrate molecule and form the proposed MnII-
alkylperoxo intermediate. This MnII-alkylperoxo intermediate is proposed to decay through a 
redox reaction that results in the dioxygenation of the substrate molecule.2  
Mn-dependent lipoxygenases (Mn-LOX) have also been proposed to form Mn-alkylperoxo 
intermediates during the hydroperoxidation of fatty acid substrates.4-6, 8 In contrast to what is 
proposed for Mn-HPCD, the formation of the MnIII-alkylperoxo intermediate of Mn-LOX is not 
the result of a direct reaction between the Mn center and dioxygen. Instead, an active-site MnIII-
hydroxo center abstracts a hydrogen atom from the substrate, generating a MnII-aqua complex and 
a substrate radical. This substrate radical then reacts with dioxygen to form a peroxyl radical, 
which is proposed to react with the MnII center and form a MnIII-alkylperoxo species.8 The MnIII 
resting state of the enzyme is regenerated through ligand substitution of the alkylperoxo moiety 
with a water molecule, concurrently yielding the final oxidized product.8 
In light of the suggested biological importance of Mn-alkylperoxo species in biology, 
efforts employing synthetic model complexes as investigative tools into the properties and 
reactivity of this class of intermediates have been underway.9-12 A report from Komatsuzaki and 
coworkers stand as the only example of a synthetic MnII-alkylperoxo species.12 However, there are 
a couple ligand systems capable of supporting MnIII-alkylperoxo complexes.9-11 Kovacs and 




- ligands. These complexes have been well characterized both spectroscopically 
and structurally by X-ray diffraction.9, 10 The complexes all feature strongly donating thiolate 
ligation cis to the alkylperoxo moiety. In addition, these complexes featured sterically bulky 
quinolyl or 6-methylpyridyl substituents cis to the alkylperoxo moiety, resulting in elongated Mn-
N bonds in the equatorial plane.9, 10 These MnIII-alkylperoxo complexes decay rapidly, even at 
temperatures as low as -15 °C. Analysis of the thermal decay products suggested a decay 
mechanism involving the homolytic cleavage of the alkylperoxo O-O bond.10 In support of this 
proposed mechanism, variable-temperature kinetic analysis of the thermal decay of this series of 
complexes revealed that both the enthalpy (ΔH‡) and the entropy (ΔS‡) of the decay process 
trended with the O-O bond distance.10 This homolytic cleavage pathway is different than that 
proposed in Mn-LOX. 
More recently, our group has reported two MnIII-alkylperoxo complexes supported by the 
pentadentate dpaq and dpaq2Me ligands, both of which feature strongly donating amide groups 
trans to the alkylperoxo moiety (dpaq = 2-[bis(pyridin-2-ylmethyl)]amino-N-quinolin-8-yl-
acetamidate, dpaq2Me = 2-[bis(pyridin-2-ylmethyl)]amino-N-2-methyl-quinolin-8-yl-
acetamidate).11 [MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+  were unstable (t1/2 = 3200 
and 3600 sec, respectively) and were characterized by electronic absorbance and FT-IR 
spectroscopies. Structural information was obtained from an analysis of extended X-ray absorption 
fine structure (EXAFS) data collected at the Mn K-edge. The formation of these complexes 
required a large excess (~100 equivalents) of tBuOOH that made detailed studies of reactivity or 
decay mechanisms difficult. However, the observation of tBuOO• in EPR analysis of the 
complexes served as indirect evidence of homolytic Mn-O bond cleavage during thermal decay of 
the complexes, potentially mimicking the proposed decay pathway of Mn-LOX.11 
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Taking note of the inherent difference in stability between the MnIII-alkylperoxo complexes 
of the sterically encumbered N4S
- ligand and our dpaq series, we sought to develop a derivative of 
the dpaq ligand that would stabilize such a species. Herein, we report the synthesis of the 2-(bis((6-
methylpyridin-2-yl)methyl)amino)-N-(quinolin-8-yl)acetamide (H6Medpaq) ligand, a derivative of 
the dpaq ligand that  incorporates steric bulk at the 6 position of the pyridyl substituents in the 
equatorial plane (Figure 4.1). Structural characterization of [MnIII(OH)(6Medpaq)](OTf) reveals 
that the 6-methylpyridinyl groups lead to elongations in the Mn-N distance of 0.11 Å relative to 
the unsubstituted analogue. This MnIII-hydroxo species reacts with stoichiometric amounts of 
tBuOOH to generate the first room-temperature stable MnIII-alkylperoxo species, 
[MnIII(OOtBu)(6Medpaq)]+. This MnIII-alkylperoxo complex is characterized by a battery of 
spectroscopic techniques, including X-ray absorption spectroscopy. 
 
Figure 4.1. H6Medpaq ligand (left), [MnIII(OH)(6Medpaq)]+ (center), and [MnIII(OOtBu)(6Medpaq)]+ 
(right). 
 
4.2 Experimental Methods. All chemicals were used as obtained from commercial 
sources unless noted otherwise. Acetonitrile, diethyl ether, and methanol were dried and degassed 
using a PureSolv Micro solvent purification system. Bis((6-methylpyridin-2-yl)methyl)amine was 
synthesized according to a reported procedure.13 The concentration of tert-butyl hydroperoxide 
(tBuOOH) in decane stock solution was found to be 4.3 M by an iodometric titration procedure.14 
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Electronic absorption spectroscopy was performed using a Varian Cary 50 Bio UV−visible 
spectrophotometer equipped with a Unisoku cryostat and stirrer. Vibrational data were obtained 
using a PerkinElmer Spectrum100 FTIR spectrometer with samples sealed in 0.1 mm gastight 
NaCl cells. Electrospray ionization mass spectrometry (ESI-MS) experiments were performed 
using an LCT Premier MicroMass electrospray time-of-flight instrument. X-band EPR 
experiments were performed using a Bruker EMXplus with Oxford ESR900 continuous-flow 
liquid helium cryostat and an Oxford ITC503 temperature system. 1H and 31P NMR spectra were 
obtained on a Bruker DRX 400 MHz NMR spectrometer. 13C and HSQC NMR spectra were 
obtained on a Avance AVIII 500 MHz NMR spectrometer. 
Synthesis of 2-(bis((6-methylpyridin-2-yl)methyl)amino)-N-(quinolin-8-yl)acetamide 
(H6Medpaq). The H6Medpaq ligand was synthesized according to a modified literature procedure.15 
Under inert atmosphere in a Schlenk flask, 8-aminoquinoline and sodium carbonate were dissolved 
in MeCN. The solution was cooled to 0°C in an ice bath. Bromoacetyl bromide was added 
dropwise to the cooled solution. The reaction was allowed to stir for one hour at 0°C. The reaction 
mixture was filtered through an ultrafine frit, and the solvent removed under vacuum. The resulting 
orange solid was combined in a flask along with sodium carbonate and dissolved in MeCN under 
inert atmosphere. The solution was cooled to 0°C in an ice bath. Bis((6-methylpyridin-2-
yl)methyl)amine was added slowly while stirring. The reaction mixture was allowed to stir 
overnight at 0°C. After the reaction was complete, the reaction mixture was filtered through a fine 
frit and the solvent removed under vacuum. The resulting red solid was purified through column 
chromatography on alumina and eluted with a DCM:MeOH solvent gradient. The final product 
was obtained as a dark yellow solid in 80% yield and characterized by 1H, 13C, and HSQC NMR. 
1H NMR data (400 MHz) for H6Medpaq (CDCl3, δ) = 11.61 (s, 1H), 8.94 (dd; J = 4.2, 1.7 Hz;1H), 
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8.75 (dd; J = 6.1, 2.9 Hz; 1H), 8.19 (dd; J = 8.3, 1.7 Hz; 1H), 7.82 (d; J = 7.7 Hz; 2H), 7.52 (m, 
5H), 7.02 (m, 2H), 3.99 (s, 4H), 3.52 (s, 2H), 2.47 (s, 6H) ppm. 13C NMR data (125 MHz) for 
H6Medpaq (CDCl3, δ) = 169.92 (s, C=O), 157.88 (s, Py), 157.80 (s, Py), 148.19 (s, Qu), 139.02 (s, 
Qu), 137.01 (s, Qu), 136.42 (s, Qu), 134.58 (s, Qu), 128.22 (s, Qu), 127.58 (s; Qu), 121.98 (s; Py),  
121.73 (d; Py,Qu), 120.30 (s, Py), 116.65 (s, Qu), 61.48 (-CH2Py), 59.39 (-CH2CO-), 24.50 
(CH3Py) ppm. 
Synthesis of [MnII(NCMe)(6Medpaq)](OTf). The MnII complex of the H6Medpaq ligand was 
generated under inert atmosphere in a glovebox. Separate solutions of Mn(OTf)2 and NaO
tBu in 
MeOH were added to a sequentially added to a solution of H6Medpaq in MeOH in a schlenk flask.  
The reaction was allowed to stir overnight. The resultant orange solution was filtered, and the 
solvent was removed under reduced pressure. The orange solid product was purified by 
recrystallization from MeCN by layering with diethyl ether. An EPR sample was prepared by 
injecting a 2 mM solution of the orange solid in MeCN into an EPR tube and immediately freezing 
the solution with liquid nitrogen. The magnetic moment of the compound was also measured using 
the Evans 1H NMR method for a 2.5 mM solution of [MnII(NCMe)(6Medpaq)](OTf) in d3-MeCN 
at 298 K. The µeff with diamagnetic correction was found to be 5.7 µB. The complex was also 
characterized by ESI-MS: m/z = 465.1196 (calculated m/z = 465.1361, Figure A3.4).  
Preparation of [MnIII(OH)(6Medpaq)](OTf). The MnIII-hydroxo complex 
[MnIII(OH)(6Medpaq)]+ was generated through the oxidation of the MnII complex with PhIO in 
MeCN. In a typical experiment, a 2 mM solution of [MnII(NCMe)(6Medpaq)]+ in MeCN was 
allowed to stir with 0.5 equivalents of PhIO and monitored by electronic absorption spectrometry 
until the spectra ceased to change. Larger scale preparations of [MnIII(OH)(6Medpaq)](OTf), in 
which a saturated MeCN solution of 20 mg of [MnII(NCMe)(6Medpaq)]+ was treated with 0.5 
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equivalents of PhIO, were carried out to obtain material for X-ray diffraction analysis. The 
formation of [MnIII(OH)(6Medpaq)](OTf) was assessed through electronic absorption spectroscopy. 
After repetitive crystallizations in MeCN/Et2O, dark grey crystals of X-ray crystallographic quality 
were obtained. Fourier transform-infrared (FT-IR) analysis was performed for 
[MnIII(OH)(6Medpaq)]+ by injecting a 2 mM solution of [MnIII(OH)(6Medpaq)]+ in MeCN into a gas 
tight IR cell and collecting the FT-IR spectrum at 298 K. A sample for 1H NMR was prepared by 
dissolving crystalline material in d3-MeCN (10 mM). The magnetic moment of the compound was 
also measured using the Evans 1H NMR method for a 1 mM solution of 
[MnIII(OH)(6Medpaq)](OTf) in d3-MeCN at 298 K. The µeff with diamagnetic correction was found 
to be 4.5 µB. The complex was also characterized by ESI-MS: m/z = 482.1340 (calculated m/z = 
482.1389, Figure A3.5).  
X-ray diffraction data collection and analysis for [MnIII(OH)(6Medpaq)](OTf). A set of 
4121 unique reflections were collected16 for a 92/8 racemically-twinned crystal of 
[Mn(C25H24N5O)(OH)][O3SCF3] using 1.0⁰-wide ω- or ϕ-scan frames with scan times of 8-30 
seconds and monochromated CuK radiation (= 1.54178 Å) on a Bruker Proteum Single Crystal 
Diffraction System equipped with dual CCD area detectors.  Data collection utilized a Platinum 
135 CCD detector and Helios high-brilliance multilayer optics.  X-rays were provided with a 
Bruker MicroStar microfocus Cu rotating anode x-ray source operating at 45kV and 60mA.  The 
integrated data17 were corrected empirically for variable absorption effects using equivalent 
reflections.  The Bruker software package SHELXTL was used to solve the structure using “direct 
methods” techniques.  All stages of weighted full-matrix least-squares refinement were conducted 
using Fo
2 data with the SHELXTL XL v2014 software package18.   
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The asymmetric unit of [Mn(C25H24N5O)(OH)][O3SCF3] contains an ordered 
[Mn(C25H24N5O)(OH)]
+ cation and an ordered triflate anion.  All nonhydrogen atoms of 
[Mn(C25H24N5O)(OH)][O3SCF3] were included in the structural model with anisotropic thermal 
parameters that were allowed to vary along with their positional parameters in least-squares 
refinement cycles.  The hydrogen atom of the coordinated hydroxyl group was located from a 
difference Fourier and included in the structural model as an independent isotropic atom whose 
parameters was also allowed to vary.  Methyl groups for [Mn(C25H24N5O)(OH)][O3SCF3] were 
incorporated into the structural model as idealized rigid rotors (using sp3-hybridized geometry and 
a C‒H bond length of 0.98 Å) that were permitted to rotate freely about their C‒C bonds in least-
squares refinement cycles. The remaining non-methyl hydrogen atoms for 
[Mn(C25H24N5O)(OH)][O3SCF3] were included in the structural model as idealized riding-model 
atoms (assuming sp2- or sp3-hybridization of the carbon atoms with C‒H bond lengths of 0.95 or 
0.99 Å).  The isotropic thermal parameters of all idealized hydrogen atoms were fixed at values 
1.2 (nonmethyl) or 1.5 (methyl) times the equivalent isotropic thermal parameter of the carbon 
atom to which they are covalently bonded. Cartesian coordinates are presented in Table A3.2, and 
final crystallographic details are summarized in Table A3.3.   
Preparation of [MnIII(OOtBu)(6Medpaq)](OTf). A MnIII-alkylperoxo complex was 
generated from either the MnII complex or the MnIII-hydroxo complex by reacting with tBuOOH. 
To determine the minimum amount of tBuOOH required for full conversion, aliquots of tBuOOH 
(0.5, 1.0, 1.5, 2.5, or 5 equivalents) were added to a 2 mM solution of the MnII complex in MeCN 
while monitoring by electronic absorption spectroscopy and comparing the absorbance of the 
spectra collected with different aliquots. In this manner, the maximum formation of 
[MnIII(OOtBu)(6Medpaq)](OTf) from [MnII(NCMe)(6Medpaq)](OTf) was found to require the 
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addition of 1.5 equivalents of tBuOOH (Figure A3.3). The formation of 
[MnIII(OOtBu)(6Medpaq)](OTf) from [MnIII(OH)(6Medpaq)](OTf) was found to require 1 equivalent 
tBuOOH.  
FT-IR analysis of [MnIII(OOtBu)(6Medpaq)](OTf) was performed by injecting the solution 
following the reaction between [MnIII(OH)(6Medpaq)](OTf) and 1 equivalent of tBuOOH directly 
into gastight IR cells, and immediately collecting FT-IR data. A 1H NMR sample was prepared by 
injecting the solution following the reaction between [MnIII(OH)(6Medpaq)](OTf) and 1 equivalent 
of tBuOOH into an NMR tube. The magnetic moment of the compound was also measured using 
the Evans 1H NMR method for a 1 mM solution of [MnIII(OH)(6Medpaq)](OTf) in d3-MeCN at 298 
K. The µeff with diamagnetic correction was found to be 4.5 µB. The Mn
III-alkylperoxo complex 
was also characterized by ESI-MS: m/z =554.1968 (calculated m/z = 554.1964, Figure A3.8). The 
thermal decay of [MnIII(OOtBu)(6Medpaq)](OTf) and was monitored at 298 K and 328 K by 
electronic absorption spectroscopy. 
X-ray Absorption Data Collection and Analysis. A 10 mM solution of 
[MnII(6Medpaq)](OTf) was prepared in MeCN and immediately injected into sample holders with 
a Kapton tape window and frozen in liquid nitrogen. A 10 mM sample of 
[MnIII(OOtBu)(6Medpaq)](OTf) was prepared by a similar procedure. Full formation of 
[MnIII(OOtBu)(6Medpaq)](OTf) was confirmed by electronic absoprtion spectroscopy. Mn Kedge 
XAS data were collected at Stanford Synchrotron Radiation Lightsource (SSRL) Beamline 9-3. 
Mn K-edge XAS spectra were collected at 10 K over a range in energy from 6.3 to 7.25 keV using 
a Si(111) monochromator. The fluorescence excitation spectra were obtained using a 100-element 
Ge array. Spectra of manganese foil were collected with each scan as a reference and were 
calibrated by assigning the zero crossing of the second derivative of the foil K-edge energy to 
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6539.0 eV. During data collection, the rising edge of each spectrum was monitored for evidence 
of photoreduction. No photoreduction was observed for either the MnII or the MnIII-alkylperoxo 
samples. XAS data reduction and averaging was performed using the Athena program.19 Each data 
set was normalized using the edge-step normalization procedure. A Gaussian function was fit to 
the pre-edge background and subtracted from the whole spectrum as a background correction. The 
spectrum was then spline-corrected to remove low-frequency background contributions. EXAFS 
refinement was performed on k3χ(k) data, using phase and amplitude functions obtained from 
FEFF, version 6,20 and structural models of [MnII(6Medpaq)]+ and [MnIII(OOtBu)(6Medpaq)]+ 
obtained from density functional theory (DFT) geometry optimizations (vide infra). The EXAFS 
data were fit using the Artemis program.19 The average distances between Mn and scattering atoms 
(r) and Debye−Waller factors (σ2) were optimized for each fit, while the number of atoms in the 
shell (n) was kept fixed. n was systematically varied between fits. The threshold energy E0, in 
electronvolts (k = 0 point), was kept at a common, variable value for every shell of a given fit. The 
goodness-of-fit was evaluated using the R-factor: 











Electronic Structure Computations. All computations were performed using the ORCA 
4.0.1.2 software program.21 Initial coordinates for [MnII(NCMe)(6Medpaq)]+ were obtained through 
modification of the X-ray crystal structure of [MnII(dpaq)]+ by adding methyl substituents to the 6 
position of the pyridine arms. The polymeric structure from the X-ray crystal structure of 
[MnII(dpaq)]+ was truncated by replacing the amide donor of a nearby MnII complex with an 
acetonitrile molecule. The resulting structure was subjected to unconstrained geometry 
optimization converged to the S = 5/2 spin state. The geometry optimization of 
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[MnII(NCMe)(6Medpaq)]+ was performed  using the B3LYP functional22-24 with the SVP basis set 
for C and H atoms, and the TZVP basis set for manganese, oxygen, and nitrogen atoms.25, 26 The 
integration grid was set to 4, with RI integral transformation approximations and the SVP/J and 
TZVP/J auxiliary basis sets.25-27 Tight convergence criteria were employed. Cartesian coordinates 
are presented in Table A3.1.  
Initial coordinates for [MnIII(OOtBu)(6Medpaq)]+ were obtained by modifying the X-ray 
crystal structure coordinates of [MnIII(OH)(6Medpaq)]+ to replace the hydroxo ligand with a 
tbutylperoxo ligand, and the resulting structure was subjected to unconstrained geometry 
optimization converged to the S = 2 spin state. The geometry optimization of 
[MnIII(OOtBu)(6Medpaq)]+ was performed using the TPSS functional with D3 dispersion 
correction,28, 29 the def2-SVP basis set for carbon and hydrogen atoms, and the def2-TZVP basis 
set was for manganese, nitrogen, and oxygen atoms.25, 26, 30 The integration grid was set to 4, with 
RI integral transformation approximations27 and the def2/J auxiliary basis set.27 Cartesian 
coordinates are presented in Table A3.4. 
Reaction of [MnIII(OOtBu)(6Medpaq)](OTf) with H2O. The formation of 
[MnIII(OOtBu)(6Medpaq)](OTf) was achieved by adding 1 equivalent of tBuOOH to a 2 mM 
solution of [MnIII(OH)(6Medpaq)](OTf) in MeCN while monitoring by electronic absorption 
spectroscopy. Upon full formation of the MnIII-alkylperoxo species, 100 equivalents of H2O were 
added via syringe at 298 K. The resulting reaction was monitored by electronic absorption 
spectroscopy. The products of the reaction were analyzed by ESI-MS and 1H NMR analyses. 
Reaction of [MnIII(OOtBu)(6Medpaq)](OTf) with 9,10-dihydroanthracene. The formation 
of [MnIII(OOtBu)(6Medpaq)](OTf) was achieved by adding 1 equivalent of tBuOOH to a 1.25 mM 
MeCN solution of [MnIII(OH)(6Medpaq)](OTf) in a quartz cuvette with a pierceable septum. Upon 
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full formation of the MnIII-alkylperoxo species, 175 equivalents of 9,10-dihydroanthracene 
(DHA), which had been dissolved in 100 µL of dichloromethane, were added via gas-tight syringe. 
The resulting reaction was allowed to stir for 30 hours at 323 K while monitoring by electronic 
absorption spectroscopy. The organic products of the reaction were separated by passing the 
solution through a 1 inch silica plug and eluting with dichloromethane. The solvent was removed, 
and a sample for 1H NMR analysis was prepared in CDCl3 using 1,4-benzoquinone as an internal 
reference. 
Reaction of [MnIII(OOtBu)(6Medpaq)](OTf) with triphenylphosphine. The formation of 
[MnIII(OOtBu)(6Medpaq)](OTf) was achieved under inert atmosphere by adding 1 equivalent of 
tBuOOH to a 1.25 mM solution of [MnIII(OH)(6Medpaq)](OTf) in MeCN that had been sealed in a 
quartz cuvette with a pierceable septum in a glovebox. Upon full formation of the MnIII-
alkylperoxo species, 100 equivalents of triphenylphosphine (PPh3), which had been dissolved in 
100 µL of O2-free MeCN, were added. The resulting reaction was allowed to stir at 298 K while 
monitoring by electronic absorption spectroscopy until the spectra ceased to change. The organic 
products of the reaction were separated by evaporating the solvent and dissolving the organic 
products in diethyl ether. Diethyl ether was removed, and the resulting white crystals were 
dissolved in CDCl3 and injected into an NMR tube for 
31P NMR analysis. 
4.3 Results and discussion. 
Synthesis of (H6Medpaq). The synthesis of H6Medpaq was carried out according to a 
modified procedure of the synthesis of the Hdpaq ligand (Scheme 4.1).15 The alkylation of 8-
aminoquinoline was achieved through the addition of bromo acetyl bromide in MeCN under inert 
atmosphere at 273 K. Bis((6-methylpyridin-2-yl)methyl)amine, which was synthesized according 
to a published procedure,13 was subsequently added to the reaction solution and allowed to stir 
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overnight at 273 K. The product was purified by column chromatography and obtained in 80% 
yield. Analysis by 1H, 13C, and HSQC NMR confirmed the formation of H6Medpaq (Figure A3.1-
3). 
 
Scheme 4.1. Synthesis of H6Medpaq. 
 
Characterization of [MnII(NCMe)(6Medpaq)]+. Metallation of the H6Medpaq ligand with 
MnII(OTf)2  results in the formation of a bright orange solid. Mass-spectral analysis of the orange 
solid revealed a peak at m/z = 465.1196, consistent with the [MnII(6Medpaq)]+ ion (calculated m/z 
= 465.1361, Figure A3.4). We presume that the MnII center is six-coordinate in solution with an 
acetonitrile ligand, [MnII(NCMe)(6Medpaq)]+. An EPR spectrum obtained for a 2 mM solution of 
[MnII(NCMe)(6Medpaq)]+ in MeCN revealed a 6-line signal (g = 2.00, A = 9.39 mT; Figure 4.2). 
The g-value and hyperfine splitting observed in this EPR spectrum are similar to those reported 
for the high-spin [MnII(N4S)]+ complexes (g = 1.98 - 2.00, A = 9.0 – 10.0 mT) and 
[MnII(NCMe)(dpaq2Me)]+ (g = 2.04).31, 32 The magnetic moment of [MnII(NCMe)(6Medpaq)]+ was 
measured to be 5.7 µB using the Evans method with diamagnetic correction, consistent with the 
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assignment of this species as a high-spin MnII complex (the calculated spin-only value for an S = 
5/2 species is 5.91 µB). 
 
Figure 4.2. EPR spectrum obtained for a 2 mM solution of [MnII(NCMe)(6Medpaq)]+ in MeCN 
showing a six-line signal consistent with the assignment of a MnII species (g = 2.00 , A = 9.39 
mT). 
 
[MnII(NCMe)(6Medpaq)]+ was also subjected to Mn K-edge XAS analysis. This technique 
was used previously to characterize the MnII complexes of other dpaq derivatives, and as such 
served as a good method to validate our formulation of the orange species as a MnII complex.33 
The Mn K-edge energy of the spectrum was found to be 6547.1 eV, similar to the edge energies 
reported for [MnII(NCMe)(dpaq)](OTf) and [MnII(NCMe)(dpaq2Me)](OTf) (6547.9 and 6548.6, 
respectively; Table 1; Figure 4.3). The pre-edge features of the three MnII-complexes are of similar 
energy, though the area under the pre-edge feature of [MnII(NCMe)(6Medpaq)]+ is higher (Table 
4.1, Figure 4.3 inset).33 As the energy of the pre-edge features and the Mn K-edge are sensitive to 
oxidation state, these findings support our assignment of the orange species as containing a MnII 
center. However, the difference in the area of the pre-edge feature suggests that there are geometric 






Figure 4.3. Mn K-edge near-edge spectra of [MnII(NCMe)(6Medpaq)]+ (blue), 
[MnII(NCMe)(dpaq)]+ (red), and [MnII(NCMe)(dpaq2Me)]+ (green) collected for frozen solutions 
in MeCN at 10 K. Inset: Expanded view of the pre-edge region. 




Pre-edge area Edge energy Reference 
[MnII(MeCN)(6Medpaq)]+ 6540.1 5.3 6547.1 This work 
[MnII(MeCN)(dpaq)]+ 6540.2 4.9 6547.9 30 
[MnII(MeCN)(dpaq2Me]+ 6540.2 4.3 6548.6 30 
  
Insight into possible structural differences between [MnII(NCMe)(6Medpaq)]+ and the 
previously reported MnII complexes can be garnered from the analysis of the extended X-ray 
absorption fine structure (EXAFS) data collected for [MnII(NCMe)(6Medpaq)]+. The Fourier 
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transform of the EXAFS spectrum of [MnII(NCMe)(6Medpaq)]+ consists of an intense peak at 1.81 
Å with shoulders at 1.01 and 1.44 Å, as well as a smaller peak at 2.61 Å with a shoulder at 2.19 Å 
(Figure 4.4). This set of peaks is best fit using a shell of 6 N/O atom scatterers at an average 
distance of 2.25 Å (Table 4.2.) The distance for this scattering shell agrees well with the average 
Mn-N/O distance from a DFT-optimized structure of [MnII(NCMe)(6Medpaq)]+ (Table 4.3). While 
splitting the N/O shell improves the goodness of fit, the resulting Debye-Waller factor is smaller 
than expected (Table 4.2). It is important to note that the EXAFS spectra of [MnII(NCMe)(dpaq)]+ 
and [MnII(NCMe)(dpaq2Me)]+ were also best fit using single shells of N atom scatterers.33 A shell 
of 6 C atoms at 3.09 Å was included to account for the second coordination sphere (Table 4.2). 
 
Table 4.2. Fits of EXAFS data of [MnII(NCMe)(6Medpaq)]+.a 
Fit 
Mn-N/O Mn-N/O Mn-C Goodness 
of fitb n r (Å) σ2 n r (Å) σ2 n r (Å) σ2 
1 6 2.25 0.005       0.358 
2 5 2.25 0.004       0.359 
3 5 2.26 0.003 1 2.49 0.003    0.361 
4 4 2.27 0.003 2 2.50 0.003    0.429 
5 6 2.25 0.005    6 3.10 0.005 0.285 
6 6 2.25 0.005    4 3.10 0.003 0.286 





Figure 4.4. Fourier transform of the Mn K-edge EXAFS data, and EXAFS spectra (inset), for 
[MnII(NCMe)(6Medpaq)]+ in frozen MeCN. Experimental data are in black, while fit 5 (see table 2) 
is in red. 
 
 
The DFT-optimized structure of [MnII(NCMe)(6Medpaq)]+ that was used for EXAFS data 
refinement has a six-coordinate Mn center, similar to those reported in the crystal structures of 
[MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf).31, 34 The calculated distances between the Mn center 
and the pyridine substituents are 2.40 and 2.43 Å (Table 4.3). These distances are longer than the 
Mn-pyridine distances reported for the crystal structures of [MnII(dpaq)](OTf) and 
[MnII(dpaq2Me)](OTf)  by 0.11 to 0.19 Å, presumably due to the steric bulk imparted by the methyl 
substitutions adjacent to the donor nitrogen atom (Figure 4.5, Table 4.3).31, 34 The calculated 
structure of [MnII(NCMe)(6Medpaq)]+ also has a Mn-amide N bond distance of 2.09 Å which is 
shorter than what is observed for [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) by 0.10 and 0.08 
Å, respectively (Table 4.3).31, 34 The remaining Mn-ligand bond lengths of the calculated structure 
of [MnII(NCMe)(6Medpaq)]+ are similar to that reported for [MnII(dpaq)](OTf)  and 




Figure 4.5. DFT-optimized structure of [MnII(NCMe)(6Medpaq)]+. 
Table 4.3. Comparison of the scattering distance from the EXAFS fit of [MnII(NCMe)(6Medpaq)]+ 
to bond lengths obtained from a DFT-optimized structure of [MnII(NCMe)(6Medpaq)]+ and bond 
lengths obtained from the X-ray structures of [MnII(dpaq)](OTf) and [MnII(dpaq2Me)](OTf) 
(distances in Å). 
 
[MnII(NCMe)(6Medpaq)]+ [MnII(dpaq)](OTf)a [MnII(dpaq2Me)](OTf)a 
EXAFS DFT   
Mn-Namide -- 2.09 2.191(3) 2.172(3) 
Mn-NPy  -- 2.40, 2.43 2.244(3), 2.286(3) 2.275(3), 2.286(3) 
Mn-Namine -- 2.32 2.314(3) 2.317(3) 
Mn−NQu -- 2.24 2.214(3) 2.268(3) 
Mn-N (avg.) 2.25 2.30 2.250 2.264 
Mn---C 
(avg.) 
3.10 3.07 3.08 3.08 
a From references 31, 34. 
 
Formation and characterization of [MnIII(OH)(6Medpaq)](OTf). Previously reported MnII 
complexes from our group have shown varying reactivity with dioxygen to generate MnIII 
species.31, 34, 35 The [MnII(dpaq)](OTF) complex, along with the [MnII(dpaq5OMe)](OTF) and 
[MnII(dpaq5Cl)](OTF) complexes, react with dioxygen to generate mononuclear MnIII-hydroxo 
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complexes that exist in equilibria with (µ-oxo)dimanganese(III, III) species.35 The sterically 
modified [MnII(dpaq2Me)](OTF) also reacts with dioxygen, but in this case strictly forms a 
monomeric MnIII-hydroxo complex.31, 35 When the dpaq ligand is functionalized with and electron-
withdrawing NO2 group, [Mn
II(dpaq5NO2)](OTF) reacts with dioxygen very slowly (only partial 
conversion was observed after 24 hours of reaction), and instead requires the use of iodosylbenzene 
(PhIO) to form an equilibrium mixture of MnIII-hydroxo and (µ-oxo)dimanganese(III, III) 
species.35 These MnIII species all exhibit similar electronic absorption spectra with a feature around 
770 nm that has been assigned to the MnIII dx2-y2 to dz2 transition.
31, 34, 35 
 [MnII(NCMe)(6Medpaq)]+ reacts very slowly with dioxygen, with only partial oxidation 
being observed after a period of 48 hours. Presumably, the elongation of the Mn-NPy bond, and 
resultant withdrawal of electron density at the metal center, raises the MnIII/II reduction potential 
enough to reduce reactivity with dioxygen. However, the reaction between 
[MnII(NCMe)(6Medpaq)]+ and PhIO is rapid, resulting in the formation of a dark orange solution 
with a single electronic absorption feature at 500 nm (Figure 4.6). Mass spectral analysis of the 
dark orange solution shows a peak at m/z = 482.1340, consistent with the MnIII-hydroxo complex 
[MnIII(OH)(6Medpaq)]+ (calculated m/z = 482.1389, Figure A3.5). The magnetic moment of 
[MnIII(OH)(6Medpaq)]+ as determined using the Evans 1H NMR method with diamagnetic 
correction supported the assignment of this species as a high-spin MnIII center (µeff = 4.5 µB, 




Figure 4.6. Electronic absorption spectra monitoring the reaction of a 2 mM solution of 
[MnII(NCMe)(6Medpaq)]+ with 0.5 equivalents of PhIO in MeCN at 298 K. 
 
 
Repeated recrystallizations of the dark orange solution obtained following the reaction of 
[MnII(NCMe)(6Medpaq)]+ with PhIO resulted in the formation of dark grey crystals that were 
suitable for XRD analysis. The X-ray crystal structure of [MnIII(OH)(6Medpaq)](OTf) contains a 
six-coordinate MnIII center with a distorted octahedral geometry (Figure 4.7). The 6Medpaq ligand 
is coordinated to the metal center in a pentadentate fashion, with the amide function trans to the 
hydroxo ligand. This coordination mode is identical that observed in MnIII-hydroxo complexes of 
other dpaq derivatives.31, 34, 35 The Mn-O distance is 1.806(6) Å, which is identical to that observed 
for [MnIII(OH)(dpaq)](OTf) (Table 4.4).34. These Mn-O distances are on the low end of the range 
of Mn-O bond lengths reported for MnIII-hydroxo complexes (1.81-1.86 Å).31, 36-44  Inspection of 
the extended structure of [MnIII(OH)(6Medpaq)]+ reveals that the hydrogen atom of the hydroxo 
ligand is involved in a hydrogen-bonging interaction with the amide oxygen of a neighboring 
[MnIII(OH)(6Medpaq)]+ complex (H…O distance of 2.008 Å, Figure A3.6). A free triflate ion is also 
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present in the asymmetric unit, though not directly associated with the Mn center (Mn-O distance 
of ~7.5 Å).   
The Mn-NPyridine distances in the crystal structure of [Mn
III(OH)(6Medpaq)](OTf) are 0.114 
Å longer than the corresponding distances in [MnIII(OH)(dpaq)]+ (Table 4.4).34 This elongation is 
caused by the steric bulk of the methyl functions. Similar bond lengths have been observed in the 
crystal structures of MnIII complexes of the N4S- class of ligands. These complexes featured 6-
methylpyridinyl or quinolinyl substituents in the equatorial field, with the Mn-N bond length 
ranging from 2.352 – 2.581 Å.9, 10, 32 For [MnIII(OH)(6Medpaq)](OTf), the longer Mn-NPyridine 
distances are accompanied by modest contractions of the Mn-Namide, Mn-NQuinoline, and Mn-Namine 
bonds by 0.013, 0.029, and 0.043 Å, respectively, relative to [MnIII(OH)(dpaq)](OTf) (Table 4). 
The paired elongation of Mn-NPyridine distances and contraction of the other Mn-N distances is 
consistent with our calculated structure of the MnII complex (Figure 4.5, Table 4.3). 
 
 
Figure 4.7. ORTEP diagram of cationic portion of [MnIII(OH)(6Medpaq)](OTf)showing 50% 




Table 4.4. Manganese-ligand bond lengths (Å) from the crystal structures of 
[MnIII(OH)(6Medpaq)](OTf) and [MnIII(OH)(dpaq)](OTf). 
Bond [MnIII(OH)(6Medpaq)](OTf) [MnIII(OH)(dpaq)](OTf)a 
Mn-O(H) 1.806(6) 1.806(13) 
Mn-Namide 1.962(6) 1.975(14) 
Mn-NPyidine 2.322(6), 2.381(7) 2.260(14), 2.216(15) 
Mn-NQuinoline 2.041(7) 2.072(14) 
Mn-Namine 2.130(6) 2.173(14) 
a From reference 26. 
 
 
The MnIII-hydroxo complex [MnIII(OH)(6Medpaq)](OTf) was also characterized by 1H 
NMR spectroscopy in MeCN at 298 K. The spectrum exhibits seven hyperfine-shifted peaks, as 
well as two peaks in the 0 - 10 ppm region (Figure 4.8, red trace and Table 4.5). The 1H NMR data 
suggest that the oxidation of [MnII(NCMe)(6Medpaq)]+ with PhIO does not result in the formation 
of an equilibrium mixture of a MnIII-hydroxo species and a to (µ-oxo)dimanganese(III, III) dimer. 
The chemical shifts for the hyperfine-shifted peaks of  [MnIII(OH)(6Medpaq)]+ are quite similar to 
that observed in the 1H NMR spectra of [MnIII(OH)(dpaq)]+ (Figure 4.8, red and blue traces and 
Table 4.5).35, 45 The four most strongly up-field-shifted peaks of [MnIII(OH)(dpaq)]+, at -15.5, -
33.7, -53.8, and -63.4 ppm (Figure 4.8), were previously assigned to protons from the quinolinyl 
moiety.46 The upfield region of the 1H NMR spectrum of  [MnIII(OH)(6Medpaq)]+ shows three sharp 
peaks at -19.3, -45.0, and -61.6 ppm that resemble the peaks of [MnIII(OH)(dpaq)]+ at -15.5, -33.7, 
-53.8 ppm. The 1H NMR spectrum of  [MnIII(OH)(6Medpaq)]+ lacks a broad, highly upfield-shifted 
peak analogous to the weak, broad -63.4 ppm signal of [MnIII(OH)(dpaq)]+. The overall similarities 
between the upfield region of the 1H NMR spectra of [MnIII(OH)(6Medpaq)]+ to that of  
[MnIII(OH)(dpaq)]+ are expected given the lack of changes to the quinolinyl group in the former 
complex. The 1H NMR signals of [MnIII(OH)(dpaq)]+ at 130.5, 60.9, 54.3, and -4.6 ppm were 
119 
 
attributed to pyridyl protons.46 Consequently, the larger perturbations in the down-field regions of 
the 1H NMR spectra of [MnIII(OH)(dpaq)]+ and [MnIII(OH)(6Medpaq)]+ can be rationalized by 
changes in chemical shifts of pyridyl protons. The peak at 130.5 ppm for [MnIII(OH)(dpaq)]+ was 
assigned to the α-H of the pyridine substituent. The lack of a corresponding peak in the 1H NMR 
spectrum of [MnIII(OH)(6Medpaq)]+ is consistent with the 6-methyl-pyridine functionalization of 
the ligand. The 1H NMR spectrum of [MnIII(OH)(6Medpaq)]+ contains a broad, up-field-shifted 
peak at -9.5 ppm, lacking in the 1H NMR spectrum of [MnIII(OH)(dpaq)]+, that could arise from 
the protons of the 6-methyl-pyridyl groups. 
 
Figure 4.8. 1H NMR spectra of 2 mM solutions of [MnIII(OH)(6Medpaq)]+ (top), 
[MnIII(OOtBu)(6Medpaq)]+ (center), and a 15 mM solution of [MnII(OH)(dpaq)]+ (bottom) with 45 
µL D2O in d3-MeCN at 298 K. Inset: expanded view of the 0 to 20 ppm region. 
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Table 4.5. 1H NMR Chemical Shifts (ppm) for [MnIII(OH)(6Medpaq)]+, [MnIII(OOtBu)(6Medpaq)]+, 
and [MnIII(OH)(dpaq)]+ in CD3CN. 
[MnIII(OH)(6Medpaq)]+ [MnIII(OOtBu)(6Medpaq)]+ [MnIII(OH)(dpaq)]+a,b 
    130.5 (H-py) 
66.0 66.8 62.7 (H-qn) 
51.4 46.1 60.9 (H-py) 
44.8 42.2 54.3 (H-py) 
    40.5 
8.9 9.2  
5.5 5.5  
-9.6 -10 -4.6 (H-py) 
-19.3 -22 -15.5 (H-qn) 
   -33.7 (H-qn) 
-45 -46.9 -53.8 (H-qn) 
-61.6 -60 -63.4 (H-qn) 
a From the spectrum of [MnIII(OH)(dpaq)]+ in d3-MeCN with 880 equivalents of D2O.
35 b Tentative 




The electronic absorption spectrum of [MnIII(OH)(6Medpaq)]+ reveals stark differences to 
that observed in [MnIII(OH)(dpaq)]+ and its previously reported derivatives (Figure 4.9). While the 
previous MnIII-hydroxo complexes have all exhibited an electronic absorption feature around 770 
nm, such a signal is not observed for [MnIII(OH)(6Medpaq)]+.31, 34, 35 This is presumed to be an 
effect of the distorted geometric environment around the Mn center (Figure 4.7, Table 4.4). 
Namely, the methyl functionalization adjacent to the coordinating N atom of the pyridine arms 
results in an elongation of the Mn-NPy bond. This withdrawal of electron density as a result of this 
weakened coordination stabilizes the dx2-y2 orbital. As the feature observed around 770 nm for 
[MnIII(OH)(dpaq)]+ was assigned as a dx2-y2 to dz2 transition, stabilization of the dx2-y2 orbital would 
blue-shift this electronic transition. A significant enough shift in energy may cause this band to be 




Figure 4.9. The electronic absorption spectrum of MnIII(OH)(6Medpaq)]+ (red trace) consists of an 
intense feature at 510 nm and a weak shoulder around 620 nm. Electronic absorption spectrum of 
[MnIII(OH)(dpaq)]+ shown for comparison (red trace). 
 
 
Reactions of [MnII(6Medpaq)]+ and [MnIII(OH)(6Medpaq)]+ with tBuOOH. Species 
[MnII(NCMe)(6Medpaq)]+ reacts with tBuOOH in MeCN at 298 K to form a green species (species 
1). The electronic absorption spectrum of this green chromophore has a shoulder near 500 nm and 
prominent band at 650 nm (Figure 4.10, left). The maximum formation of 1, as assessed by the 
lack of further growth of electronic absorption features, was observed with the addition of 1.5 
equivalents of tBuOOH (Figure A3.7).  The addition of tBuOOH to [MnII(NCMe)(6Medpaq)]+ 
initially results in the formation of a broad, featureless spectrum, with the eventual appearance of 
bands around 510 and 650 nm (Figure 4.10, left). While the intensity of the 650 nm band 
maximizes at ca. 60 minutes after tBuOOH addition, the band at 510 nm reaches a maximum at 80 
minutes and then drops in intensity over the course of 40 minutes (Figure 4.10, left inset). The 
observation of the initial growth and subsequent disappearance of a band at 510 nm suggests that 
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the reaction between [MnII(NCMe)(6Medpaq)]+ and tBuOOH proceeds through the 
[MnIII(OH)(6Medpaq)]+, which reacts with tBuOOH to generate species 1. The formation of a MnIII-
hydroxo intermediate during the reactivity of MnII complexes with tBuOOH has been observed in 
a previous report.11 
 
Figure 4.10. Left: Electronic absorption spectra showing the formation of a weak shoulder around 
500 nm and a feature at 650 nm following the reaction of [MnII(NCMe)(6Medpaq)]+ (blue trace) 
with 1.5 equivalents of tBuOOH (red trace). Right: Electronic absorption spectra showing the 
formation of a weak shoulder around 500 nm and a feature at 650 nm following the reaction of 
[MnIII(OH)(6Medpaq)]+ (blue trace) with 1 equivalent of tBuOOH (red trace). Time course of the 
reactions are shown in the insets. 
 
To test our proposal that [MnIII(OH)(6Medpaq)]+ reacts with tBuOOH to form species 1, we 
treated this MnIII-hydroxo complex with 1 equivalent of tBuOOH From monitoring this reaction 
by electronic absorption spectroscopy, we observed the formation of the 650 nm electronic 
absorption band of 1 along with the decay of the 510 nm band of [MnIII(OH)(6Medpaq)]+ (Figure 
4.10, right). This conversion is accompanied with isosbestic points at 505 and 555 nm, indicating 
the lack of an intermediate species in this reaction. The absorption features of this green species 
are within the range of previously reported MnIII-alkylperoxo complexes (Table 4.6).9-11 Kovacs 
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and coworkers report well-defined electronic absorption features ranging from 585 to 600 nm, and 
shoulders from 355 to 420 nm, for their crystallographically characterized MnIII-alkylperoxo 
complexes.9, 10 The electronic absorption spectra of [MnIII(OOtBu)(dpaq)]+ and 
[MnIII(OOtBu)(dpaq2Me)]+ exhibit features at 710 and 690 nm, respectively, as well as shoulders 
around 475 nm.11  
Table 4.6.  Comparison of electronic absorption band maxima (nm) and O-O stretching 
frequencies (νO-O, cm
-1) for MnIII-alkylperoxo complexes. 
Complex λ ν Reference 
1 ~500 650 877 This work 
[MnIII(OOtBu)(dpaq)]+ ~475 710 872 11 
[MnIII(OOtBu)(dpaq2Me)]+ ~475 690 NR 11 
[MnIII(OOtBu)(SMe2N4(6-Me-DPPN))]
+ 420 585 893 10 
[MnIII(OOtBu)(SMe2N4(QuinoPN))]
+ 415 590 895 10 
[MnIII(OOtBu)(SMe2N4(QuinoEN))]
+ 385 590 888 9, 10 
[MnIII(OOtBu)(SMe2N4(6-Me-DPEN))]
+ 355 600 875 10 
     
 
Mass spectral analysis of 1 showed a peak at m/z = 554.1968 that is consistent with the 
formulation of this species as [MnIII(OOtBu)(6Medpaq)]+  (calculated m/z = 554.1964, see 
appendix). The magnetic moment of 1, as determined using the Evans 1H NMR method with 
diamagnetic correction, supports the assignment of this species as a high-spin MnIII center (µeff = 
4.5 µB). The 
1H NMR spectrum of 1 is qualitatively similar to that observed for 
[MnIII(OH)(6Medpaq)]+ (Figure 4.8). Three upfield-shifted-peaks at -22, -46.9, and -60 ppm are 
only slightly perturbed from those observed in the 1H NMR spectrum of [MnIII(OH)(6Medpaq)]+ 
(Table 4.5). The broad signal at -10 ppm is still present in the 1H NMR spectrum of 1, but much 
less intense than the analogous feature observed in the 1H NMR spectrum of 
[MnIII(OH)(6Medpaq)]+ (Figure 4.8). Similar to that observed for the up-field-shifted peaks, the 
down-field-shifted peaks at 66.8, 46.1, and 42.2 ppm in the 1H NMR spectrum of 1 only show 
slight deviations from those observed 1H NMR spectrum of [MnIII(OH)(6Medpaq)]+ (Table 4.5).  
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The similarities in the 1H NMR spectra of [MnIII(OH)(6Medpaq)]+ and 1 suggest structural 
similarities between the two species. 
Further support of the formulation of 1 as a MnIII-alkylperoxo species comes from FT-IR 
experiments. The solution FT-IR spectrum obtained following the reaction between 
[MnIII(OH)(6Medpaq)]+ with 1 equivalent of tBuOOH shows a feature at 877 cm-1 that is not 
observed in the spectrum of [MnIII(OH)(6Medpaq)]+ (Figure 4.11). This band has an energy similar 
to those of O-O vibrations reported for MnIII-alkylperoxo complexes (872 – 895 cm-1; Table 4.6).9-
11 As such, we tentatively assign this feature as the O-O stretch of [MnIII(OOtBu)(6Medpaq)]+. 
Confirmation of this assignment will come from FT-IR analysis of 1 that is generated using 
tBu18O18OH. 
 
Figure 4.11. Solution FT-IR spectrum obtained following the reaction between a 2 mM solution 
of [MnIII(OH)(6Medpaq)]+ in MeCN and 1 equivalent of tBuOOH, showing a signal at 877 cm−1 
tentatively assigned as the O−O stretch of the alkylperoxo complex (green trace). The spectrum of 





Additional support for the formulation of 1 as a MnIII-alkylperoxo species comes from an 
XAS analysis of frozen MeCN solutions following the reaction between a 10 mM solution of 
[MnIII(OH)(6Medpaq)]+ and 1 equivalent of 
tBuOOH at 50°C. The Mn K-edge energy of 1 is 6549.4 
eV, similar to the edge energies reported for [MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+ 
(6550.4 and 6549.5, respectively; Table 4.7; Figure 4.12). The pre-edge features of the three MnIII-
complexes are of similar energy and area (Table 4.7, Figure 4.12 inset).11 Taken together with the 
electronic absorption, mass spectrometry, and FT-IR data, this analysis of the XAS data supports 
our assignment of 1 as [MnIII(OOtBu)(6Medpaq)]+. 
 
 
Figure 4.12. Comparison of Mn K-edge near-edge spectra of 1 (blue), [MnIII(OOtBu)(dpaq)]+ 
(red), and [MnIII(OOtBu)(dpaq2Me)]+ (green) collected for frozen solutions in MeCN at 10 K. 






















4.1 6549.5 35 
     
 
Structural information for previously reported [MnIII(OOtBu)(dpaq)]+ and 
[MnIII(OOtBu)(dpaq2Me)]+ was afforded through extended X-ray absorption fine structure 
(EXAFS) analysis of frozen MeCN solutions. A similar analysis was performed for a 10 mM 
sample of 1 in MeCN that was formed at 50°C and subsequently frozen. The Fourier transform of 
the EXAFS data of 1 consists of an intense peak at 1.99 Å with a shoulder at 1.87 Å, a peak at 2.45 
Å, and smaller features at 3.00 and 3.34 Å (Figure 4.13). The first coordination sphere was fit by 
including a shell of 2 O/N atoms at 2.00 Å and a shell of 3 N atoms at 2.35 Å (Table 4.8). This 
combination of shells results in a more intense peak than that observed in the experimental data 
(Figure 4.13). Numerous combinations of N atom and O atom shells were evaluated in an effort to 
better model the intensity of the peak at 1.99 Å, but the variations either did not improve the quality 
of the fit, or resulted in unreasonable distances or Debye-Waller factors (Table 4.8). The fit was 
improved by including a shell of 6 C atoms at 2.91 Å to account for the second coordination sphere, 
but modeling of peak intensities remained poor (Figure 4.13). The inclusion of a multiscattering 
pathway comprised of a C atom and a N atom greatly improved the fit, but resulted in negative 





Figure 4.13. Fourier transform of the Mn K-edge EXAFS data, and EXAFS spectra (inset), for 10 
mM 1 in frozen MeCN. Experimental data is in black, while fits of the data are shown in red. 
 
Table 4.8. Fits of EXAFS data of 1.a 
Fit 




















1 6 1.71 0.073                         0.999 
2 1 1.99 0.008 5 2.3 0.006                   0.714 
3 1 2.01 0.005 4 2.38 0.006                   0.613 
4 2 2.02 0.010 4 2.37 0.005                   0.574 
5 4 2.03 0.036 2 2.36 -0.001                   0.505 
6 2 2.05 0.015 3 2.36 0.002                   0.508 
7 3 2.02 0.020 3 2.36 0.002                   0.529 
8 2 2.01 0.016 2 2.70 -0.001                   0.490 
9 2 2.05 0.016 3 2.55 0.007 1 2.38 -0.004             0.384 
10 2 2.07 0.012 2 2.61 -0.001 2 2.41 -0.001             0.324 
13 2 2 0.014 3 2.35 0.002       6 2.91 0.006       0.369 
17 2 2 0.010 3 2.35 0.003       6 2.91 0.005 2 3.32 -0.0006 0.263 
aFit highlighted in bold, italicized font represents the best fit as shown in Figure A3.13 (red trace). 
bEvaluated using the R-factor. 
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Fits of the EXAFS data within different k ranges converged on shells of similar distances, 
supporting the model described above as a reasonable fit to the data (Table A3.1). EXAFS data of 
the previously reported [MnIII(OOtBu)(dpaq)]+ were similarly fit with two shells of 2 O/N atoms  
and 4 N  atoms for the first coordination sphere, and a shell of 6 C atoms for the second 
coordination sphere.11 In that case, the shell of 2 O/N atoms was attributed to contributions from 
the axial amide and alkylperoxo ligands, and the shell of 4 N atoms was attributed to the equatorial 
ligands. The structural parameters obtained from fitting the EXAFS data of [MnIII(OOtBu)(dpaq)]+ 
were very similar to those reported in the crystal structure of its MnIII-hydroxo counterpart 
(Chapter 3).11 If the shells used in the fitting of EXAFS data of 1 are assigned similarly, the analysis 
suggests unexpected deviations in Mn-ligand bond lengths between 1 and 
[MnIII(OH)(6Medpaq)](OTf) (Table 4.9). This may indicate that different structural models need to 
be considered for [MnIII(OOtBu)(6Medpaq)]+. Alternatively, since the sample of 1 was formed at 
50°C at a relatively high concentration of 10 mM, there is a possibility of some thermal decay 
product being present. Such inhomogeneity would complicate the analysis of the EXAFS data. As 
such, we plan to prepare a new sample of 1 for XAS analysis at a later time. 
Table 4.9. Comparison of the bond lengths obtained from the EXAFS analysis of 1, a DFT-
optimized structure of [MnIII(OOtBu)(6Medpaq)]+, the EXAFS analysis of [MnIII(OOtBu)(dpaq)]+, 
and the crystal structure of  [MnIII(OH)(6Medpaq)](OTf) (distances in Å).  
 1 [MnII(OOtBu)(6Medpaq)]+ [MnIII(OOtBu)(dpaq)]+ a [MnIII(OH)(6Medpaq)](OTf) 
 EXAFS DFT EXAFS XRD 
Mn-O/Namide 2.00 1.84(O), 1.97(N) 1.90 
1.806(6) (O),1.962(6) 
(N) 
Mn-NPy   2.41, 2.27 -- 2.322(6), 2.381(7) 
Mn-Namine  2.14 -- 2.130(6) 
Mn−NQu  2.03 -- 2.041(7) 
Mn-Neq 
(avg.) 
2.34 2.21 2.17 2.22 
Mn---C 
(avg.) 
2.91 2.95 2.97 2.96 
a From reference 11.  
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The DFT-optimized structure of [MnIII(OOtBu)(6Medpaq)]+ used for refinement of the 
EXAFS data predicts similar metrical parameters to those observed in the XRD structure of 
[MnIII(OH)(6Medpaq)](OTf) (Table 4.9).  The calculated structure has a six-coordinate Mn center, 
similar to the crystal structure of [MnIII(OH)(6Medpaq)](OTf) (Figures 4.7 and 4.14). The calculated 
structure of [MnIII(OOtBu)(6Medpaq)]+ has a Mn-O(OtBu) distance of 1.84 Å which is longer than 
the Mn-O(H) distance observed in the crystal structure of [MnIII(OH)(6Medpaq)]+ by ~0.03 Å. A 
similar Mn-O bond length was calculated for [MnIII(OOtBu)(dpaq)]+.11 The calculated O-O bond 
length of [MnIII(OOtBu)(6Medpaq)]+ is 1.48 Å, identical to the O-O bond lengths calculated for 
[MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+.11 The calculated distances between the Mn 
center and the pyridine substituents are 2.41 and 2.27 Å (Table 4.9). These distances are longer 
than the Mn-pyridine distances calculated for [MnIII(OOtBu)(dpaq)]+ and 
[MnIII(OOtBu)(dpaq2Me)]+ by 0.08 to 0.23 Å, due to the steric bulk imparted by the methyl 
substitutions adjacent to the donor nitrogen atom (Figure 4.14, Table 4.9).31, 34 The DFT-calculated 
Mn-Namide bond length of 1.97 Å is similar to that observed in the crystal structure of 
[MnIII(OH)(6Medpaq)](OTf) and slightly shorter than that calculated for [MnIII(OOtBu)(dpaq)]+ 
(1.99 Å, Table 4.9).11 The Mn-NQuinline and Mn-Namine bond lengths of [Mn
III(OOtBu)(6Medpaq)]+ 
are calculated to be essentially identical to those observed in the crystal structure of 





Figure 4.14. DFT-optimized structure of [MnIII(OOtBu)(6Medpaq)]+. 
 
Reactivity and decay of [MnIII(OOtBu)(6Medpaq)](OTf). The thermal decay of 
[MnIII(OOtBu)(6Medpaq)]+ occurs over a period of days at 298 K to yield a brown solution. An 
estimate of the half-life was determined by monitoring the decay with electronic absorption 
spectroscopy. After a period of 116 hours, the intensity of the electronic absorption feature at 650 
nm had decayed by 44% in MeCN at 298 K. Assuming a constant rate of decay, the half-life of 
[MnIII(OOtBu)(6Medpaq)]+ is estimated to be 5 days. The decay is quicker at 328 K (t1/2 ≈ 10 hours), 
allowing the complete decay pathway to be monitored using electronic absorption spectroscopy 
over the course of 46 hours (Figure 4.15). Monitoring the disappearance of the electronic 
absorption feature at 650 nm reveals an initial relatively slow rate of decay, followed by a more 
rapid process. Thus, the decay of [MnIII(OOtBu)(6Medpaq)]+ does not follow first-order kinetic 
behavior, precluding the determination of a pseudo-first-order rate constant for this process. The 




Figure 4.15. Electronic absorption spectra following the decay of a 2 mM solution of 1 in MeCN 
(blue trace) at 328 K over the course of  46 hours to result in a featureless spectrum (red trace). 
 
 
 1H NMR analysis of the solution following thermal decay reveals the loss of signals 
corresponding to 1 along with the appearance of hyperfine-shifted peaks that are consistent with 
the formation of [MnIII(OH)(6Medpaq)]+. Multiple other hyperfine-shifted peaks are also observed, 
indicating the formation of one or more paramagnetic species also being formed through a 
presumably complex decay mechanism (Figure 4.16, blue trace). There are very few peaks in the 
0-12 ppm region, none of which correspond to the free ligand (Figure A3.9). Mass spectral analysis 
of the solution following the decay of [MnIII(OOtBu)(6Medpaq)]+ revealed peaks associated with 




Figure 4.16. 1H NMR spectra obtained of [MnIII(OH)(6Medpaq)]+ (red trace) and 
[MnIII(OOtBu)(6Medpaq)]+ in d3-MeCN (green trace), as well as 
1H NMR spectra obtained 
following the thermal decay of a 2 mM solution [MnIII(OOtBu)(6Medpaq)]+ in d3-MeCN (blue 
trace), as well as after the reaction of [MnIII(OOtBu)(6Medpaq)]+ with 100 equivalents of H2O in 
d3-MeCN (brown trace).  
 
Taking inspiration from the proposed catalytic cycle of Mn-LOX, in which a proposed 
MnIII-alkylperoxo intermediate undergoes ligand exchange with H2O to form the Mn
III-hydroxo 
resting state of the enzyme,8 we also investigated the reactivity of [MnIII(OOtBu)(6Medpaq)]+ with 
H2O. The addition of 100 equivalents of H2O to [Mn
III(OOtBu)(6Medpaq)]+ results in the loss of 
intensity at 650 nm, resulting in an electronic absorption spectrum with a feature at ~500 nm, 
similar to what is observed in the spectrum of [MnIII(OH)(6Medpaq)]+ (Figure 4.17). However, the 
precipitation of an insoluble brown solid is also observed during this process, possibly indicative 
133 
 
of demetallation.  1H NMR analysis of the filtered solution following thermal decay reveals a 
similar set of peaks to that observed in the thermal decay of [MnIII(OOtBu)(6Medpaq)]+, including 
hyperfine-shifted signals that can be attributed to both [MnIII(OOtBu)(6Medpaq)]+ and 
[MnIII(OH)(6Medpaq)]+, as well as additional hyperfine-shifted peaks that have not been identified 
(Figure 4.16). Mass spectral analysis of the solution following the decay of 
[MnIII(OOtBu)(6Medpaq)]+ revealed peaks associated with free 6Medpaq ligand, [MnII(6Medpaq)]+, 
[MnIII(OH)(6Medpaq)]+, and [MnIII(OOtBu)(6Medpaq)]+ (Figure A3.10). While the observation of 
[MnII(6Medpaq)]+ as a major decay product may support a mechanism proceeding through Mn-O 
homolysis, the observation of other products points to a more complicated array of decay reactions 
taking place. 
 
Figure 4.17. Electronic absorption spectra monitoring the reaction of a 2 mM solution of 
[MnIII(OOtBu)(6Medpaq)]+ in MeCN with 100 equivalents of H2O at 298 K. (Inset) time course for 
the spectral changes. 
 
 
As previous studies have employed phosphines as a probe of homolytic O-O bond 
cleavage, the reactivity of [MnIII(OOtBu)(6Medpaq)]+ with PPh3 was investigated.
10, 47 The addition 
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of 100 equivalents of PPh3 to an anaerobic solution of [Mn
III(OOtBu)(6Medpaq)]+ (0.5 mM in 
MeCN) at 298 K resulted in the loss of intensity at 650 nm over the course of two hours, resulting 
in an electronic absorption spectrum consistent with the generation of MnII products (Figure 4.18). 
A 31P NMR analysis of the organic products revealed the formation of Ph3PO (Figure A3.11). 
Previously reported MnIII-alkylperoxo complexes supported by N4S
- ligands are also able to react 
with a phosphine substrate and yield the phosphine oxide product.10 In those cases, the addition of 
PPh3 did not have an effect on the decay rate of the Mn
III-alkylperoxo species, indicative of the 
MnIII-alkylperoxo decay product being responsible for the reativity.10 Since the addition of PPh3 
does affect the decay rate of [MnIII(OOtBu)(6Medpaq)]+, it is likely that the oxidation of PPh3 
follows a different pathway in which the substrate reacts directly with the MnIII-alkylperoxo 
species.  
 
Figure 4.18. Electronic absorption spectra monitoring the reaction of a 0.5 mM anaerobic solution 
of [MnIII(OOtBu)(6Medpaq)]+ (blue trace) in MeCN with 100 equivalents of PPh3 at 298 K. (Inset) 





The reaction between [MnIII(OOtBu)(6Medpaq)]+ and the hydrogen-atom donor 9,10-
dihydroanthracene (DHA) was also explored. 75 equivalents of DHA were added to a 1.25 mM 
solution of [MnIII(OOtBu)(6Medpaq)]+ in MeCN and allowed to stir for 30 hours while monitoring 
with electronic absorption spectroscopy. The slow disappearance of the electronic absorption 
feature at 650 nm was observed (Figure 4.19). 1H NMR analysis of the organic products revealed 
the formation of 14.5 equivalents of anthracene, 7 equivalents of anthrone, and 1.5 equivalents of 
anthraquinone (Figure A3.12). The total amount of oxidized products corresponds to 23 
equivalents of DHA being consumed during the reaction. The products observed can arise from 
the reactivity of DHA with a high-valent Mn complex and/ or an alkoxyl or peroxyl radical 
generated through the different possible decay pathways of [MnIII(OOtBu)(6Medpaq)]+. 
Furthermore, the presence of O2 likely has an effect on the product distribution. As such, the 
reaction between [MnIII(OOtBu)(6Medpaq)]+ and DHA has not proven insightful towards the decay 
mechanism of [MnIII(OOtBu)(6Medpaq)]+. Future experiments in which O2 is absent from the 
reaction mixture should prove more illuminating. It should be noted that DHA oxidation 
experiments with previously reported MnIII-alkylperoxo complexes supported by N4S- ligands did 
exhibit the formation of hydrogen atom transfer products. However, the presence of a substrate 
did not affect the rate of MnIII-alkylperoxo decay, suggesting that a proposed MnIV-oxo decay 




Figure 4.19. Electronic absorption spectra following the reaction of a 1.25 mM solution of 
[MnIII(OOtBu)(6Medpaq)]+ (red trace) with 9,10-dihydroanthracene in MeCN at 328 K. (Inset) time 
course for the spectral changes. 
4.4 Conclusion. In this work, a new derivative of the dpaq ligand platform was developed 
in order to stabilize a MnIII-alkylperoxo species. The MnII complex of this new ligand featuring 
methyl functionalization of pyridine donors, [MnII(NCMe)(6Medpaq)]+, was characterized by XAS, 
mass spectrometry, and EPR spectroscopy. [MnII(NCMe)(6Medpaq)]+ was oxidized by PhIO to 
form the MnIII-hydroxo complex, [MnIII(OH)(6Medpaq)]+. XRD analysis of [MnIII(OH)(6Medpaq)]+ 
revealed that the methyl functionalization of the pyridine ligand substituents resulted in the 
predicted Mn-N elongation cis to the hydroxyl ligand moiety. Both [MnII(NCMe)(6Medpaq)]+ and 
[MnIII(OH)(6Medpaq)]+ react with stoichiometric amounts of tBuOOH to generate a new 
intermediate, species 1. This room temperature-stable compound is assigned to be 
[MnIII(OOtBu)(6Medpaq)]+, based on characterization by electronic absorption, mass spectrometry, 
XAS, and 1H NMR spectroscopy. The stability of 1, combined with the ability to use only 
stoichiometric amounts of peroxide during formation, will aid in more thorough investigations of 
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the reactivity and decay of this class of compounds. The reaction of 1 with PPh3 occurs much faster 
than the thermal decay of 1, suggesting a direct reaction between the substrate and the alkylperoxo 
moiety of 1 as opposed to a high-valent Mn decay product. 
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The Reactivity of [MnIII(OH)(dpaq2Me)](OTf) and 
[MnIII(OH)(6Medpaq)](OTf) with H2O2   
140 
 
5.1 Introduction. There are several examples of Mn-dependent enzymes that are proposed to 
form peroxo intermediates as part of their catalytic cycles.1, 2 For example, the formation of a 
dimeric (μ-O)2Mn
IIIMnIV species in Mn-ribonucleotide reductase (Mn-RNR) from superoxide is 
proposed to proceed through a MnIII-peroxo intermediate.3-6 For Mn-dependent dioxygenases and 
Mn-lipoxygenases, it has been proposed that to O2-derived Mn-alkylperoxo intermediates form 
during substrate oxidation.7-11 The product-inhibited complex of manganese superoxide dismutase 
is presumed to be a MnIII-peroxo adduct,12-14 but the exact nature of this species (i.e. side-on MnIII-
peroxo versus end-on MnIII-hydroperoxo complex) is a matter of contention.15-17 Water oxidation 
by the oxygen evolving complex of Photosystem II results in a putative Mn-OO(H)-M intermediate 
(M = Mn or Ca) during O-O bond formation.18-23 The majority of these proposed intermediates 
have not been observed. 
The importance of peroxo-level intermediates in biological pathways has led to the 
development of synthetic model complexes as investigative tools. While there have been numerous 
examples of synthetic side-on Mn-peroxo species,24-44 examples of end-on Mn-hydroperoxo or 
Mn-alkylperoxo complexes are rare. Reports investigating MnIII-hydroperoxo complexes are 
especially limited in number, with only two examples having been reported.45, 46 The formation of 
the MnIII-hydroperoxo complexes [MnIII(OOH)(14-tmc)]2+ and [MnIII(OOH)(13-tmc)]2+ was 
achieved through the addition of perchloric acid to their side-on MnIII-peroxo counterparts in 
MeCN at -40°C (14-tmc = 1,4,8,11-tetramethyl-1,4,8,11-tetraaza-cyclotetradecane, 13-tmc = 
1,4,8,11-tetramethyl-1,4,8,11-tetraaza-cyclotridecane).45 The MnIII-hydroperoxo complexes were 
characterized by electronic absorption, resonance Raman, electron paramagnetic resonance (EPR), 
and X-ray absorption spectroscopy.45, 46 These complexes were only stable at -40°C, and rapidly 
carried out oxygen atom transfer (OAT) reactions with thioanisole and its derivatives at this 
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temperature.45, 46 In addition to OAT reactivity, [MnIII(OOH)(13-tmc)]2+ was also capable of 
performing hydrogen atom transfer (HAT) reactions with the hydrocarbons with weak C-H bonds, 
including xanthene, 9,10-dihydroanthracene (DHA), and 1,4-cyclohexadiene.46 Aldehyde 
deformylation of cyclohexane carboxaldehyde by [MnIII(OOH)(13-tmc)]2+ was also observed.46  
Synthetic MnIII-alkylperoxo complexes have also been studied, both for their own relevance to 
biological pathways and as analogues of the highly unstable metal-hydroperoxo intermediates 
discussed above.47-51 In work by Kovacs and coworkers, a series of MnIII-alkylperoxo complexes 
supported by N4S
- type ligands were formed through the reaction of MnII complexes with tBuOOH 
at -15°C in dichloromethane. These complexes were only stable at -15 °C. The X-ray diffraction 
structures of these complexes revealed thiolate ligands cis to the alkylperoxo moiety, along with 
elongated equatorial Mn-N bonds.49, 50 Investigations of the decay of these complexes, both in the 
presence and absence of various substrates, suggested a decay mechanism involving homolytic O‒
O bond cleavage.50 More recently, our group reported the formation of two MnIII-alkylperoxo 
species that featured amide groups trans to the alkylperoxo moiety (Chapter 3).51 The formation 
of these complexes, [MnIII(OOtBu)(dpaq)]+ and [MnIII(OOtBu)(dpaq2Me)]+, was achieved through 
the reaction of the MnII or MnIII-hydroxo counterparts with tBuOOH (dpaq = 2-(bis((pyridin-2-
yl)methyl)amino)-N-(quinolin-8-yl)acetamidate, dpaq2Me = 2-(bis(pyridin-2-ylmethyl)amino)-N-
(2-methylquinolin-8-yl)acetamidate, Chapter 3).51 Maximal conversion to the MnIII-alkylperoxo 
species was only achieved through the addition of 100 equivalents of tBuOOH, complicating 
investigations into the reactivity or decay pathways of these complexes. Nonetheless, the 
observation of •OOtBu radical in EPR analyses of the MnIII-alkylperoxo species provided 
circumstantial evidence of a decay mechanism that involves Mn-O bond homolysis.51 Building 
from these recent advancements in Mn-alkylperoxo chemistry, the development of a new 
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derivative of the dpaq ligand featuring methyl functionalization on the pyridine positions adjacent 
to the nitrogen atom, 6Medpaq,  has led to the formation of a room temperature stable MnIII-
akylperoxo complex (Chapter 4). Investigations of the reactivity and decay of this new complex 
are ongoing. 
Knowing that the [MnIII(OH)(dpaq2Me)]+ and [MnIII(OH)(6Medpaq)]+ complexes are capable of 
reacting with tBuOOH to generate end-on MnIII-alkylperoxo species (Chapters 3 and 4), we were 
interested in the possibility of generating an end-on MnIII-hydroperoxo complex by treating the 
[MnIII(OH)(dpaq2Me)]+ or [MnIII(OH)(6Medpaq)]+ complexes with H2O2. As described below, the 
addition of H2O2 to the Mn
III-hydroxo complexes in the presence of a base results in the formation 
of new intermediates (intermediates 12Me and 16Me) that have been characterized by electronic 
absorption, EPR, and 1H NMR spectroscopy. 12Me and 16Me decay over the course of minutes. 12Me 
is observed to decay to form a (μ-O)2Mn
IIIMnIV species, which then decays to regenerate 
[MnIII(OH)(dpaq2Me)]+. 16Me decays to [MnIII(OH)(6Medpaq)]+ without the formation of any 
intermediates. 
5.2 Materials and methods. All chemicals were used as obtained from commercial 
sources unless noted otherwise. Acetonitrile and diethyl ether were dried and degassed using a 
PureSolv Micro solvent purification system. [MnIII(OH)(dpaq)](OTf), 
[MnIII(OH)(dpaq2Me)](OTf), and [MnIII(OH)(6Medpaq)]+ were synthesized and characterized as 
reported previously (for synthesis of [MnIII(OH)(6Medpaq)]+, see Chapter 4).52, 53 Electronic 
absorption experiments were performed using a Varian Cary 50 Bio UV-Visible 
spectrophotometer. Electrospray ionization-mass spectrometry (ESI-MS) experiments were 
performed using an LCT Premier MicroMass electrospray time-of-flight instrument. X-band EPR 
experiments were performed using a Bruker EMXplus with Oxford ESR900 continuous-flow 
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liquid helium cryostat and an Oxford ITC503 temperature system. 1H NMR spectra were obtained 
on a Bruker DRX 400 MHz NMR spectrometer. 
Reactions between [MnIII(OH)(dpaq2Me)](OTf) and H2O2 in the presence of a base. A 3 
mM solution of [MnIII(OH)(dpaq2Me)]+ was prepared in MeCN and transferred to a quartz cuvette. 
10 equivalents of H2O2 and Et3N were simultaneously added to the cuvette at 25°C while 
monitoring the reaction by electronic absorption spectroscopy. After the addition of H2O2 and 
Et3N, the purple solution of [Mn
III(OH)(dpaq2Me)]+ instantly changed color to a bright green. The 
same reaction was performed in 1:1 MeCN:Toluene in order to prepare an EPR sample. 
Immediately after formation of the bright green species, the MeCN:Toluene solution was 
transferred to an EPR tube and frozen with liquid nitrogen. The EPR spectrum was collected at 10 
K (9.64 GHz microwave frequency, 0.126 mW microwave power, 0.4 mT modulation amplitude, 
100 kHz modulation frequency). A sample for 1H NMR was prepared by simultaneously adding 
10 equivalents of H2O2 and Et3N to a 3 mM solution of [Mn
III(OH)(dpaq2Me)]+ in d3-MeCN in an 
NMR tube. The 1H NMR spectrum was collected at 298 K immediately after the formation of the 
green species.  
Reactions between [MnIII(OH)(6Medpaq)](OTf) and H2O2 in the presence of a base. A 3 
mM solution of [MnIII(OH)(6Medpaq)]+ was prepared in MeCN and transferred to a quartz cuvette. 
20 equivalents of both H2O2 and Et3N were simultaneously added to the cuvette at 25°C while 
monitoring by electronic absorption spectroscopy. Upon the addition of H2O2 and Et3N, the dark 
orange solution of [MnIII(OH)(6Medpaq)]+ was observed to turn a bright green. 
Formation and decay of [MnIIIMnIV(µ-O)2(dpaq2Me)2]2+. A 3 mM solution of 
[MnIII(OH)(dpaq2Me)]+ was prepared in MeCN and transferred to a quartz cuvette. 1 equivalent of 
H2O2 was added to the cuvette at 25°C while monitoring the reaction by electronic absorption 
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spectroscopy. The purple solution of [MnIII(OH)(dpaq2Me)]+ changed color to an amber solution. 
After the electronic absorption spectra ceased to change, the MeCN solution was transferred to an 
EPR tube and frozen with liquid nitrogen. The EPR spectrum was collected at 10 K (9.64 GHz 
microwave frequency, 2 mW microwave power, 0.4 mT modulation amplitude, 100 kHz 
modulation frequency). Spin quantification of the 16-line EPR signal was determined against a 
sample of [MnIIIMnIV(µ-O)2(N4Py)2]
+ prepared by the addition of 5 equivalents of H2O2 to a 10 
mM solution of [MnII(N4Py)(OTf)](OTf)  in 2,2,2-trifluoroethanol.44 A sample of [MnIIIMnIV(µ-
O)2(dpaq
2Me)2]
2+ for 1H NMR measurement was prepared by adding 1 equivalent of H2O2 to a 3 
mM solution of [MnIII(OH)(dpaq2Me)]+ in d3-MeCN in an NMR tube. The thermal decay of 
[MnIIIMnIV(µ-O)2(dpaq
2Me)2]
2+ was also monitored using electronic absorption spectroscopy at 
25°C. 
Reaction of [MnIIIMnIV(µ-O)2(dpaq2Me)2]2+ with 2,4-ditertbutylphenol. A 3 mM solution 
of [MnIIIMnIV(µ-O)2(dpaq
2Me)2]
2+ was prepared in MeCN in a quartz cuvette, as described above. 
Upon full formation of [MnIIIMnIV(µ-O)2(dpaq
2Me)2]
2+, 100 equivalents of 2,4-ditertbutylphenol, 
dissolved in 100 µL of MeCN, was added to the cuvette via syringe while monitoring the reaction 
by electronic absorption spectroscopy at 25°C. 
Formation and decay of [MnIIIMnIV(µ-O)2(dpaq)2]2+. The [Mn
IIIMnIV(µ-O)2(dpaq)2]
2+ 
complex was generated by following a previously reported protocol.54 A 0.5 mM solution of 
[MnIII(OH)(dpaq)]+ was prepared in MeCN and transferred to a quartz cuvette. 5 equivalents of 
H2O2 and 5 equivalents of Et3N were added to the cuvette at 25°C, while monitoring the reaction 
by electronic absorption spectroscopy.54 The complex was allowed to thermally decay at 25°C 




5.3 Results and discussion. 
Reactions of [MnIII(OH)(dpaq2Me)](OTf) and H2O2 in the presence of a base. Upon the 
addition of 2.5 equivalents of both H2O2 and Et3N to [Mn
III(OH)(dpaq2Me)]+ in MeCN at 25 °C, 
the purple MnIII-hydroxo complex is rapidly converted to a bright green species (termed 12Me). 
This conversion can be monitored by electronic absorption, where the features of 
[MnIII(OH)(dpaq2Me)]+ at 515 and 770 nm are immediately replaced by new signals at 615 and 450 
nm upon the addition of H2O2 and Et3N (Figure 5.1, left). The electronic absorption signals of 12Me 
are similar to those of side-on MnIII-peroxo complexes (Table 5.1).24, 34, 35, 39, 40, 44 Under these 
conditions, 12Me decays over a period of 60 seconds, resulting in the formation of an amber species 
(22Me) with intense UV-Vis signals around 500 and 710 nm (Figure 5.1, center). 22Me decays over 
the course of three hours to yield the [MnIII(OH)(dpaq2Me)]+ starting complex in 89% yield (Figure 
5.1, right).  
 
 
Figure 5.1. Left: The reaction of a 3 mM MeCN solution of [MnIII(OH)(dpaq2Me)]+ with 2.5 
equivalents of both H2O2 and Et3N at 25 °C results in the formation of 12Me (green trace). Center: 
12Me rapidly converts to 22Me with a feature at 710 nm (brown trace). Right: 22Me decays back to 





Table 5.1. Comparison of spectroscopic characteristics of select MnIII-peroxo species. 
Complex λ (nm) g A Reference 
12Me 450, 615 8.6 -- This work. 
16Me 450, 610 -- -- This work. 
[MnIII(O2)(Me2EBC)]+ 400, 650 7.96 6.84 
40 
[MnIII(O2)(N4Py)]
+ 617 7.85 6.8 34, 44 
[MnIII(O2)(mL5
2)]+ 585 8.1 6.6 34 
[MnIII(O2)(Tp
Ph2)(THF)] 379, 435 8.3 9.1 35 
[MnIII(O2)(Pro3Py)]
+ 580 8.3 -- 39 
[MnIII(O2)(H2bupa)]
- 490, 660 8.2 5.7 24 
 
Intermediate 12Me is more stable when formed through the reaction of a 3 mM solution of 
[MnIII(OH)(dpaq2Me)]+ with 10 equivalents of both H2O2 and Et3N in MeCN at 25 °C. Under these 
formation conditions, the feature of 12Me at 450 nm is more resolved, either suggesting more 
complete formation of 12Me or the lack of some impurity that absorbs in the UV region (Figure 
5.2). When formed in this manner, 12Me persists for 6 minutes before decaying over the period of 
half an hour to result in an amber solution with a brown precipitate. Since the formation of 12Me 
under these conditions results in a more stable complex, analysis of 12Me through 1H NMR was 
attempted by collecting the 1H NMR spectrum immediately after the initial formation of 12Me. 
However, the 1H NMR spectrum primarily consists of peaks that arise from free Hdpaq2Me ligand, 




Figure 5.2. Electronic absorption spectra of a 3 mM solution of [MnIII(OH)(dpaq2Me)]+ (purple 
trace) in MeCN, solutions of 12Me in MeCN, formed by the addition of 10 equivalents of H2O2 and 
10 equivalents Et3N (green solid trace) and 2.5 equivalents of H2O2 and 2.5 equivalents Et3N 
(green dashed trace). 
 
 
Figure 5.3. 1H NMR spectrum obtained following the reaction of a 3 mM solution of 
[MnIII(OH)(dpaq2Me)]+ with 10 equivalents of both H2O2 and Et3N in d3-MeCN (red trace). Inset: 
expanded view of the 12 to 6 ppm region comparing the spectrum obtained after the reaction of 
[MnIII(OH)(dpaq2Me)]+ with 10 equivalents of H2O2 and Et3N in d3-MeCN to the spectrum of the 




An EPR sample of 12Me was prepared through the reaction of a 3 mM solution of 
[MnIII(OH)(dpaq2Me)]+ with 10 equivalents of both H2O2 and Et3N in 1:1 MeCN:Toluene at 25 °C. 
After formation of 12Me, the solution was transfered to an EPR tube and frozen with liquid nitrogen. 
The EPR spectrum of 12Me at 10 K reveals an intense, broad, derivative-shaped signal with a g 
value of 8.6 (Figure 5.4). Mononuclear, S = 2 MnIII centers often exhibit parallel-mode EPR signals 
at similar g values.24, 34, 35, 40  However, the strong derivative shape of the EPR signal of 12Me, and 
the absence of a six-line hyperfine splitting makes the EPR signature of this complex distinct from 
that usually seen for MnIII-peroxo complexes.35, 39, 40 While the shape of the signal is unusual for a 
mononuclear MnIII complex, a MnIII-peroxo complex reported by Borovik and coworkers also 
exhibited a derivative-shaped EPR signal, though with resolved hyperfine splitting.24  Similarly 
shaped signals, without observable hyperfine splitting, have been observed in trimeric Mn(III) 
complexes reported by Agapie and coworkers.55 However, in these cases, the derivative-shaped 
signals were centered around 40-50 mT, which would correspond to a much higher g value than 
that of 12Me.55 Thus, while the field position of the EPR signal of 12Me is consistent with that of a 
mononuclear MnIII center, further investigations, including studies of the temperature-dependence 





Figure 5.4. The parallel-mode EPR spectrum obtained at 10 K following the reaction of a 3 mM 
solution of [MnIII(OH)(dpaq2Me)]+ in 1:1 MeCN:Toluene with 10 equivalents of both H2O2 and 
Et3N at 25°C.  
 
 
Based on the knowledge that [MnIII(OH)(6Medpaq)]+ reacts with tBuOOH to form a stable 
MnIII-alkylperoxo species (Chapter 4), similar reactions between [MnIII(OH)(6Medpaq)]+ and H2O2 
were investigated. A 3 mM solution of [MnIII(OH)(6Medpaq)]+ in MeCN  reacts with 20 equivalents 
of H2O2 and Et3N at 25 °C to form a green species (16Me) with a well-defined electronic absorption 
feature at 610 nm, and a shoulder around 450 nm (Figure 5.5, red trace). 16Me decays back to 
[MnIII(OH)(6Medpaq)]+ over the course of 3 minutes (Figure 5.5). Attempts to form 16Me using less 
than 20 equivalents of H2O2 and Et3N did not result in the observation of 16Me, presumably due to 
the rapid decay of this transient species. Unlike 12Me, demetallation is not observed upon the decay 
of 16Me. This finding is unexpected considering the elongated Mn-pyridine bonds of the 




Figure 5.5. Electronic absorption of 16Me (red trace) and its decay to form [MnIII(OH)(6Medpaq)]+ 
(blue trace) over the course of 3 minutes. 
 
 
Reaction between [MnIII(OH)(dpaq2Me)](OTf) and H2O2 in the absence of a base. 
Intermediate 22Me is directly formed when a 3 mM solution of [MnIII(OH)(dpaq2Me)]+ in MeCN is 
treated with 1 equivalent of H2O2 in the absence of Et3N at 25 °C. Over the course of one minute 
after the addition of H2O2, intense electronic absorption features around 500 and 710 nm are 
formed, indicative of the formation of 22Me (Figure 5.6).  Perpendicular-mode EPR investigation 
of a frozen MeCN solution of 22Me reveals a 16-line signal (Figure 5.7; g = 2.01, A = 7.70 mT). 
The electronic absorption features and the position and hyperfine splitting pattern of the EPR 
signal are similar to those previously reported for (μ-oxo)2dimanganese(III,IV) complexes (Table 
5.2).44, 54, 56-59 Spin quantification of the EPR signal of 22Me indicates that this signal accounts for 









Figure 5.6. Electronic absorption spectra following the reaction of a 3 mM solution of 
[MnIII(OH)(dpaq2Me)]+ in MeCN at 25 °C (red trace) with 1 equivalent of H2O2. An amber solution, 
characterized by an intense feature at 710 nm is formed over the course of 60 seconds (brown solid 
trace). The electronic absorption spectrum of the species formed through the reaction of 
[MnIII(OH)(dpaq2Me)]+ with 2.5 equivalents of H2O2 in the presence of Et3N is shown for 
comparison (brown dashed trace). 
 
 
Table 5.2. Comparison of spectroscopic characteristics of select MnIIIMnIV(μ-O)2 species. 
Complex λ (nm) g A (mT) Reference 
22Me ~500, 710 2.01 7.7 This work 
[MnIIIMnIV(µ-O)2(N4Py)2]
3+ 439, 562, 667 2.01 7.7 44 
[MnIIIMnIV(µ-O)2(
DMMN4Py)2]
3+ 440, 562, 667 2.01 7.7 56 
[MnIIIMnIV(µ-O)2(dpaq)2]















Figure 5.7. 10 K perpendicular-mode EPR spectrum obtained following the reaction of a 3 mM 
solution of [MnIII(OH)(dpaq2Me)]+ with 1 equivalent of H2O2 in MeCN at 25°C showing a 16-line 
signal consistent with a (μ-O)2Mn
IIIMnIV dimer, which accounts for ca. 80% of total Mn in the 
sample. Inset: full range of the collected spectrum. 
 
 
22Me undergoes thermal decay over the course of 24 hours to regenerate 
[MnIII(OH)(dpaq2Me)]+ in 99% yield (Figure 5.8). 22Me is much more stable in the absence of a base 
(t1/2 ≈ 2 hours) than in the presence 10 equivalents of Et3N (t1/2 ≈ 8 minutes). For comparison, a 
solution of [MnIIIMnIV(µ-O)2(dpaq)2]
+ was prepared according to a previously reported procedure 
and allowed to decay while monitoring by electronic absorption spectroscopy.54 The decay of 
[MnIIIMnIV(µ-O)2(dpaq)2]
+ resulted in the formation of MnIII-hydroxo complex in 98% yield, 
similar to that seen for the decay of 22Me (Figure 5.9). 22Me is more stable than [MnIIIMnIV(µ-
O)2(dpaq)2]






Figure 5.8. Electronic absorption spectra monitoring the thermal decay of [MnIIIMnIV(µ-
O)2(dpaq
2Me)2]
+ (brown trace) in MeCN to regenerate [MnIII(OH)(dpaq2Me)]+ (red trace). Inset: 
time course of the decay. 
 
 
Figure 5.9. Electronic absorption spectra obtained while monitoring the thermal decay of 
[MnIIIMnIV(µ-O)2(dpaq)2]
+ (brown trace) to yield [MnIII(OH)(dpaq)]+ (blue trace). Inset: time 




In MeCN, 22Me reacts with 100 equivalents of 2,4-ditertbutyl phenol over the course of 2 
minutes (Figure 10). The resulting electronic absorption spectrum is poorly defined with a broad 
feature around 750 nm (Figure 5.10, red trace). This spectrum is different than what is observed 
following the reaction of [MnIIIMnIV(µ-O)2(dpaq)2]
+ with phenol substrates, during which a MnIII-
hydroxo complex is generated.54 In a previous report from our group, [MnIIIMnIV(μ-O)2(N4Py)]
3+ 
and [MnIIIMnIV(μ-O)2(
DMMN4Py)]3+ were seen to react with phenol substrates to generate a 
mixture of MnII and MnIII products.56 The amorphous electronic absorption features observed 
following the reaction of [MnIIIMnIV(μ-O)2(dpaq
2Me)]+ may be indicative of similar Mn products 
being formed. Alternatively, it is possible that [MnIII(OH)(dpaq2Me)]+ is the sole Mn product 
formed, but subsequently reacts with the phenol substrate to result in a mixture of MnII and MnIII 
products.52 
 
Figure 5.10. Electronic absorption spectra obtained while monitoring the reaction of 
[MnIIIMnIV(µ-O)2(dpaq
2Me)2]
+ (brown trace) with 2,4-ditertbutyl phenol in MeCN to result in a 




5.4 Outlook and future work. Both [MnIII(OH)(dpaq2Me)]+ and [MnIII(OH)(6Medpaq)]+ 
react with H2O2 to form new intermediates, 12Me and 16Me. The electronic absorption features of 
12Me and 16Me (λmax = 615 and 610 nm, respectively) are within the range of those reported for 
MnIII-peroxo complexes (λmax = 435 to 660 nm, Table 5.1). Additionally, the EPR spectrum of 
12Me is consistent with the complex containing a MnIII center. However, confident formulation of 
these species requires more characterization. 
12Me is much more stable at lower temperatures, persisting for two hours at -40°C, 
potentially allowing for additional characterization. 1H NMR analysis of 12Me at -40°C would 
allow for characterization of the complex without signals associated with decay products 
dominating the spectrum, as is observed in experiments carried out at room temperature (Figure 
3). Comparison of the 1H NMR spectrum of 12Me to that obtained for [MnIII(OH)(dpaq2Me)]+ can 
give some insight into solution-phase structure.60 If 12Me is an end-on MnIII-hydroperoxo species, 
the 1H NMR spectrum would likely look similar to that observed for [MnIII(OH)(dpaq2Me)]+ due 
to a similar molecular symmetry. The 1H NMR spectrum of a side-on MnIII-peroxo species may 
be significantly different, reflective of geometric distortion that occurs in accommodating the η2 
binding mode of the peroxo ligand. Similar experiments carried out with 16Me would have the 
added benefit of being able to compare to [MnIII(OOtBu)(6Medpaq)]+, a possible structural analogue 
to an end-on MnIII-hydroperoxo (Chapter 4). Collection of the EPR spectrum of 12Me at a range of 
temperatures will help to determine the zero-field splitting parameters of the complex, which can 
subsequently be compared to those reported for MnIII-peroxo complexes.1 
Characterization of 12Me and 16Me by FTIR, either by analysis of cold solutions or by way 
of ReactIR instrumentation, would allow for a comparison of O-O bond vibration energy to those 
reported for the end-on MnIII-alkylperoxo complexes and  [MnIII(OOtBu)(dpaq2Me)]+ and 
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[MnIII(OOtBu)(6Medpaq)]+ (Chapter 4).51 The O-O bonds of side-on MnIII-peroxo complexes tend 
to be shorter than those reported for end-on MnIII-alkylperoxo complexes, potentially resulting in 
a higher energy O-O bond vibration.1 Similar trends have also been seen in iron systems.47, 48 
Notably, the O-O vibrational frequency measured for [MnIII(OOH)(tmc)]2+, one of only two 
reported MnIII-hydroperoxo species (νO-O = 792 cm
-1),45 is much lower than those reported for 
MnIII-alkylperoxo complexes (νO-O = 872 – 893 cm
-1, Chapters 3 and 4).49-51 
A comparison of XAS data of 12Me and 16Me and their respective MnII or MnIII-hydroxo 
analogues would give additional insight into the oxidation state, geometry, and Mn-ligand 
distances of the complexes. Mn K-edge energy is sensitive to oxidation state and could confirm 
our tentative assignment of 12Me and 16Me containing a MnIII center. Analysis of any pre-edge 
features is often used to probe geometric differences between complexes. Finally, fitting the 
extended X-ray absorption fine structure region of the spectrum will give structural information 
regarding the distance between the Mn center and surrounding ligand. 
Mass spectral analysis of a cold solution of 12Me may be helpful in determining whether or 
not these new species are peroxo-level intermediates. If 12Me is cationic end-on MnIII-hydroperoxo 
species, we would expect to see a peak near the calculated m/z of 484.12. If 12Me is a side-on MnIII-
peroxo species, the overall charge of the complex would be neutral. Charged species are required 
in order to see a mass spectral signal. As such, the mass spectrum of a side-on MnIII-peroxo species 
would have to include the association of a proton or a Na+ ion, resulting in signals near the 
calculated m/z of 484.12 or 506.10. While the two possible formulations of 12Me share a peak at 




5.5 Conclusion. Drawing from the ability of [MnIII(OH)(dpaq2Me)]+ and 
[MnIII(OH)(6Medpaq)]+ to react with alkylhydroperoxides to form end-on MnIII-alkylperoxo 
complexes, this work exploredsimilar reactivity between the MnIII-hydroxo complexes and H2O2 
in an attempt to form end-on MnIII-hydroperoxo complexes. Through the reactions of 
[MnIII(OH)(dpaq2Me)]+ and [MnIII(OH)(6Medpaq)]+ with H2O2, two new species are generated, 12Me 
and 16Me. These species were characterized by electronic absorption spectroscopy and exhibited 
features similar to those reported for MnIII-peroxo complexes. The EPR spectrum of complex 12Me 
showed a signal at a field position consistent with a mononuclear MnIII complex. However, the 
exact nature of this species remains unclear, warranting further characterization. The lifetime of 
12Me is short at room temperature (ca. 30 seconds) and decays to form a (µ-O)2Mn
IIIMnIV dimer, 
which in turn decays to form [MnIII(OH)(dpaq2Me)]+. Complex 16Me is also short lived, decaying 
over a three minute period to form  [MnIII(OH)(6Medpaq)]+. 
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6.1 Summary. This work has served to expand our understanding of the reactivity of Mn 
complexes with dioxygen and its reduced derivatives. Major findings include: 
- A steric effect on the activation of dioxygen by MnII complexes. 
- The synthesis and characterization of three new MnIII-alkylperoxo complexes. 
- The development of a new derivative of the dpaq ligand with steric functionalization to 
the equatorial pyridine donors.  
- Supported by this new ligand, the formation of a new MnII complex, its MnIII-hydroxo 
counterpart and the first room-temperature stable MnIII-alkylperoxo complex. 
- The reaction of two MnIII-hydroxo complexes with H2O2 and Et3N to generate two new 
species that bear spectroscopic similarities to MnIII-peroxo species.  
- The formation of a new (µ-O)2MnIIIMnIV dimer. 
 
6.2 Outlook. Through the development of model complexes, we have a powerful tool to aid 
in the understanding of metalloenzyme mechanisms. New synthetic complexes are continually 
being published exhibiting one exciting property or another, and I’m proud to have been a part of 
this effort over the past five years. While the work presented in the previous chapters adds new 
insight towards the reactivity and stability of Mn complexes, our quest for knowledge remains a 
major undertaking. Though the potential effects of steric bulk on O2 reactivity by [Mn
II(dpaq2Me)]+ 
have been established, the intermediates along the pathway remain unknown. Though we have 
three more examples of rare MnIII-alkylperoxo complexes, the intricacies of how they react and 
what governs their (in)stability remain unclear. Though we have realized the reactivity of MnIII-
hydroxo complexes with reactive oxygen species, the products formed remain unidentified. I 
discuss a few potential approaches to answering some of these remaining questions in this chapter. 
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 The control afforded by a simple steric modification on the activation of O2 is exciting. 
However, intermediates have so far gone unobserved in the oxygenation of [MnII(dpaq)]+ and its 
derivatives. The design of new ligand derivatives with more significant perturbations is worth 
exploring within the context of gaining control over the intermediates formed. Noting the effect of 
a simple methyl group on the O2-activation mechanism, developing a ligand that features even 
greater steric bulk around the active site may help to favor the formation of a terminal high-valent 
Mn-oxo by preventing dimerization. Building off of previous work in which hydrogen bond donors 
are able to stabilize MnIV-oxo species, such modifications to the dpaq ligand may be of interest, 
though certainly synthetically challenging. 
It is obvious that the mechanism involved in the reaction of [MnII(dpaq2Me)]+ with PhIO as 
an oxidant differs from that with dioxygen. In fact, this reaction has resulted in the formation of a 
new, as-of-yet unidentified, intermediate not seen in the reaction of the MnII complex with O2. As 
such, this reactivity should be more thoroughly investigated. Spectroscopic characterization of the 
new intermediate is paramount to our understanding, as it is likely too unstable to isolate. Upon 
characterization, investigations of the reactivity of this intermediate with hydrogen atom and 
oxygen atom substrates, as well as probing its thermal decay, may lend insight into the unknowns 
of dioxygen activation by this series of complexes. 
The development of a room-temperature stable MnIII-alkylperoxo species is a promising 
result in and of itself, inching towards a structural and reactive model of the proposed intermediate 
of Mn-lipoxygenase. That being said, investigations towards how these complexes decay and how 
the decay pathways compare to the proposed enzyme mechanism are still in their infancy. 
Expanding upon the limited investigations into substrate reactivity reported in this work, as well 
as computational studies to analyze the electronic structure of the complex in regards to 
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alkylperoxo binding and decay pathways, will serve as a means to compare with and add to the 
limited understanding of this class of compounds. Additionally, modifications to the 6Medpaq 
ligand in which the 5-position of the quinoline is functionalized with electron withdrawing or 
donating groups will be carried out to investigate the effects of modulating the donation of the 
amide nitrogen trans to the alkylperoxo moiety, thereby influencing the energy of the dz2 orbital 
and potentially affecting alkylperoxo binding (Figure 6.1). 
 
Figure 6.1. Electron donating and withdrawing functionalization of the 6Medpaq ligand results in 
modulation of the donating properties of the amide nitrogen trans to the alkylperoxo moiety. 
 
In short, while our understanding of the reactivity of MnII complexes with O2 and its 
derivatives remains in the early stages, there are clear ways forward towards learning more about 
these processes. As new ligands and their metal complexes are developed and new sets of reactions 
are performed on these complexes, our knowledge set grows and the importance of model 













Figure A1.1. Overlay of electronic absorption spectra obtained during O2-titration experiments 











Figure A1.2. Time course of the reaction of a 6 mM solution of [MnII(dpaq)]+ with excess O2 in 





Figure A1.3. 1H-NMR analysis of the oxidation of 9,10-dihydroanthracene in the presence of 
[MnII(dpaq)]+ (top) or [Mn
III(OH)(dpaq)]+ (bottom) and excess O2 in d3-MeCN (6 mM) at 25°C. 
Quantification of products was obtained by using 1,4-benzoquinone (10 molar equivalent relative 





















O2 present      
[MnII(dpaq)]+ 3.0 12.9 2.0 7.9 25.8 
[MnII(dpaq2Me)]+ 3.0 11.5 1.5 7.5 23.5 
[MnIII(OH)(dpaq)]+ 3.1 15.0 2.4 9.4 29.9 
[MnIII(OH)(dpaq2Me)]
+ 
4.0 15.7 2.6 11.5 33.8 





Figure A1.4. Overlay of electronic absorption spectra obtained during O2-titration experiments 








Figure A1.5. Time course of the reaction of a 6 mM solution of  [MnII(dpaq2Me)]+ with excess O2 





Figure A1.6. 1H-NMR spectra after the treatment of [MnII(dpaq2Me)]+ (top) or 
[MnIII(OH)(dpaq2Me)]+ (bottom) with 9,10-dihydroanthracene in the presence of  and excess O2 in 
d3-MeCN (6 mM) at 25°C. Quantification of products was obtained by using 1,4-benzoquinone 




Figure A1.7. ESI-MS data for [MnIII(OH)(dpaq2Me)]+ from the reaction of [MnII(dpaq2Me)](OTf) 












Figure A2.1: ESI-MS data of the reaction solution of 1 and 0.5 equivalents of tBuOOH in MeCN 
at -15°C in the presence of Et3N. The spectra reveal peaks associated with several Mn
III species, 
including 1a and [MnIII(OtBu)(dpaq)]+. Peaks associated with the MnIII-OMe and MnIII-Cl adducts 
are commonly observed in ESI-MS data of solution of 1a. 
 
 
Figure A2.2: Electronic absorption spectra of the reaction of 1a (red trace) with 2 equivalents of 





Figure A2.3: Time course of the reaction of 1a with 50 equivalents of tBuOOH in MeCN at -15°C 
in the presence of Et3N monitored at 700 nm (cf. Figure 4).  
 
Figure A2.4: Electronic absorption spectra showing the formation of 1b from the reaction of 1a 




Figure A2.5: Time course of the reaction of 1a with 100 equivalents of tBuOOH in MeCN at -
15°C in the presence (left) and absence (right) of Et3N, monitored at 700 nm. 
 
Figure A2.6: Plot comparing the ratio of intensities at 710 nm and 590 nm as a metric of 1b 
formation. The low initial ratio marks near 100% formation of 1a in solution. The first change in 
the ratio (10 to 50 equivalents tBuOOH) marks solutions dominated by the MnIIIMnIV dimer, as 
assessed by EPR spectrosscopy. The highest ratios, observed upon addition of 100 and 140 








Figure A2.7. EPR spectrum of 1b reaction mixture at 77 K (top) and 5 K (bottom), showing a 
rhombic signal with g values of 2.033, 2.007, and 2.002 that correspond to the tBuOO• radical.  
 
 
Figure A2.8. Electronic absorption spectra of the reaction of 1a (red trace) with 50 equivalents of 
tBuOOH in the absence of Et3N to form 1b at -15 °C in MeCN (blue trace). The reaction proceeds 






Figure A2.9. Electronic absorption spectra of reactions between 2 and tBuOOH in the presence of 
10 equivalents of  Et3N showing full formation of 2a with the addition of ~0.5 eq of 
tBuOOH at -
15 °C in MeCN. 
 
Figure A2.10. Electronic absorption spectrum showing the formation of 2b (red trace) from 2a 
(blue trace) upon the reaction with ~100 eq. of tBuOOH in the presence of 10 equivalents of Et3N 





Figure A2.11. 5 K EPR spectrum of 2b reaction mixture showing signals at g = 2.03 and 2.003 
corresponding to tBuOO• radical. 
 
Figure A2.12. Solution FT-IR spectra of tBuOOH and 1a.  corresponds to the assigned O−O 





Figure A2.13. Comparison of solution FT-IR spectra of 1b (blue) and 2b (red) in MeCN. No signal 
corresponding to the O−O vibration of 2b could be identified, presumably due to the signal 
overlapping with one of the intense vibrations of free tBuOOH. 
 
Figure A2.14. Time course of the decay of 1b in MeCN at -15°C in the presence of Et3N monitored 





Figure A2.15. 5 K EPR spectrum of decay solution of 1b showing a less intense tBuOO• signal 





Figure A2.16. 5 K EPR spectrum of decay solution of 2b showing a less intense tBuOO• signal 





Figure A2.17: ESI-MS data of the solution following the decay of 1b in MeCN at -15°C in the 


















Table A2.1. Cartesian coordinates (Å) for DFT energy minimized  [MnIII(OOtBu)(dpaq)]+ model. 
Atom        x                 y                 z          
Mn    -0.151764   -0.044942   -0.941100 
  O     -0.123922   -1.229666    3.013223 
  O     -0.208315    0.255084   -2.752633 
  C      0.790374   -0.791350   -4.663368 
  N     -0.114053    2.011581   -0.636806 
  N     -0.133478    0.017106    1.049476 
  N     -0.162952   -2.275144   -0.517387 
  N      1.948242   -0.600816   -0.892484 
  N     -2.265844   -0.597020   -0.867768 
  C     -0.105911    2.958348   -1.574243 
  C     -0.068510    4.324218   -1.250999 
  C     -0.037994    4.703603    0.075593 
  C     -0.044798    3.722018    1.095130 
  C     -0.014332    4.015577    2.480809 
  C     -0.023565    2.977722    3.388353 
  C     -0.062341    1.623530    2.985449 
  C     -0.092788    1.291450    1.632754 
  C     -0.084303    2.359835    0.689046 
  C     -0.145301   -1.132705    1.775202 
  C     -0.202901   -2.426657    0.967084 
  C      1.072595   -2.850540   -1.096131 
  C      2.238156   -1.915912   -0.887883 
  C      3.546735   -2.371784   -0.755879 
  C      4.577524   -1.442398   -0.637864 
  C      4.270539   -0.082036   -0.645983 
  C      2.941070    0.297689   -0.770347 
  C     -1.381787   -2.828429   -1.155818 
  C     -2.552897   -1.912605   -0.901265 
  C     -3.855628   -2.378076   -0.749531 
  C     -4.885360   -1.456535   -0.571795 
  C     -4.582716   -0.095640   -0.545381 
  C     -3.257531    0.293494   -0.693305 
  H     -0.129469    2.611081   -2.602536 
  Atom        x                 y                 z          
  C      0.065112    0.193034   -5.579095 
  C      0.839529   -2.194412   -5.270898 
  O     -0.025207   -1.027388   -3.462546 
  C      2.180895   -0.293057   -4.279494 
  H     -0.063491    5.057907   -2.048902 
  H     -0.008227    5.754074    0.350103 
  H      0.015748    5.050651    2.806498 
  H     -0.000165    3.194423    4.452288 
  H     -0.067932    0.838473    3.727125 
  H     -1.124337   -2.943018    1.253415 
 H      0.629167   -3.056390    1.295865 
  H      1.290013   -3.839248   -0.677358 
  H      0.906981   -2.959379   -2.171464 
  H      3.748020   -3.437965   -0.746348 
  H      5.605090   -1.775294   -0.533709 
  H      5.041936    0.673666   -0.550739 
  H      2.647674    1.342622   -0.775515 
  H     -1.597985   -3.842253   -0.800822 
  H     -1.195958   -2.869089   -2.233319 
  H     -4.053312   -3.444784   -0.768049 
  H     -5.908566   -1.796402   -0.448299 
  H     -5.353640    0.653530   -0.404209 
  H     -2.967303    1.339448   -0.669946 
  H     -0.940748   -0.171531   -5.809223 
  H     -0.012166    1.172944   -5.101061 
  H      0.621171    0.305635   -6.515251 
  H     -0.169150   -2.556509   -5.490451 
  H      1.409995   -2.160139   -6.203812 
  H      1.332464   -2.895815   -4.590670 
  H      2.699475   -1.028739   -3.658595 
  H      2.772780   -0.123679   -5.184482 










Table A2.2. Cartesian coordinates (Å) for DFT energy minimized [MnIII(OOtBu)(dpaq2Me)]+ 
model. 
Atom        x                 y                 z          
Mn    -0.229079   -0.052843    0.017737 
  O     -0.363260   -1.554686    3.856195 
  O     -0.180712    0.082483   -1.816887 
  C      1.312551   -0.543670   -3.577367 
  N     -0.331604    2.034664    0.518314 
  N     -0.247858   -0.153327    2.000588 
  N     -0.368996   -2.292214    0.274598 
  N      1.815875   -0.626742    0.196164 
  N     -2.367313   -0.517892   -0.084343 
  C     -0.466966    3.104807   -0.277404 
  C     -0.230472    4.409016    0.215527 
  C      0.140532    4.602570    1.523977 
  C      0.255829    3.493757    2.394624 
  C      0.601474    3.608934    3.762754 
  C      0.667555    2.473103    4.540743 
  C      0.389594    1.195656    4.010883 
  C      0.046808    1.042024    2.668676 
  C     -0.005558    2.208159    1.847264 
  C     -0.395213   -1.349521    2.631408 
  C     -0.693767   -2.526823    1.707354 
  C      0.932978   -2.879827   -0.112691 
  C      2.079886   -1.947448    0.204159 
  C      3.366763   -2.422727    0.443161 
  C      4.395883   -1.513411    0.673521 
  C      4.110987   -0.148207    0.668817 
  C      2.804991    0.254870    0.430368 
  C     -1.478490   -2.711693   -0.615947 
  C     -2.660248   -1.793061   -0.409808 
  C     -3.976682   -2.219532   -0.558303 
  C     -5.009557   -1.301719   -0.378791 
  C     -4.698852    0.014173   -0.038165 
  C     -3.362387    0.364896    0.105341 
  C     -0.878996    2.912667   -1.705317 
  C      0.382346    0.113515   -4.595701 
  C      1.919230   -1.839160   -4.121251 
  O      0.526022   -1.049416   -2.449626 
  C      2.394270    0.416232   -3.087767 
  H     -0.350817    5.248730   -0.460283 
  H      0.332124    5.601749    1.904754 
  H      0.805374    4.591450    4.177174 
  H      0.934256    2.550586    5.590567 
  H      0.436031    0.323886    4.646839 
 Atom        x                 y                 z                
  H     -1.766168   -2.728553    1.794048 
  H     -0.165535   -3.408243    2.082666 
  H      1.088973   -3.848447    0.374474 
  H      0.916578   -3.037723   -1.193497 
  H      3.551699   -3.491880    0.450733 
  H      5.404533   -1.865617    0.863328 
  H      4.880485    0.593304    0.850590 
  H      2.527918    1.304083    0.418950 
  H     -1.770007   -3.753536   -0.440295 
  H     -1.122251   -2.614659   -1.646266 
  H     -4.183363   -3.255666   -0.805310 
  H     -6.043067   -1.612544   -0.491772 
  H     -5.473098    0.755794    0.122920 
  H     -3.063747    1.370983    0.382798 
  H     -1.557048    2.064387   -1.814290 
  H     -0.001714    2.711503   -2.329897 
  H     -1.361424    3.819389   -2.076804 
  H     -0.403391   -0.585640   -4.897837 
  H     -0.082850    1.004750   -4.167230 
  H      0.951440    0.409457   -5.482822 
  H      1.133016   -2.535362   -4.427888 
  H      2.539701   -1.606409   -4.991813 
  H      2.548430   -2.317589   -3.364358 
  H      3.081802   -0.092425   -2.406846 
  H      2.965235    0.795358   -3.941173 
  H      1.941664    1.264278   -2.5675
181 
 
Table A2.3. DFT calculated Energies (eV) and Compositions (%) of O and N 2p-based MOs and 
the Mn 3d-based MOs of 1b. 




Mn 3d OOtBu N dpaq 
112     (Mn yz/pya) α 1 -10.3105 15.2 2.7 4.6 
116     (Mn xy/qna) α 1 -9.9976 26.7 1.8 9.9 
120     (Mn xz/xy) α 1 -9.7213 45.8 3.4 5.8 
121     (Mn xy) α 1 -9.6262 29 2 5.5 
136     (Mn x2-y2) α 1 -6.4694 35.6 4.2 34.2 
137     (Op) α 1 -6.3241 8.2 74.2 3.7 
139     (Mn z2) α 0 -2.7084 54.7 12.8 12.8 
        
127     (Op) β 1 -8.0848 2.2 58.7 7.6 
133     (Op) β 1 -6.4901 8.5 79.6 0.6 
135     (Mn xy/xz/qna) β 0 -2.633 26.9 0.5 9.3 
136     (Mn xz) β 0 -2.3198 56 4.8 6.1 
137     (Mn yz) β 0 -1.8989 54.6 8.8 8.1 
138     (Mn xy/yz) β 0 -1.6911 32.7 1.4 11.3 
139     (Mn xy) β 0 -1.6522 38.2 1.1 11 
140     (Mn xz/pya) β 0 -1.2709 22.5 1.4 13.3 
144     (Mn x2-y2) β 0 -0.6198 78.6 0.5 8.5 
145     (Mn z2) β 0 -0.5196 53.8 4.5 9.3 
146     (Mn z2/qna) β 0 -0.4665 27.8 2.8 8.6 
aqn = quinoline, py = pyridine 
 
 
Figure A2.18. Surface contour plots of -type Mn 3dyz (left) and 3dxz (right) MOs (isovalue = 
0.05) calculated for 1b showing minor alkylperoxo contributions. 
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Table A2.4. DFT calculated Energies (eV) and Compositions (%) of O and N 2p-based MOs and 
the Mn 3d-based MOs of 2b. 




Mn 3d OOtBu N dpaq 
113     (Mn yz) α 1 -10.5807 16.2 7.9 2.6 
114     (Mn xz) α 1 -10.528 16.1 2.8 7.1 
117     (Mn x2-y2/pya) α 1 -10.33 26.7 0.8 4.8 
120     (Mn xy) α 1 -9.9901 47.5 0.8 7.4 
122     (Mn yz) α 1 -9.8999 50 6.9 2.9 
129     (Mn xz/xy/Op) α 1 -8.8937 18.4 17.9 6 
133     (Mn xy/pya) α 1 -8.4342 20.3 8.1 26.7 
140     (Mn x2-y2) α 1 -6.6088 33.7 1.1 39.5 
141     (Op) α 1 -6.4684 5.9 37.5 4 
143     (Mn z2) α 0 -2.9457 55.3 13.1 16.4 
       
131     (Op) β 1 -8.0843 3.6 50.3 8.9 
137     (Op) β 1 -6.6203 7.6 76.5 0.2 
139     (Mn xz/xy/qna) β 0 -2.6198 31.4 0.9 8.3 
140     (Mn yz/xy) β 0 -2.4242 66.4 5.7 4.3 
141     (Mn xz/yz) β 0 -2.1 55.1 8.7 7.2 
142     (Mn xy) β 0 -1.8747 25.1 0.1 13.2 
143     (Mn xy) β 0 -1.7131 29.7 0.6 15.2 
144     (Mn xz/xy/pya) β 0 -1.3599 30.5 2.2 13.6 
148     (Mn x2-y2) β 0 -0.8508 71.4 0.8 8.5 
149     (Mn z2) β 0 -0.732 68.1 6.2 9.7 
aqn = quinoline, py = pyridine 
 
 





Figure A2.20. TD-DFT predicted electronic absorbtion spectrum of 2b showing a feature arising 
from a Mn 3dx2-y2 to 3dz2 transition (i), higher energy features arising from ligand-to-metal charge 
transfer from both dpaq and the alkylperoxo moiety to MnIII (ii), and higher intensity features 
















Table A2.5. TD-DFT Calculated Energies, Percent Contributions from Dominant One-electron 
Excitations, and Oscillator Strengths for the Major Electronic Transitions of 1b. 
 State Energy (cm-1)a ƒosc Transitionb % donor MO Acceptor MO comments 
 1 12600 0.001801 136a → 139a 75.3 Mn 3dx²-y² Mn 3dz² d-d 
   (794 nm)   137a → 139a 14.6 O1 py Mn 3dz²   
                 
i 2 15200 0.000748 136a → 139a 14.6 Mn 3dx²-y² Mn 3dz² LMCT 
    (658 nm)   137a → 139a 54.7 O1 py Mn 3dz²   
       138a → 139a 17.4 N px Mn 3dz²   
                 
 3 18200 0.001639 137a → 139a 17.6 O1 py Mn 3dz² LMCT 
   (549 nm)   138a → 139a 69.9 N px Mn 3dz²   
ii                 
 4 19200 0.000879 138a → 140a 38.1 N px C px LMCT 
    (520 nm)   134b → 135b 51.1 C px Mn 3dxy   
         
 5 21200 0.000157 133b → 135b 31.0 O1 py Mn 3dxy LMCT 
  (472 nm)  133b → 136b 56.1 O1 py Mn 3dxz  
                 
 6 22900 0.00270 133b → 135b 53.2 O1 py Mn 3dxy LMCT 
   (437 nm)    133b → 136b 28.6 O1 py Mn 3dxz   
         
iii 8 23900 0.009660 138a → 140a 16.2 N px C px LMCT 
    (418 nm)   134b → 136b 62.8 C px Mn 3dxz   
                 
 
14 28600 0.014191 129a → 139a 16.6 Mn 3dxy Mn 3dz² d-d 
    (350 nm)   133b → 137b 19.8 O1 py Mn 3dyz   










Table A2.6.  TD-DFT Calculated Energies, Percent Contributions from Dominant One-electron 
Excitations, and Oscillator Strengths for the Major Electronic Transitions of 2b. 
 State Energy (cm-1)a ƒosc Transitionb % donor MO acceptor MO Comments 
 1 12700 0.001248 140a → 143a 86.6 Mn 3 dx²-y² Mn 3dz² d-d 
  (787 nm)       
i         
 2 14200 0.001767 141a → 143a 50.6 O px Mn 3dz² LMCT 
  (704 nm)  142a -> 143a 35.4 N px Mn 3dz² 
 
          
 3 17300 0.002954 142a → 143a 54.6 N px Mn 3dz² LMCT 
  (578 nm)  141a → 143a 35.3 O px Mn 3dz² 
 
ii          
 4 19200 0.000827 142a → 144a 35.3 N px N px LMCT 
  (521 nm)  138b → 139b 48.5 C px Mn 3dyz/xz 
 
         
 6 22100 0.010782 138b → 140b 77.5 C px Mn 3dyz LMCT 
  (452 nm)       
         
 7 23800 0.012161 142a → 144a 14.5 N px N px LMCT 
  (420 nm)  137b → 139b 16.6 O px Mn 3dyz/xz 
 
iii    138b → 139b 21.1 C px Mn 3dyz/xz  
         
 9 24500 0.015256 137b → 139b 49.3 O px Mn 3dyz/xz LMCT 
  (408 nm)  137b → 140b 13.4 O px Mn 3dyz 
 
         
 11 26700 0.005050 133a → 143a 43.4 Mn 3dxy Mn 3dz² d-d 
  (375 nm)  120a → 143a 18.4 Mn 3dxy Mn 3dz² 
 













Figure A3.1. 1H NMR spectrum of H6Medpaq 
 




Figure A3.3. HSQC NMR of H6Medpaq. 
 




Figure A3.5. ESI-MS of [MnIII(OH)(6Medpaq)]+ in MeCN. 
 
 





Figure A3.7. Electronic absorption spectra obtained upon the addition of varying amounts of 
tBuOOH to a solution of [MnII(MeCN)(6Medpaq)]+ in MeCN at 293 K. Full formation of 
[MnIII(OOtBu)(6Medpaq)]+ is achieved upon the addition of 1.5 equivalents of  tBuOOH. 
 
 





Figure A3.9. Expanded view of the 0 – 12 ppm region of the 1H NMR spectra obtained following 
the thermal decay of [MnIII(OOtBu)(6Medpaq)]+ (blue trace) and the reaction of 
[MnIII(OOtBu)(6Medpaq)]+ with water (brown trace). 
 
Figure A3.10. Top: ESI-MS analysis of the thermal decay products of [MnIII(OOtBu)(6Medpaq)]+. 





Figure A3.11. 31P NMR analysis of the oxidation of PPh3 by [Mn
III(OOtBu)(6Medpaq)]+ in d3-
MeCN at 298 K. 
 
Figure A3.12. 1H-NMR analysis of the oxidation of 9,10-dihydroanthracene in the presence of 
[MnIII(OOtBu)(6Medpaq)]+ and O2 in d3-MeCN (6 mM) at 25°C. Quantification of products was 
obtained by using 1,4-benzoquinone (10 molar equivalent relative to starting MnII complex) as an 






Table A3.1. Cartesian coordinates (Å) for DFT energy minimized [MnII(NCMe)(6Medpaq)]+ 
model. 
Atom  x   y   z   
Mn  2.15602548217922      7.46295424269347      8.19202491377767 
  O   3.50770763845712      3.57175447202422      7.37581953820193 
  H   1.24391078981109      9.05306068889888     10.93025953793888 
  H   5.61121665559816      9.37150670068334     10.66699941412803 
  N   1.94449613915688      7.18996512944906     10.40336728178133 
  N   2.82620615657731      5.50318309118796      8.49240135372917 
  N   2.66463107128470      6.87513587657535      6.00951966927692 
  N   4.31065905016550      8.40870096248932      7.72185809800856 
  N   0.08618649542393      6.58316149103237      7.27573014903808 
  C   1.51780858599440      8.06089971638517     11.30183314303751 
  C   1.40567088378433      7.76155280307500     12.67365732986173 
  H   1.04812675284421      8.52142147120179     13.37107442280863 
  C   1.75544306038964      6.49541576210509     13.09997206019657 
  H   1.68148521412163      6.22121421995783     14.15603581331577 
  C   2.21599993782425      5.53031700591559     12.16788196679292 
  C   2.58587351257352      4.21180929186273     12.53959060180259 
  H   2.52041745135521      3.91047953602503     13.58759154593645 
  C   3.01968244897337      3.33573142186253     11.56518986886231 
  H   3.30534802442507      2.31717846183598     11.84108606933748 
  C   3.10909498259431      3.71273307019892     10.20567618639165 
  H   3.45244908577013      2.99735143450870      9.46197887423207 
  C   2.76347009219031      5.00021114433863      9.78352003095573 
  C   2.30202387888840      5.92685557371501     10.79171198152248 
  C   3.20586424850626      4.76175573008272      7.42551202419680 
  C   3.34773966645768      5.55271059160065      6.10552796756830 
  H   3.02685339526506      4.88986760896914      5.28648984009178 
  H   4.43000801908591      5.70345052823538      5.97304401146531 
  C   3.54603079904907      7.92056839255703      5.46302889177170 
  H   3.97764254720605      7.62867857885512      4.48790646420382 
  H   2.93018586516592      8.81749065683212      5.28122871246634 
  C   4.65071563062300      8.29734499536038      6.42493883329210 
  C   5.94121200482267      8.56253513709214      5.96442649658565 
  H   6.18078666817278      8.44653091038558      4.90548188357910 
  C   6.90845665019292      8.97389377680667      6.88191635111147 
  H   7.92911372518491      9.18933362251897      6.55645394534177 
  C   6.54938675426331      9.09893335507714      8.22116319105261 
  H   7.27919730881921      9.41689845264749      8.96797642564531 
  C   5.23724527737671      8.80271720523842      8.61767080916931 
  C   4.82556147024779      8.90313290458448     10.05920626761811 
  C   1.40550164239418      6.79870293689996      5.24885303322700 
  H   1.55083824278964      6.28747060641525      4.28008037480154 
194 
 
  H   1.08918546112329      7.83042803802915      5.02306414144507 
  C   0.28335716363725      6.14166695324974      6.01900976965485 
  C   -0.54479041327072      5.19524835121001      5.41780606248257 
  H   -0.34082873250596      4.85192047889950      4.40172200763710 
  C   -1.63588784437824      4.70663295353864      6.13945809550316 
  H   -2.30482408950039      3.96199344179977      5.70125671741943 
  C   -1.85867006131122      5.19292589853583      7.42330984995761 
  H   -2.71102273632153      4.84752550835660      8.01160092180582 
  C   -0.97320854588194      6.13377347567664      7.97290773469130 
  C   -1.18454576381744      6.65769404213062      9.36627603177769 
  H   3.90354720630522      9.49330905043215     10.16493472860039 
  H   4.62243737299525      7.90330650551495     10.47314610367208 
  H   -0.55846593464899      6.10618024167276     10.08531666814477 
  H   -0.91021698073491      7.71922512167019      9.43500735586743 
  H   -2.23185344982929      6.54097025107603      9.67826692735709 
  C   0.86494005136532     10.59393905624052      7.96153739898651 
  N   1.29847337926877      9.53373304638078      8.04866503166463 
  C   0.31316157983020     11.93491579455562      7.85051809197128 
  H   0.37612919180278     12.44876343635712      8.82199948628504 
  H   -0.74190468383347     11.88338146178019      7.54075129795379 




Table A3.2. Cartesian coordinates (Å) for XRD structure of [MnIII(OH)(6Medpaq)](OTf). 
Atom        x  y                  z                   
Mn      4.942504    1.025872    2.950393 
O       5.113484    1.483793    4.688828 
H       5.365861    2.229268    4.751408 
O       5.500008   -1.008284   -0.538879 
N       3.340021    2.172002    2.417424 
N       4.701950    0.405972    1.104413 
N       6.602738   -0.305757    2.863592 
N       3.997112   -0.973515    3.658584 
N       6.761895    2.428675    2.324713 
C       2.710215    3.065755    3.166060 
H       2.971687    3.177218    4.072304 
C       1.655232    3.860315    2.648041 
H       1.216413    4.496372    3.199668 
C       1.286897    3.698744    1.358207 
H       0.602523    4.249926    0.996637 
C       1.900788    2.719093    0.535403 
C       1.543822    2.435833   -0.813534 
H       0.882184    2.960427   -1.245796 
195 
 
C       2.144071    1.421414   -1.484525 
H       1.853041    1.208713   -2.364115 
C       3.194506    0.669803   -0.898132 
H       3.596946   -0.035791   -1.389497 
C       3.637872    0.954086    0.384748 
C       2.930761    1.960324    1.117160 
C       5.545481   -0.513345    0.579440 
C       6.673221   -0.900911    1.521609 
H       6.677769   -1.886697    1.616638 
H       7.532669   -0.639125    1.106730 
C       6.391286   -1.342674    3.922809 
H       6.582275   -0.947950    4.810511 
H       7.021093   -2.092240    3.777949 
C       4.972516   -1.867268    3.901949 
C       4.722413   -3.182331    4.209052 
H       5.438619   -3.791801    4.350436 
C       3.410505   -3.596484    4.307557 
H       3.201327   -4.492282    4.545127 
C       2.412364   -2.686370    4.054921 
H       1.502896   -2.962472    4.080416 
C       2.726130   -1.369261    3.762883 
C       7.835067    0.456080    3.201985 
H       8.628578   -0.089989    2.972527 
H       7.853256    0.624809    4.177762 
C       7.907824    1.754782    2.480003 
C       9.167437    2.290624    2.081348 
H       9.970043    1.791595    2.189124 
C       9.187900    3.550467    1.538993 
H      10.013243    3.937010    1.267815 
C       8.005592    4.262197    1.384862 
H       8.010139    5.132429    1.004749 
C       6.802821    3.670111    1.799741 
C       1.664326   -0.324164    3.577463 
H       1.803020    0.399837    4.222959 
H       0.782142   -0.726046    3.722323 
H       1.714347    0.034768    2.667742 
C       5.525018    4.455468    1.689647 
H       4.870201    3.944168    1.168151 
H       5.702364    5.309339    1.241160 











Table A3.3.  Crystal data and structure refinement for [Mn(OH)(C25H24N5O)][O3SCF3]. 
Identification code  v60d 
Empirical formula  C26 H25 F3 Mn N5 O5 S 
Formula weight  631.51 
Temperature  200(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 22.7367(9) Å α= 90°. 
 b = 10.2260(4) Å β= 90°. 
 c = 11.5888(4) Å γ = 90°. 
Volume 2694.46(18) Å3 
Z 4 
Density (calculated) 1.557 Mg/m3 
Absorption coefficient 5.315 mm-1 
F(000) 1296 
Crystal size 0.100 x 0.050 x 0.030 mm3 
Theta range for data collection 3.888 to 68.257°. 
Index ranges -26<=h<=24, -12<=k<=8, -13<=l<=13 
Reflections collected 9990 
Independent reflections 4121 [R(int) = 0.0477] 
Completeness to theta = 66.000° 99.5 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.699 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4121 / 1 / 378 
Goodness-of-fit on F2 1.162 
Final R indices [I>2sigma(I)] R1 = 0.0603, wR2 = 0.1696 
R indices (all data) R1 = 0.0659, wR2 = 0.1757 
Absolute structure parameter 0.082(14) 
Extinction coefficient 0.0012(4) 





Table A3.4. Cartesian coordinates (Å) for DFT energy minimized [MnIII(OOtBu)(6Medpaq)]+ 
model. 
Atom            x    y                    z                    
Mn  0.20788856685387     -0.06877261869516     -0.01971964192381 
  O   0.19885371085901     -0.15933770481435      1.81712414885873 
  O   0.58052633953373      1.14108597773279      2.39605864778137 
  O   0.90672330498638     -1.12865715155843     -3.90966205765125 
  N   -1.45684142992269      1.07365133218609     -0.24464378124565 
  N   0.02828819574899     -0.16728447541523     -1.97467718971810 
  N   1.83741786060127     -1.40740471659932     -0.38680489300892 
  N   -0.87804416763294     -2.21542646203937     -0.00963791635814 
  N   2.05762693840085      1.25247239360241     -0.07527568012501 
  C   -2.12970498557802      1.69747408518598      0.72206055738680 
  H   -1.71195145452423      1.61675134753181      1.72786735459437 
  C   -3.31155609469838      2.41950238703521      0.45438926184590 
  H   -3.83039639386978      2.91599203940850      1.27810449341117 
  C   -3.79522893520917      2.48094336041484     -0.84497702808377 
  H   -4.71400506433023      3.03009388368087     -1.07326930210411 
  C   -3.09454348326991      1.82637896568247     -1.89630968270667 
  C   -3.50242575393783      1.82195948574107     -3.26108878292065 
  H   -4.41484235001659      2.35192695537757     -3.54996410380613 
  C   -2.73478995850563      1.14546124532922     -4.19824946118130 
  H   -3.04607866491542      1.13902709213629     -5.24795535056745 
  C   -1.54558825945074      0.45353812164044     -3.84737728012931 
  H   -0.96488136251189     -0.06566917583334     -4.60924593725589 
  C   -1.11188151232541      0.43520615055110     -2.51737855738744 
  C   -1.90175874584403      1.12491098080579     -1.54396716092378 
  C   0.94123427229524     -0.88824564814082     -2.69507039609399 
  C   2.13423196364131     -1.33788728413477     -1.85416051878059 
  H   2.51102763579265     -2.30675912089936     -2.21782099860613 
  H   2.93000272524082     -0.59186382212491     -2.01256024122496 
  C   1.45733072477176     -2.78869455727618      0.02523948774553 
  H   1.49699515091454     -2.81629624277177      1.12556878532123 
  H   2.18224950588466     -3.51865830407298     -0.36994656988776 
  C   0.05162313797589     -3.11531053007874     -0.40666780765804 
  C   -0.27552531860913     -4.28279967492528     -1.09712403726994 
  H   0.51005472732023     -4.97659668581890     -1.40862788169109 
  C   -1.62863210236687     -4.53800818194086     -1.36472700015796 
  H   -1.92656833527487     -5.43771784487540     -1.91181873793046 
  C   -2.58979718365490     -3.63898694623947     -0.90110478930203 
  H   -3.65585180004173     -3.82718854301669     -1.05824877169233 
  C   -2.18738866770021     -2.47667608386328     -0.21333470018957 
  C   2.98520603152837     -0.92647339550133      0.42851259348390 
198 
 
  H   3.90766872444472     -1.47478363782696      0.17324823959324 
  H   2.74203677349919     -1.13529044468686      1.48290871065489 
  C   3.16878424909834      0.55826219446276      0.24306094272392 
  C   4.41060111469390      1.17517561386782      0.42396929226151 
  H   5.29011179092805      0.57420350770622      0.67025034140863 
  C   4.48903409157460      2.56388104052706      0.27827890832702 
  H   5.44185291452171      3.08406871966001      0.41621823020434 
  C   3.33529989925165      3.27720067337239     -0.06253999502472 
  H   3.36620698450704      4.36150010567823     -0.20009441688364 
  C   2.12161679465832      2.59445520704301     -0.24119534350879 
  C   -3.20393226764729     -1.51375369181876      0.33639259236694 
  H   -2.79353345799657     -0.96886767037659      1.19849746241080 
  H   -4.11092809777345     -2.05538935534780      0.64989897672459 
  H   -3.51368747498270     -0.78147575931671     -0.43004153184853 
  C   0.85846728629360      3.31857184632367     -0.60661620595893 
  H   0.36822054879245      2.83884241372617     -1.46948540855704 
  H   1.06796474574749      4.36870544001288     -0.85862848073187 
  H   0.14946746160680      3.30185623630354      0.23874184328402 
  C   0.73257498231338      0.98253784117370      3.84426162207099 
  C   -0.60021393070324      0.55441989590626      4.46705496431330 
  C   1.85524970860265     -0.01536888497647      4.14583477895792 
  C   1.12062964340263      2.40719769855560      4.25787455964562 
  H   -0.50463309208562      0.48508487793548      5.56467636541621 
  H   -1.39203728249467      1.28800907368860      4.23518587431727 
  H   -0.90904675091583     -0.43152612085403      4.08281503710602 
  H   1.59496907680015     -1.01877420480660      3.77118588375308 
  H   2.79922257722715      0.30916152350248      3.67575546386125 
  H   2.01809156846153     -0.08674585184023      5.23530146771773 
  H   2.05472387512379      2.71781246434636      3.75967859932327 
  H   0.32338902060931      3.12309184284655      3.99457515420106 




Table A3.5. Comparison EXAFS data fits within different k ranges for 10 mM MeCN solution of 
1. 
k range 
Mn-N/O Mn-N Mn-C 
Goodness of 
fitb 
n r (Å) σ2 n r (Å) σ2 n r (Å) σ2 
 
2-12 2 2.00 0.008 4 2.34 0.006 6 2.93 0.005 0.278 
2-13 2 2.00 0.014 3 2.35 0.002 6 2.91 0.006 0.369 
3-13 2 2.00 0.011 3 2.34 0.004 6 2.91 0.005 0.381 
 
 
